
<html lang="en"     class="pb-page"  data-request-id="d98704da-8db8-445c-abe3-f31196210452"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm5017279;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-4"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 4′-Chloromethyl-2′-deoxy-3′,5′-di-O-isobutyryl-2′-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection" /></meta><meta name="dc.Creator" content="Guangyi  Wang" /></meta><meta name="dc.Creator" content="Jerome  Deval" /></meta><meta name="dc.Creator" content="Jin  Hong" /></meta><meta name="dc.Creator" content="Natalia  Dyatkina" /></meta><meta name="dc.Creator" content="Marija  Prhavc" /></meta><meta name="dc.Creator" content="Joshua  Taylor" /></meta><meta name="dc.Creator" content="Amy  Fung" /></meta><meta name="dc.Creator" content="Zhinan  Jin" /></meta><meta name="dc.Creator" content="Sarah K.  Stevens" /></meta><meta name="dc.Creator" content="Vladimir  Serebryany" /></meta><meta name="dc.Creator" content="Jyanwei  Liu" /></meta><meta name="dc.Creator" content="Qingling  Zhang" /></meta><meta name="dc.Creator" content="Yuen  Tam" /></meta><meta name="dc.Creator" content="Sushmita M.  Chanda" /></meta><meta name="dc.Creator" content="David B.  Smith" /></meta><meta name="dc.Creator" content="Julian A.  Symons" /></meta><meta name="dc.Creator" content="Lawrence M.  Blatt" /></meta><meta name="dc.Creator" content="Leo  Beigelman" /></meta><meta name="dc.Description" content="Respiratory syncytial virus (RSV) is a leading pathogen of childhood and is associated with significant morbidity and mortality. To date, ribavirin is the only approved small molecule drug, which h..." /></meta><meta name="Description" content="Respiratory syncytial virus (RSV) is a leading pathogen of childhood and is associated with significant morbidity and mortality. To date, ribavirin is the only approved small molecule drug, which h..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 10, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5017279" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5017279" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5017279" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5017279" /></link>
        
    
    

<title>Discovery of 4′-Chloromethyl-2′-deoxy-3′,5′-di-O-isobutyryl-2′-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5017279" /></meta><meta property="og:title" content="Discovery of 4′-Chloromethyl-2′-deoxy-3′,5′-di-O-isobutyryl-2′-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0013.jpeg" /></meta><meta property="og:description" content="Respiratory syncytial virus (RSV) is a leading pathogen of childhood and is associated with significant morbidity and mortality. To date, ribavirin is the only approved small molecule drug, which has limited use. The only other RSV drug is palivizumab, a monoclonal antibody, which is used for RSV prophylaxis. Clearly, there is an urgent need for small molecule RSV drugs. This article reports the design, synthesis, anti-RSV activity, metabolism, and pharmacokinetics of a series of 4′-substituted cytidine nucleosides. Among tested compounds 4′-chloromethyl-2′-deoxy-2′-fluorocytidine (2c) exhibited the most promising activity in the RSV replicon assay with an EC50 of 0.15 μM. The 5′-triphosphate of 2c (2c-TP) inhibited RSV polymerase with an IC50 of 0.02 μM without appreciable inhibition of human DNA and RNA polymerases at 100 μM. ALS-8176 (71), the 3′,5′-di-O-isobutyryl prodrug of 2c, demonstrated good oral bioavailability and a high level of 2c-TP in vivo. Compound 71 is a first-in-class nucleoside RSV polymerase inhibitor that demonstrated excellent anti-RSV efficacy and safety in a phase 2 clinical RSV challenge study." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5017279"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5017279">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5017279&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5017279&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5017279&amp;href=/doi/10.1021/jm5017279" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1862-1878</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501680m" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501760d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 4′-Chloromethyl-2′-deoxy-3′,5′-di-<i>O</i>-isobutyryl-2′-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guangyi++Wang">Guangyi Wang</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jerome++Deval">Jerome Deval</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Hong">Jin Hong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natalia++Dyatkina">Natalia Dyatkina</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marija++Prhavc">Marija Prhavc</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joshua++Taylor">Joshua Taylor</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy++Fung">Amy Fung</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhinan++Jin">Zhinan Jin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+K.++Stevens">Sarah K. Stevens</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vladimir++Serebryany">Vladimir Serebryany</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jyanwei++Liu">Jyanwei Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qingling++Zhang">Qingling Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuen++Tam">Yuen Tam</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sushmita+M.++Chanda">Sushmita M. Chanda</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+B.++Smith">David B. Smith</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julian+A.++Symons">Julian A. Symons</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence+M.++Blatt">Lawrence M. Blatt</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leo++Beigelman">Leo Beigelman</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div><div class="corresp-info"><strong>*</strong>For G.W.: phone, 650-635-5506; E-mail, <a href="/cdn-cgi/l/email-protection#234454424d4463424f4a4c50414a4c534b42514e420d404c4e"><span class="__cf_email__" data-cfemail="e08797818e87a0818c898f9382898f908881928d81ce838f8d">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For L.B.: phone, 650-635-5508; E-mail, <a href="/cdn-cgi/l/email-protection#650907000c02000908040b2504090c0a16070c0a150d041708044b060a08"><span class="__cf_email__" data-cfemail="d2beb0b7bbb5b7bebfb3bc92b3bebbbda1b0bbbda2bab3a0bfb3fcb1bdbf">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5017279&amp;href=/doi/10.1021%2Fjm5017279" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1862–1878</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 10, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 November 2014</li><li><span class="item_label"><b>Published</b> online</span>10 February 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 February 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5017279" title="DOI URL">https://doi.org/10.1021/jm5017279</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1862%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGuangyi%2BWang%252C%2BJerome%2BDeval%252C%2BJin%2BHong%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D4%26contentID%3Djm5017279%26title%3DDiscovery%2Bof%2B4%25E2%2580%25B2-Chloromethyl-2%25E2%2580%25B2-deoxy-3%25E2%2580%25B2%252C5%25E2%2580%25B2-di-O-isobutyryl-2%25E2%2580%25B2-fluorocytidine%2B%2528ALS-8176%2529%252C%2BA%2BFirst-in-Class%2BRSV%2BPolymerase%2BInhibitor%2Bfor%2BTreatment%2Bof%2BHuman%2BRespiratory%2BSyncytial%2BVirus%2BInfection%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1878%26publicationDate%3DFebruary%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5017279"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3803</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">78</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5017279" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 4′-Chloromethyl-2′-deoxy-3′,5′-di-O-isobutyryl-2′-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Guangyi&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jerome&quot;,&quot;last_name&quot;:&quot;Deval&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;Natalia&quot;,&quot;last_name&quot;:&quot;Dyatkina&quot;},{&quot;first_name&quot;:&quot;Marija&quot;,&quot;last_name&quot;:&quot;Prhavc&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;Taylor&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;Fung&quot;},{&quot;first_name&quot;:&quot;Zhinan&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;K. Stevens&quot;},{&quot;first_name&quot;:&quot;Vladimir&quot;,&quot;last_name&quot;:&quot;Serebryany&quot;},{&quot;first_name&quot;:&quot;Jyanwei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Qingling&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Yuen&quot;,&quot;last_name&quot;:&quot;Tam&quot;},{&quot;first_name&quot;:&quot;Sushmita&quot;,&quot;last_name&quot;:&quot;M. Chanda&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;B. Smith&quot;},{&quot;first_name&quot;:&quot;Julian&quot;,&quot;last_name&quot;:&quot;A. Symons&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;M. Blatt&quot;},{&quot;first_name&quot;:&quot;Leo&quot;,&quot;last_name&quot;:&quot;Beigelman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;1862-1878&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5017279&quot;},&quot;abstract&quot;:&quot;Respiratory syncytial virus (RSV) is a leading pathogen of childhood and is associated with significant morbidity and mortality. To date, ribavirin is the only approved small molecule drug, which has limited use. The only other RSV drug is palivizumab, a monoclonal antibody, which is used for RSV prophylaxis. Clearly, there is an urgent need for small molecule RSV drugs. This article reports the design, synthesis, anti-RSV activity, metabolism, and pharmacokinetics of a series of 4′-substituted cytidine nucleosides. Among tested compounds 4′-chloromethyl-2′-deoxy-2′-fluorocytidine (2c) exhibited the most promising activity in the RSV replicon assay with an EC50 of 0.15 μM. The 5′-triphosphate of 2c (2c-TP) inhibited RSV polymerase with an IC50 of 0.02 μM without appreciable inhibition of human DNA and RNA polymerases at 100 μM. ALS-8176 (71), the 3′,5′-di-O-isobutyryl prodrug of 2c, demonstrated good oral bioavailability and a high level of 2c-TP in vivo. Compound 71 is a first-in-class nucleoside RSV polymer&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5017279&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017279" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5017279&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017279" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5017279&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017279" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5017279&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017279&amp;href=/doi/10.1021/jm5017279" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5017279" /></input><a href="/doi/pdf/10.1021/jm5017279" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5017279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5017279%26sid%3Dliteratum%253Aachs%26pmid%3D25667954%26genre%3Darticle%26aulast%3DWang%26date%3D2015%26atitle%3DDiscovery%2Bof%2B4%25E2%2580%25B2-Chloromethyl-2%25E2%2580%25B2-deoxy-3%25E2%2580%25B2%252C5%25E2%2580%25B2-di-O-isobutyryl-2%25E2%2580%25B2-fluorocytidine%2B%2528ALS-8176%2529%252C%2BA%2BFirst-in-Class%2BRSV%2BPolymerase%2BInhibitor%2Bfor%2BTreatment%2Bof%2BHuman%2BRespiratory%2BSyncytial%2BVirus%2BInfection%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D4%26spage%3D1862%26epage%3D1878%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291594" title="Silica">Silica</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jmcmar.2015.58.issue-4/20150226/jmcmar.2015.58.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Respiratory syncytial virus (RSV) is a leading pathogen of childhood and is associated with significant morbidity and mortality. To date, ribavirin is the only approved small molecule drug, which has limited use. The only other RSV drug is palivizumab, a monoclonal antibody, which is used for RSV prophylaxis. Clearly, there is an urgent need for small molecule RSV drugs. This article reports the design, synthesis, anti-RSV activity, metabolism, and pharmacokinetics of a series of 4′-substituted cytidine nucleosides. Among tested compounds 4′-chloromethyl-2′-deoxy-2′-fluorocytidine (<b>2c</b>) exhibited the most promising activity in the RSV replicon assay with an EC<sub>50</sub> of 0.15 μM. The 5′-triphosphate of <b>2c</b> (<b>2c</b>-<b><b>TP</b></b>) inhibited RSV polymerase with an IC<sub>50</sub> of 0.02 μM without appreciable inhibition of human DNA and RNA polymerases at 100 μM. ALS-8176 (<b>71</b>), the 3′,5′-di-<i>O</i>-isobutyryl prodrug of <b>2c</b>, demonstrated good oral bioavailability and a high level of <b>2c</b>-<b>TP</b> in vivo. Compound <b>71</b> is a first-in-class nucleoside RSV polymerase inhibitor that demonstrated excellent anti-RSV efficacy and safety in a phase 2 clinical RSV challenge study.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human respiratory syncytial virus (RSV) is a negative-sense, single-stranded RNA virus and a member of the <i>Paramyxoviridae</i> family.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The 15.2-kb genomic RNA contains 10 genes, four of which code for intracellular proteins that are involved in genome transcription, replication, and particle budding and have orthologues in all members of the Mononegavirales, namely N (nucleoprotein), P (phosphoprotein), M (matrix protein), and L (“large” protein, containing the RNA polymerase catalytic motifs).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> RSV is among the most important pathogens of childhood and is associated with significant morbidity and mortality. RSV causes common cold symptoms in most patients. In vulnerable children, RSV can progress to bronchiolitis and/or pneumonia with an increased chance of significant morbidity or death.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> By 2 years of age, most children have developed this infection at least once, which is associated with approximately 24 hospitalizations per 1000 infants and 1 million deaths worldwide per year.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Previous infections do not lead to persistent immunity, and reinfection is common. The primary therapy for RSV is supportive in nature and is comprised of measures to ensure adequate oxygenation and maintenance of appropriate fluid and nutritional requirements. No vaccine currently exists for active prophylaxis against RSV. To date, the only safe and efficacious approach to RSV prophylaxis is the humanized monoclonal antibody palivizumab, which is largely restricted to infants with an increased risk of hospitalization due to RSV infection. Ribavirin (1-β-<span class="smallcaps smallerCapital">d</span>-ribofuranosyl-1,2,4-triazole-3-carboxamide) is the only small molecule drug approved for use against RSV infection. It has a restricted utility due to its controversial efficacy, toxicity, and requirement of special equipment for administration.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Undoubtedly, there is an urgent, unmet medical need for new RSV therapeutics.</div><div class="NLM_p">In the last two decades, a number of highly potent RSV entry inhibitors targeting the F protein have been reported, with EC<sub>50</sub> values in the nano- or picomolar range, suggesting considerable potential for further development as novel anti-RSV therapeutics.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Several of these compounds have successfully completed preclinical and early clinical studies, but they have not progressed to late stage human clinical trials.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> However, recently, GS-5806 completed an RSV phase 2 challenge study. The results showed that GS-5806 significantly reduced viral load and clinical symptoms, thus demonstrating proof of concept for small molecule entry inhibitors in RSV treatment.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> A siRNA agent (ALN-RSV01) administered as an inhaled drug was reported to have shown promising anti-RSV activity but subsequently failed to achieve its primary end point in a phase 2b clinical trial.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Another class of small molecule anti-RSV compounds are the inhibitors of transcription and replication of the viral genome. Liuzzi and co-workers reported a series of compounds that blocked cotranscriptional mRNA guanylylation by the viral RNA-dependent RNA polymerase.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Sudo and co-workers reported another series of compounds represented by YM-53403 that inhibited the replication of RSV in plaque reduction assays.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Resistance studies showed that YM-53403 targeted the viral RNA polymerase L protein, which catalyzes the transcription and replication of the viral genome. Very recently, new analogues of YM-53403 were reported to be significantly more potent in vitro and investigated in preclinical studies.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> To date, compounds in this class have not yet entered clinical studies.</div><div class="NLM_p">Ribavirin, the only approved small molecule RSV drug, is a broad-spectrum antiviral agent and active against a wide range of RNA viruses. Although the precise mechanism of action for ribavirin inhibiting viral replication has not been established, it is commonly accepted that the compound may have multiple mechanisms of action, of which viral mutagenesis and inhibition of IMPDH are well documented.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> Although ribavirin 5′-triphosphate is the substrate of several viral polymerases, it is unlikely that inhibition of viral polymerases is a primary mechanism of action for antiviral activity as no significant viral polymerase inhibition by ribavirin triphosphate has been reported. In contrast, most antiviral nucleoside drugs in clinical use are known to target viral polymerases of DNA or retro viruses such as HIV, HBV, and herpes viruses or of RNA viruses such as HCV. Potent inhibition of a viral polymerase is well-known to efficiently shut down viral replication and thus represents a clinically validated approach to control viral infections.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> A safe and efficacious antiviral nucleoside has to satisfy three main criteria: (a) be a potent inhibitor of the viral polymerase, (b) do not inhibit host DNA or RNA polymerases, including mitochondrial enzymes, and (c) be efficiently phosphorylated by host kinases to generate high levels of active nucleoside 5′-triphosphate in target tissues. The majority of currently approved antiviral nucleoside drugs inhibit viral polymerases by a chain termination mechanism where the nucleoside analogue is efficiently incorporated into a growing DNA (or RNA) chain and then prevents subsequent nucleotide incorporation, thus “chain terminating” viral genome replication. Structurally, the chain termination mechanism stems usually from unique sugar modification(s) of the terminating nucleoside analogue that is (are) typically highly specific for the particular class of viral polymerases.</div><div class="NLM_p">In search of effective nucleoside RSV polymerase inhibitors, we focused more on sugar-modified nucleosides that have the potential to inhibit RSV polymerase activity by chain termination. Thus, a large number (>100) of structurally diverse, novel sugar-modified nucleosides were designed and prepared for screening in cell-based RSV assays. In addition, we also converted the above nucleoside analogues to their respective 5′-triphosphates and screened the resulting NTP library in an inhibition assay of RNA synthesis by RSV RNA dependent RNA polymerase. In the initial phenotypic screening, only one compound, 4′-azido-2′-deoxy-2′,2′-difluorocytidine (<b>1a</b>), exhibited potent inhibition of RSV-induced cytopathic effect against the RSV Long strain, with an EC<sub>50</sub> of 1 μM. Furthermore, the corresponding triphosphate was identified as a potent RSV polymerase inhibitor with an IC<sub>50</sub> of 0.3 μM. Later, the nucleoside was shown to also inhibit the RSV A2 strain in an RSV replicon system, with an EC<sub>50</sub> of 0.75 μM. We were encouraged by the initial anti-RSV results but also noted that a 4′-azido nucleoside could be a potential safety concern as RG-1626, a 4′-azidocytidine prodrug, caused severe adverse effects in phase 2 clinical trials that were halted.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In addition to the 4′-azido group, the 2′,2′-difluororibose sugar moiety of <b>1a</b> was another potential concern as it exists in gemcitabine, a well-known cytotoxic compound. Our initial optimization was focused on the 2′-position of the sugar while the 4′-azido group remained intact. After testing a series of 2′-modified 4′-azidocytidines, 2-deoxy-2-fluororibofuranose was selected as a preferred sugar template because 4′-azido-2′-deoxy-2′-fluorocytidine (<b>1d</b>) exhibited potent anti-RSV activity with a good selectivity window. Subsequently, an intensive optimization was focused on replacement of the 4′-azido group, which resulted in discovery of <b>2c</b>, a potent, selective RSV polymerase inhibitor, and its 3′,5′-di-<i>O</i>-isobutyryl derivative (<b>71</b>) as an oral prodrug. Compound <b>71</b> is a first-in-class nucleoside inhibitor of RSV infection in phase 2 clinical trials that demonstrated excellent anti-RSV efficacy and safety.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In this article, we report synthesis, in vitro activity, metabolism, and pharmacokinetics of compounds <b>1</b>–<b>3</b> as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and ester prodrugs of <b>2c</b> (Schemes <a class="ref internalNav" href="#sch7" aria-label="7">7</a>–<a class="ref internalNav" href="#sch9" aria-label="9">9</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. RSV nucleoside inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41062" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41062" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>1b</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a><b>1c</b>,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a><b>1a</b>, and <b>1d</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> were prepared by procedures similar to those published. Synthesis of compounds <b>2a</b>–<b>e</b> is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Commercially available 2′-deoxy-2′-fluorouridine (<b>4</b>) was converted to the 3′-<i>O</i>-TBS derivative <b>5</b> via three standard protection and deprotection steps. Oxidation of the 5′-hydroxyl of <b>5</b>, the subsequent aldol reaction, and reduction afforded the diol <b>7</b>. Compound <b>7</b> was selectively tritylated at the 4′-hydroxymethyl group on the α-face of the sugar, and the resulting <b>8</b> was isolated in 63% yield after purification by chromatography. Such selectivity was well documented and applied to both purine and pyrimidine nucleosides.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> Compound <b>8</b> was protected with TBDPS at the 5′-hydroxyl, and the resulting <b>9</b> was detritylated to yield the 4′-hydroxymethyl derivative <b>10</b>, which served as a common intermediate for several desired cytidine analogues. Iodination of <b>10</b> with Ph<sub>3</sub>P and iodine, followed by hydrogenolysis, yielded the 4′-methyl uridine <b>11</b>. Chlorination of <b>10</b> with Ph<sub>3</sub>P and CCl<sub>4</sub> yielded the 4′-chloromethyl uridine <b>12</b>. Oxidation of <b>10</b> and the subsequent Wittig reaction afforded the 4′-vinyl uridine <b>13</b>, which was further converted to the 4′-cyclopropyluridine <b>14</b> with diazomethane. The uridines <b>11</b>, <b>12</b>, <b>13</b>, and <b>14</b> were then converted to the cytidines <b>15</b>, <b>16</b>, <b>17</b>, and <b>19</b>, respectively, in good yields by <i>O</i><sup>4</sup>-sulfonation and the subsequent ammonia treatment. Further desilylation with ammonium fluoride afforded the desired cytidine analogues <b>2a</b>, <b>2c</b>, <b>2e</b>, and <b>2j</b>. Compound <b>2f</b> was prepared by hydrogenation of <b>17</b> and the subsequent desilylation. Compound <b>2b</b> was prepared from <b>9</b> by a multistep conversion. The uracil base of <b>9</b> was protected by 4-methoxybenzyl (PMB), and then the 3′,5′-<i>O</i>-silyl groups were removed. The resulting <b>20</b> was subjected to benzylation at the 3′- and 5′-hydroxyls and detritylation and fluorination at the 4′-position to afford the 4′-fluoromethyl derivative <b>21</b>. After removal of PMB protecting group, the resulting <b>22</b> was converted to the cytidine by the standard method as shown above, which was then protected by MMTr at the <i>N</i><sup>4</sup>-position of the base to facilitate the product purification on silica gel. Debenzylation of <b>23</b>, followed by acidic hydrolysis, afforded the desired <b>2b</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) DMTrCl, py, (ii) TBSCl, imidazole, DCM, (iii) 80% AcOH, 89% (3 steps); (b) IBX, CH<sub>3</sub>CN, reflux; (c) (i) 37% CH<sub>2</sub>O, NaOH, 1,4-dioxane, (ii) NaBH<sub>4</sub>, 36% (3 steps); (d) DMTrCl, py; 63%; (e) TBDPSCl, imidazole, DCM; (f) 80% AcOH, 72% (2 steps); (g) (i) Ph<sub>3</sub>P, I<sub>2</sub>, imidazole, 80 °C, THF, 43%, (ii) H<sub>2</sub>, 10% Pd/C, TEA, EtOH, 95% of <b>11</b>; (h) Ph<sub>3</sub>P, CCl<sub>4</sub>, DCE, 130 °C, MW, 69% of <b>12</b>; (i) (i) DMP, DCM, (ii) Ph<sub>3</sub>P═CH<sub>2</sub>, THF, 71% of <b>13</b> (2 steps); (j) (i) BzCl, DMAP, TEA, DCM, (ii) CH<sub>2</sub>N<sub>2</sub>, Pd(OAc)<sub>2</sub>, DCM, (iii) NH<sub>3</sub>, MeOH, 28% (3 steps); (k) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, then NH<sub>3</sub>; (l) H<sub>2</sub>, Pd/C, MeOH, 91%; (m) NH<sub>4</sub>F, MeOH, reflux, 22% of <b>2a</b> (2 steps from <b>11</b>), 42% of <b>2c</b> (2 steps from <b>12</b>), 63% of <b>2e</b> (2 steps from <b>13</b>), 62% of <b>2f</b> (2 steps from <b>17</b>), 24% of <b>2j</b> (2 steps from <b>14</b>); (n) (i) PMBCl, K<sub>2</sub>CO<sub>3</sub>, DMF, 75%, (ii) TBAF, THF, 82%; (o) (i) BnBr, NaH, THF, 79%, (ii) Same as f, 73%, (iii) DAST, toluene, 60 °C, 45%; (p) CAN, CH<sub>3</sub>CN, 50%, (q) (i) same as k, (ii) same as d, 40% (2 steps); (r) (i) ammonium formate, 10% Pd/C, acetone, reflux, 68%, (ii) 80% HCOOH, 50 °C, 72%.</p></p></figure><div class="NLM_p">Synthesis of <b>2d</b>, <b>2k</b>, <b>3a</b>, and <b>3b</b> is shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. 2′-Deoxyuridines <b>4</b>, <b>24</b>, and <b>25</b> were converted to <b>29</b>–<b>31</b>, respectively, in the same manner as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. After reaction with triflic anhydride, the resulting bis-triflates <b>32</b>–<b>34</b> were treated with sodium hydride to yield the 2,5′-anhydrouridines <b>35</b>–<b>37</b>, respectively. Reaction of <b>35</b> with lithium bromide, followed by alkaline hydrolysis, gave the 4′-bromomethyluridine <b>38</b> while reaction of <b>35</b> with NaSCH<sub>3</sub> yielded the 4′-methylthiomethyluridine <b>39</b>. Clearly, the intermediate <b>35</b> led to a more efficient synthetic route for the 4′-substituted nucleosides. Under the reaction conditions used, bromide selectively replaced the 4′-triflate with the anhydro-ring intact. After tritylation at the 5′-OH of <b>38</b> and <b>39</b>, the resulting uridines <b>42</b> and <b>43</b> were converted to the desired cytidines <b>2d</b> and <b>2k</b>, respectively, by the standard method as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Reaction of the triflates <b>36</b> and <b>37</b> with LiCl, followed by a sequence of treatments similar to those described for <b>35</b>, gave the desired cytidines <b>3a</b> and <b>3b</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) TBDPSCl, py, (ii) MMTrCl, AgNO<sub>3</sub>, collidine, DCM, (iii) TBAF, THF, 86% of <b>26</b> from <b>4</b>, 82% of <b>27</b> from <b>24</b>, 29% of <b>28</b> from <b>25</b>; (b) (i) DMP, py, DCM, (ii) 37% HCHO, NaOH, 1,4-dioxane, 63% of <b>29</b> from <b>26</b>, 56% of <b>30</b> from <b>27</b>, 51% of <b>31</b> from <b>28</b>; (c) Tf<sub>2</sub>O, py, DCM, −35 °C, 88% of <b>32</b>, 70% of <b>33</b>, 67% of <b>34</b>; (d) NaH, DMF, 0 °C; (e) (i) LiBr, DMF, (ii) NaOH, H<sub>2</sub>O, THF, 0 °C, 59% of <b>38</b> (3 steps); (f) NaSMe, DMF, 15-crown-5, 59% of <b>39</b> (2 steps from <b>32</b>); (g) (i) LiCl, DMF, (ii) NaOH, H<sub>2</sub>O, THF, 0 °C, 83% of <b>40</b> from <b>33</b>, 72% of <b>41</b> from <b>34</b>; (h) MMTrCl, AgNO<sub>3</sub>, collidine, DCM, 73% of <b>42</b>, 66% of <b>43</b>; (i) TBSCl, py, 60% of <b>44,</b> 90% of <b>45</b>; (j) (i) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, (ii) aq NH<sub>3</sub>, (iii) 80% AcOH, 60 °C, 22% of <b>2d</b> (3 steps), 43% of <b>2k</b> (3 steps); (k) (i) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, then NH<sub>3</sub>, (ii) MMTrCl, AgNO<sub>3</sub>, collidine, DCM, (iii) TBAF, THF, (iv) 80% AcOH, 45% of <b>3a</b> from <b>44</b>; (l) (i) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, then NH<sub>3</sub>, (ii) 80% HCOOH, 49% of <b>3b</b> from <b>45</b>.</p></p></figure><div class="NLM_p">Synthesis of the 4′-ethynyl derivative <b>2g</b> started with 2′-deoxy-2′-fluorocytidine (<b>46</b>) as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The standard protection and deprotection of <b>46</b> by a similar method as shown for <b>26</b> gave the 3′-<i>O</i>,<i>N</i><sup>4</sup>-bis-MMTr derivative <b>47</b>, which was converted to the diol <b>48</b> in the same manner as shown in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The selective silylation at the 4′-hydroxymethyl of <b>48</b>, followed by tritylation at the 5′-OH and the subsequent desilylation, afforded the 4′-hydroxymethyl derivative <b>49</b>. The silylation of <b>48</b> had only moderate selectivity on the 4′-α-hydroyxmethyl, which led to <b>49</b> in relatively low yield. Conversion of the 4′-hydroxymethyl of <b>49</b> to the 4′-ethynyl was achieved by treatment of a chlorovinyl Wittig product with BuLi.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Detritylation of the resulting <b>50</b> afforded the desired 4′-ethynylcytidine <b>2g</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) TBSCl, py, (ii) MMTrCl, AgNO<sub>3</sub>, collidine, DCM, (iii) TBAF, THF, 66% (3 steps); (b) (i) DMSO, EDCI, TFA, py, (ii) 37% HCHO, NaOH, 1,4-dioxane, overnight, then NaBH<sub>4</sub>, 60% (2 steps); (c) same as (a), 28% (3 steps); (d) (i) DMP, DCM, (ii) Ph<sub>3</sub>P═CHCl, THF, (iii) BuLi, THF, −78 °C, 61% (3 steps); (e) 80% AcOH, 40 °C, 45%.</p></p></figure><div class="NLM_p">An alternative approach for derivatization at the 4′-position was explored in the synthesis of <b>2h</b> and <b>2i</b>, as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> where <b>4</b> was converted to the 4′,5′-olefinic intermediate <b>51</b> via 2′,5′-didexoy-2′-fluoro-5′-iodouridine. After protection of the 3′-OH with TBS, the olefin was oxidized to the epoxide <b>52</b>. Compound <b>53</b> was prepared from <b>52</b> by a selective allylation similar to that for synthesis of a ribonucleoside.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Conversion of the uridine <b>53</b> to the cytidine <b>55</b> was achieved by the standard method as shown in earlier schemes. After protection of the cytosine base with MMTr, the resulting <b>56</b> was hydrogenated to give the 4′-propyl derivative <b>57</b>. Desilylation of <b>55</b> and <b>57</b> yielded <b>2h</b> and <b>58</b>, respectively. Detritylation of <b>58</b> afforded <b>2i</b> in good yield.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) I<sub>2</sub>, Ph<sub>3</sub>P, imidazole, THF, (ii) DBU, THF, 60 °C, 47% (2 steps); (b) (i) TBSCl, imidazole, DCM, 71%, (ii) DMDO in acetone, DCM; (c) allyl-TMS, SnCl<sub>4</sub>, DCM, −40 to 0 °C, 41% (2 steps); (d) TBSCl, imidazole, DCM; (e) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, overnight, then aq NH<sub>3</sub>, 69% (2 steps); (f) NH<sub>4</sub>F, MeOH, reflux, 50%; (g) MMTrCl, AgNO<sub>3</sub>, collidine, DCM, 76%; (h) H<sub>2</sub>, 10% Pd/C, 84%; (i) TBAF, THF, 74%; (j) 80% HCOOH, 65%.</p></p></figure><div class="NLM_p">The 4′-OMe cytidine <b>2l</b> was prepared from the olefinic intermediate <b>51</b> as shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Treatment of <b>51</b> with iodine and PbCO<sub>3</sub> in methanol<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> yielded the 4′-methoxy derivative <b>59</b> in good yield. After 3′- and 5′-benzoylation, the resulting uridine <b>61</b> was converted to the cytidine by the standard method as shown above. Compound <b>61</b> was further benzoylated on the base for facilitating the product purification on silica gel. Finally, treatment of well-purified <b>62</b> with ammonia afforded the desired <b>2l</b> in good yield.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) I<sub>2</sub>, PbCO<sub>3</sub>, MeOH, 72%; (b) BzCl, py; (c) NaOBz, 15-crown-5, DMF 70 °C, 35% (2 steps); (d) (i) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, (ii) NH<sub>3</sub>, (iii) BzCl, py, 15% (3 steps); (e) NH<sub>3</sub>/MeOH, 79%.</p></p></figure><div class="NLM_p">Synthesis of the 4′-chloromethyl arabino and ribo derivatives <b>3c</b> and <b>3d</b> is shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. 2′,3′-<i>O</i>-Cyclopentylideneuridine (<b>63</b>) was converted to the 4′-chloromethyl derivative <b>65</b> in the same manner as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. After protection of the 5′-OH with Bz, the resulting intermediate was converted to the cytidine <b>66</b>, which was subjected to acidic hydrolysis and a subsequent ammonia treatment to yield <b>3d</b>. After removal of 2′3′-cyclopentylidene from <b>65</b>, the resulting 4′-chloromethyluridine was converted to the 2,2′-anhydroruidine <b>67</b>. Hydrolysis of <b>67</b> yielded the arabinouridine derivative, which, after silylation of the sugar, was converted to the cytidine <b>68</b> by the standard method. Tritylation on the base of <b>68</b>, followed by desilylation and detritylation, afforded the desired <b>3c</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) IBX, CH<sub>3</sub>CN, 80 °C, (ii) aq CH<sub>2</sub>O, NaOH, dioxane, (iii) NaBH<sub>4,</sub> 60% (3 steps); (b) (i) Tf<sub>2</sub>O, py, DCM, (ii) NaH, DMF, (iii) LiCl, DMF, (iv) aq NaOH, THF, 28% (4 steps); (c) (i) BzCl, TEA, DCM, (ii) TPSCl, DMAP, TEA, (iii) aq NH<sub>3</sub>, 39% (3 steps); (d) (i) 80% HCOOH, (ii) NH<sub>3</sub>/MeOH, 40% (2 steps); (e) (i) 80% HCOOH, 50 °C, (ii) (PhO)<sub>2</sub>CO, NaHCO<sub>3</sub>, DMF, 100 °C, 60% (2 steps); (f) (i) aq NaOH, EtOH/H<sub>2</sub>O, (ii) TBSCl, imidazole, AgNO<sub>3</sub>, DMF, (iii) TPSCl, DMAP, TEA, CH<sub>3</sub>CN; (iv) aq NH<sub>3</sub>, 39% (4 steps); (g) (i) DMTrCl, AgNO<sub>3</sub>, collidine, DCM, (ii) NH<sub>4</sub>F, MeOH, reflux, (iii) TFA, 50 °C, 30% (3 steps).</p></p></figure><div class="NLM_p">As can be seen in the results and discussion section, <b>2c</b> was selected as a development candidate. Typically, an unprotected cytidine has high polarity and thus cannot achieve good bioavailability when administered orally. Therefore, we focused our attention on improving its bioavailability by prodrug approach that is commonly used for addressing the issue. As can be seen in the DMPK section, compound <b>2c</b> was well phosphorylated in cells to its 5′-triphosphate, therefore, the prodrug exploration of <b>2c</b> focused on nonphosphate prodrugs including 3′-<i>O</i>- and 5′-<i>O</i>-monoester and 3′,5′-<i>O</i>-diester as well as valinyl prodrugs as shown in Schemes <a class="ref internalNav" href="#sch7" aria-label="7">7</a>–<a class="ref internalNav" href="#sch9" aria-label="9">9</a>. These ester prodrugs of <b>2c</b> were expected to enhance bioavailability significantly based on literature precedence<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> and our own experience.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) DMTrCl, py, (ii) TBAF, THF, 70% (2 steps); (b) (i) acid anhydride, py, (ii) 80% HCOOH, 40 °C, 43–61% for <b>70</b>–<b>73</b> (2 steps); (c) (i) <i>n</i>-octanoic acid, DCC, DMAP, py, (ii) 80% HCOOH, 40 °C, 24% of <b>74</b>, 9% of <b>75</b>, 9% of <b>76</b> (2 steps).</p></p></figure><div class="NLM_p">Synthesis of the ester prodrugs is shown in Schemes <a class="ref internalNav" href="#sch7" aria-label="7">7</a>, <a class="ref internalNav" href="#sch8" aria-label="8">8</a>, and <a class="ref internalNav" href="#sch9" aria-label="9">9</a>. The 3′,5′-<i>O</i>-bis-silylated derivative <b>16</b> in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was tritylated on the base, followed by desilylation, to give <b>69</b>. Simple esterification using acid anhydrides afforded the dipropionyl ester <b>70</b>, the diisobutyryl ester <b>71</b>, the dipentanoyl ester <b>72</b>, and the dihexanoyl ester <b>73</b>. The dioctanoyl ester <b>74</b>, the 5′-<i>O</i>-octanoyl ester <b>75</b>, and the 3′-<i>O</i>-octanoyl ester <b>76</b> were synthesized by coupling of <b>69</b> with octanoic acid in the presence of DCC and DMAP.</div><div class="NLM_p">The bis-triflate <b>32</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> was converted, via the intermediate <b>77</b>, to the 3′-<i>O</i>,<i>N</i><sup>4</sup>-bis-tritylated cytidine <b>78</b> as shown in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a> in the same manner as described for <b>44</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Coupling of <b>78</b> with <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-valine gave, after removal of Boc, the 5′-<i>O</i>-valinyl prodrug <b>79</b>. Simple esterification of <b>78</b> and the subsequent detritylation afforded the 5′-<i>O</i>-isobutyryl ester <b>80</b>.</div><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) NaH, DMF, (ii) LiCl, (iii) aq NaOH, THF, (iv) TBSCl, imidazole, DCM; (b) (i) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, then NH<sub>3</sub>, (ii) DMTrCl, AgNO<sub>3</sub>, collidine, DCM, (iii) TBAF, THF; (c) (i) <i>N</i>-Boc-Val-OH, BOP-Cl, 3-nitro-1,2,4-triazole, DIPEA, THF, (ii) 80% HCOOH; (d) (i) isobutyric anhydride, py, (ii) 80% HCOOH.</p></p></figure><div class="NLM_p">Compound <b>2c</b> in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> reacted directly with <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-valine<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and gave, after removal of Boc, the 3′-<i>O</i>-valinyl prodrug <b>81</b> as shown in Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>. The bis-tritylated intermediate <b>83</b> was prepared, via the intermediate <b>82</b>, from <b>7</b> by similar procedures as described in the synthesis of <b>3a</b>. Simple esterification of <b>83</b> gave, after detritylation, the prodrugs <b>84</b> and <b>85</b>.</div><figure id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Inhibition of RSV Polymerase</h3><div class="NLM_p">The inhibitory effect of the nucleoside 5′-triphosphate (NTP) on RSV RNA synthesis was determined in a cell-free system using a crude RSV RNP complex (RSVpol) extracted from RSV infected cells.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> This assay was used to measure changes in the incorporation of the radio-labeled <sup>33</sup>P CMP or <sup>33</sup>P GMP tracer into RNA in the presence of increasing concentration of an NTP analogue. In this assay, the first active NTP, <b>1a</b>-<b>TP</b>, inhibited <sup>33</sup>P CMP incorporation to the RNA chain elongated by RSVpol with an IC<sub>50</sub> of 0.3 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). All NTPs with an azido group at the 4′-position and F or OH at the 2′-postion, either on α or β face (<b>1a</b>-<b>TP</b>, <b>1b</b>-<b>TP</b>, <b>1c</b>-<b>TP</b> and <b>1d</b>-<b>TP</b>) exhibited potent inhibition. However, because of the potential safety concern of the 4′-azido group,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> a series of nonazido, 4′-substituted nucleosides and their NTPs were investigated. Most of the TPs of <b>2a</b>–<b>l</b> having α-F at the 2′-position showed potent inhibition of RSV polymerase activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), with <b>2a</b>-<b>TP</b> and <b>2c</b>-<b>TP</b> having the 4′-methyl and 4′-chloromethyl being the most potent inhibitors (IC<sub>50</sub> = 0.01 and 0.02 μM, respectively). While the high potency of <b>2a</b>-<b>TP</b> might be ascribed to the smaller size of the 4′-Me, the three larger, closely related 4′-halomethyl NTPs (<b>2b</b>-<b>TP</b>, <b>2c</b>-<b>TP</b>, and <b>2d</b>-<b>TP</b>) also showed good inhibitory activity with an IC<sub>50</sub> of 0.12, 0.02, and 0.15 μM, respectively. The NTPs having the 4′-vinyl, 4′-ethyl, 4′-ethynyl, and 4′-methoxy, respectively (<b>2e</b>-<b>TP</b>, <b>2f</b>-<b>TP</b>, <b>2g</b>-<b>TP</b>, and <b>2l</b>-<b>TP</b>), also exhibited good inhibitory activity, with IC<sub>50</sub> values in the 0.09–0.15 μM range. With a three-atom substituent at the 4′-position, the NTPs exhibited a varied inhibitory activity, with IC<sub>50</sub> values ranging from 0.09 to 2.7 μM. While the 4′-allyl <b>2h</b>-<b>TP</b> and the 4′-cyclopropyl <b>2j</b>-<b>TP</b> still showed good inhibitory effect the 4′-<i>n</i>-propyl <b>2i</b>-<b>TP</b> and the 4′-methylthiomethyl <b>2k</b>-<b>TP</b> were >10-fold less potent. Obviously, the binding site on the polymerase had a good tolerance to the 4′-substituents, but certain size limitations are apparent. The TPs of <b>3a</b>–<b>d</b> that have a 4′-chloromethyl and either F or OH at the 2′-position except for 2′-α-F showed much lower inhibition, which was in a sharp contrast to the TPs of <b>1a</b>–<b>d</b> that were all active regardless of F or OH at the 2′-position. Thus, the 4′-azido group might serve as a predominant determinant, which could overcome certain changes at the 2′-position. It will be interesting to elucidate the role of the azido group at the 4′-position. The mechanism of RSV polymerase inhibition by <b>2c</b>-<b>TP</b> was carefully investigated. It was concluded that nucleotide incorporation and subsequent chain termination was the mechanism of action for the inhibition of RNA synthesis by recombinant RSV polymerase.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of RNA Polymerase Activity from a Crude RSV RNP Complex by NTPs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">NTP</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">NTP</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="left"><b>2g</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="center">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="left"><b>2h</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="center">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left"><b>2i</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="center">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1d</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left"><b>2j</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="center">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="left"><b>2k</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="center">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="left"><b>2l</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="center">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="left"><b>3a</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="center">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2d</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="left"><b>3b</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="center">38<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2e</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="left"><b>3c</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="center">6<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2f</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="left"><b>3d</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="center">1.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">The compound concentration at which the enzyme-catalyzed rate was reduced by 50% (IC<sub>50</sub>) was calculated by fitting the data to a nonlinear regression (4-parameter equation) using GraphPad Prism.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">% inhibition at 10 μM of NTP.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">% inhibition at 30 μM of NTP.</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Inhibition of Human DNA Polymerases α, β, γ, and RNA Polymerase II</h3><div class="NLM_p last">The potential inhibition by the NTP analogues of human DNA polymerases α, β, and γ as well as human RNA polymerase II was determined using in vitro DNA-dependent DNA polymerase (DdDp) assays for DNA polymerases α, β, and γ using recombinant enzymes and using a HeLa cell extract for the DNA dependent RNA polymerase (DdRp) activity of RNA polymerase II. The known polymerase inhibitors aphidicolin, dTTP and α-amanitin were used as control, respectively. When used at a concentration of 100 μM, <b>1a</b>-<b>TP</b>, <b>2b</b>-<b>TP</b>, <b>2c</b>-<b>TP</b>, and <b>2f</b>-<b>TP</b> all showed <50% inhibition of the DdDp activity of the purified human polymerases α, β, or γ and the DdRp activity of human RNA polymerase II. The results demonstrated that the NTPs in the study have high selectivity between the RSV polymerase and the host polymerases, which satisfies one of the prerequisites for a safe antiviral nucleoside analogue.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Nucleotide Incorporation by Human Mitochondrial RNA Polymerase (HMRP)</h3><div class="NLM_p">The substrate efficiency of a selection of CTP analogues was also tested against the DdRp activity of human mitochondrial RNA polymerase under conditions similar to those reported for other nucleotide analogues.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The natural CTP was used as the control to validate the assay. In the presence of 100 μM CTP, the majority of the 12-mer primer was converted to a 13-mer product (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Natural UTP, ATP, and GTP were used as negative controls for base pair mismatch as they set the baseline level for mis-incorporation for this enzyme. Under these assay conditions, the ATP (A:G) and UTP (U:G) mismatch controls demonstrated low but significant levels of incorporation while the GTP (G:G) mismatch control displayed very low levels of incorporation, at the limit of detection for this assay. In comparison, three CTP analogues in this work, <b>1a</b>-<b>TP</b>, <b>2c</b>-<b>TP</b>, and <b>2f</b>-<b>TP</b>, also showed undetectable to very low levels of incorporation, at a level below the mis-incorporation observed with UTP and ATP. In contrast, 2′-F-CTP, 2′-diF-CTP, 2′-ara-CTP, <b>1d</b>-<b>TP</b>, and <b>2b</b>-<b>TP</b> were recognized as efficient substrates for human mitochondrial RNA polymerase, at a level well above the level of mis-incorporation observed with UTP and ATP.</div><figure id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Incorporation of nucleotide analogues at 100 μM NTP by human mitochondrial RNA polymerase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the basis of the RSV polymerase inhibitory potency and host polymerase inhibition results, clearly, <b>2c</b>-<b>TP</b> demonstrated excellent activity and selectivity that satisfied the criteria for a safe and efficacious antiviral nucleoside analogue.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vitro Antiviral Activity in an RSV Replicon Assay</h3><div class="NLM_p">The RSV subgenomic replicon system in 395 HeLa cells was performed according to the protocols provided by Apath (Brooklyn, NY, USA). The system was originally developed by Peeples and co-workers.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> To generate the subgenomic RSV replicon, three glycoprotein genes for SH, G, and F, were deleted from a full-length recombinant GFP-expressing (rg)RSV antigenomic cDNA. In their place, a blasticidin S deaminase (<i>bsd</i>) gene was inserted. Through multiple steps, the RSV replicon was established in the HeLa cells. All the nucleosides in this work were tested in the replicon system, and a number of them showed very potent anti-RSV activity with EC<sub>50</sub> values as low as 150 nM as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. All the 4′-azido nucleosides <b>1a</b>–<b>d</b> exhibited potent inhibition in the replicon assay, consistent with the RSV polymerase inhibitory results for their corresponding 5′-triphosphates. Compounds <b>2b</b>, <b>2c</b>, <b>2d</b>, <b>2f</b>, <b>2g</b>, and <b>2j</b> also exhibited good anti-RSV activity in the replicon assay, consistent with the potent inhibition of the RSV polymerase by their triphosphates. These cell-based anti-RSV results suggested that these nucleosides were well phosphorylated to their NTPs by cellular kinases and that the NTPs were potent RSV inhibitors in the cells. However, nucleosides <b>2a</b>, <b>2e</b>, <b>2h</b>, and <b>2l</b> were less active in the replicon with EC<sub>50</sub> values ranging from 1.9 to 12.7 μM although their 5′-triphosphates were potent inhibitors of the RSV polymerase. In this case, cellular phosphorylation, metabolic stability, or other unknown reasons may have contributed to the lower activity in the replicon assay. Nucleosides <b>2i</b> and <b>3a</b>–<b>d</b> were less active or inactive in the replicon assay, consistent with the fact that their 5′-triphosphates were either less potent or inactive in the RSV polymerase assay. However, <b>2k</b> exhibited good activity in the replicon with an EC<sub>50</sub> of 0.51 μM despite <b>2k</b>-<b><b>TP</b></b> not demonstrating potent activity in the RSV polymerase inhibition assay. Potentially, an oxidized form of <b>2k</b> such as the sulfoxide or sulphone analogue could have been responsible for the cell-based activity. To clarify this assumption, the sulfoxide and sulphone versions of <b>2k</b>-<b>TP</b> were prepared and tested. However, these nucleosides and their respective NTPs were even less active than <b>2k</b> and <b>2k</b>-<b>TP</b> (results not shown), which excludes the possibility that the activity resulted from these two possible metabolites. It is interesting to note that the 4′-azidocytidines <b>1a</b>–<b>c</b> with either difluoro or OH at the 2′-position were all active in the replicon assay, while the 4′-chloromethylcytidines <b>3b</b>–<b>d</b> with difluoro or OH at the 2′-position showed little activity. Clearly, the 4′-azido group was unique, overcoming the changes at the 2′-position and leading to good activity in both RSV polymerase and cell-based assays. In contrast, the 4′-chloromethyl resulted in potent anti-RSV inhibition only when it was combined with the 2′-α-F, as compound <b>2c</b> showed. This, together with the fact that several 2′-α-F-4′-substituted cytidines were potent anti-RSV inhibitors, suggested that the 2′-α-F was a preferred modification for RSV polymerase inhibition. The active nucleosides in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> demonstrated little cytotoxicity in the HeLa cells. Among the most potent compounds are <b>1d</b>, <b>2b</b>, and <b>2c</b>, as demonstrated by their activity in the replicon assay and the RSV polymerase inhibitory effects of their 5′-triphosphates. However, the potent anti-RSV activity of <b>1d</b> and <b>2b</b> was confounded by their unfavorable incorporation into RNA by human mitochondrial RNA polymerase, as shown above. Compound <b>2c</b> also demonstrated submicromolar activity against all RSV strains tested, including RSV B strains and RSV A clinical isolates.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> On the basis of the RSV polymerase inhibition, lack of host polymerase inhibition, RSV replicon activity, and other drug like properties, compound <b>2c</b> was selected for clinical development.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. RSV Replicon Activity of the 4′-Substituted Cytidines<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">nucleoside</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.75</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char=".">>80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="char" char=".">2.14</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2e</b></td><td class="colsep0 rowsep0" align="char" char=".">1.91</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2f</b></td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2g</b></td><td class="colsep0 rowsep0" align="char" char=".">1.12</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2h</b></td><td class="colsep0 rowsep0" align="char" char=".">2.64</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2i</b></td><td class="colsep0 rowsep0" align="char" char=".">2.69</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2j</b></td><td class="colsep0 rowsep0" align="char" char=".">0.56</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2k</b></td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">>63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2l</b></td><td class="colsep0 rowsep0" align="char" char=".">12.7</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="char" char=".">>65</td><td class="colsep0 rowsep0" align="char" char=".">62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">The replicon assay was performed in 395 HeLa cells.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">EC<sub>50</sub>, the concentration of the drug required for reducing RSV replicon RNA by 50% in relation to the untreated cell control value, was calculated by 4 Parameter Logistic Model in XLfit5 Software (IDBS, Alameda, CA). CC<sub>50</sub>, the concentration of the drug required for reducing viable cells by 50% in relation to the untreated cell control value, was calculated with the same method.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">The reported values are the mean of at least two repeats. The assay CV (coefficient of variation) among repeats is equal or less than 20%.</p></div></div></div><div class="NLM_p">As noted above, the ester prodrugs of <b>2c</b> were intended to improve oral bioavailability of <b>2c</b>. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, all the ester prodrugs are active in the replicon assay with EC<sub>50</sub> values ranging from 30 to 340 nM. Most of the prodrugs had no appreciable cytotoxicity up to 100 μM, however, a few of them did show CC<sub>50</sub> values less than 100 μM. It was noted that poor aqueous solubility was a common feature of these prodrugs. The prodrugs in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were further evaluated for their oral bioavailability and other drug-like properties.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. RSV Replicon Activity of <b>2c</b> Prodrugs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">prodrug</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">>66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">>70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">>90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>84</b></td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">>88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>85</b></td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">>89</td></tr></tbody></table></div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Metabolic and Pharmacokinetic Properties of <b>2c</b> and Its Prodrugs</h3><div class="NLM_p">In vivo nucleoside 5′-triphosphate (NTP) levels in the target tissue are critical to in vivo efficacy of an antiviral nucleoside polymerase inhibitor. In vitro NTP formation in appropriate cell lines may provide the first assessment for predicting the in vivo NTP level. Thus, we measured the in vitro NTP level of three potent nucleosides <b>2b</b>, <b>2c</b>, and <b>2f</b> in four cell types, A549, HEp-2, normal human bronchiolar epithelial (NHBE), and human nasal cells. In vitro NTP levels were obtained by incubating each nucleoside with each cell line for 24 h and analyzing the cell extracts for the corresponding NTP concentration. All three nucleosides formed high levels of NTPs in cells as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, with <b>2c</b> and <b>2f</b> displaying high levels of NTPs in all four cell types. On the basis of these results, <b>2c</b> and <b>2f</b> were expected to be well phosphorylated to their respective NTPs in vivo.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. NTP Formation in Cells, pmol/Million Cells</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">A549</th><th class="colsep0 rowsep0" align="center" char=".">HEp-2</th><th class="colsep0 rowsep0" align="center" char=".">NHBE</th><th class="colsep0 rowsep0" align="center" char=".">human nasal cells</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="char" char=".">55.0</td><td class="colsep0 rowsep0" align="char" char=".">27.9</td><td class="colsep0 rowsep0" align="char" char=".">153</td><td class="colsep0 rowsep0" align="char" char=".">240</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="char" char=".">137</td><td class="colsep0 rowsep0" align="char" char=".">94.7</td><td class="colsep0 rowsep0" align="char" char=".">581</td><td class="colsep0 rowsep0" align="char" char=".">185</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2f</b></td><td class="colsep0 rowsep0" align="char" char=".">85.1</td><td class="colsep0 rowsep0" align="char" char=".">119</td><td class="colsep0 rowsep0" align="char" char=".">489</td><td class="colsep0 rowsep0" align="char" char=".">140</td></tr></tbody></table></div></div><div class="NLM_p">In vivo PK studies following IV administration at 5 mg/kg were conducted in hamsters, rats, and monkeys in order to differentiate these three nucleoside analogues based on their PK properties. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <b>2c</b> and <b>2f</b> had comparable PK properties in hamsters, rats, and monkeys. Both compounds had moderate clearance, moderate to high volume of distribution, and moderate to long half-life. High blood exposure to both <b>2c</b> and <b>2f</b> were observed in all three species studied. Compound <b>2b</b> had a low clearance in rats and high clearance in monkeys. In monkeys, <b>2b</b> was extensively metabolized to its uridine analogue, an inactive metabolite. The exposure ratios of uridine metabolite to the parent cytidine analogue were 3.39, 0.48, and 0.67 for <b>2b</b>, <b>2c</b>, and <b>2f</b>, respectively. In monkeys, high levels of the phosphorylated metabolites were formed in the lung at 1 h (<b>2f</b> and <b>2c</b>) or 2 h (<b>2b</b>) following IV administration at 5 mg/kg. The lung nucleoside monophosphate (NMP) concentrations were 3312, 9923, and 5577 nM and the lung NTP concentrations were 374, 4065, and 3069 nM for <b>2b</b>, <b>2c</b>, and <b>2f</b>, respectively. These results were consistent with the in vitro NTP formation in cells. On the basis of the exposure, consistency of PK cross species, low uridine conversion, and high levels of NMP and NTP formation in monkey lungs, <b>2c</b> was considered to have the best PK profile among the three nucleoside analogues tested and, therefore, selected for further development.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Properties of <b>2b</b>, <b>2c</b>, and <b>2f</b> in Hamsters, Rats, and Monkeys Following Intravenous Administration at 5 mg/kg</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>inf</sub> (h·ng/mL)</th><th class="colsep0 rowsep0" align="center">U/C</th><th class="colsep0 rowsep0" align="center">lung NMP (nM)</th><th class="colsep0 rowsep0" align="center">lung NTP (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hamster</td><td class="colsep0 rowsep0" align="left"><b>2f</b></td><td class="colsep0 rowsep0" align="char" char=".">1.23</td><td class="colsep0 rowsep0" align="char" char=".">34.1</td><td class="colsep0 rowsep0" align="char" char=".">1.07</td><td class="colsep0 rowsep0" align="char" char=".">2459</td><td class="colsep0 rowsep0" align="center">0.0005</td><td class="colsep0 rowsep0" align="center">144<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">42.2<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="char" char=".">3.98</td><td class="colsep0 rowsep0" align="char" char=".">28.6</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">3226</td><td class="colsep0 rowsep0" align="center">0.025</td><td class="colsep0 rowsep0" align="center">287<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">70.9<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left"><b>2f</b></td><td class="colsep0 rowsep0" align="char" char=".">1.34</td><td class="colsep0 rowsep0" align="char" char=".">25.5</td><td class="colsep0 rowsep0" align="char" char=".">1.67</td><td class="colsep0 rowsep0" align="char" char=".">3415</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="char" char=".">6.01</td><td class="colsep0 rowsep0" align="char" char=".">31.8</td><td class="colsep0 rowsep0" align="char" char=".">4.10</td><td class="colsep0 rowsep0" align="char" char=".">2667</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="char" char=".">9.49</td><td class="colsep0 rowsep0" align="char" char=".">2.69</td><td class="colsep0 rowsep0" align="char" char=".">1.87</td><td class="colsep0 rowsep0" align="char" char=".">31835</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left"><b>2f</b></td><td class="colsep0 rowsep0" align="char" char=".">7.52</td><td class="colsep0 rowsep0" align="char" char=".">19.2</td><td class="colsep0 rowsep0" align="char" char=".">1.80</td><td class="colsep0 rowsep0" align="char" char=".">4360</td><td class="colsep0 rowsep0" align="center">0.67</td><td class="colsep0 rowsep0" align="center">3312<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">3069<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="char" char=".">5.44</td><td class="colsep0 rowsep0" align="char" char=".">28.0</td><td class="colsep0 rowsep0" align="char" char=".">3.00</td><td class="colsep0 rowsep0" align="char" char=".">2980</td><td class="colsep0 rowsep0" align="center">0.48</td><td class="colsep0 rowsep0" align="center">9923<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">4065<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="char" char=".">7.66</td><td class="colsep0 rowsep0" align="char" char=".">54.3</td><td class="colsep0 rowsep0" align="char" char=".">5.60</td><td class="colsep0 rowsep0" align="char" char=".">1540</td><td class="colsep0 rowsep0" align="center">3.39</td><td class="colsep0 rowsep0" align="center">5577<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">374<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Lungs taken at 1 h postdose.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Lungs taken at 2 h postdose; ND, not determined; U/C, ratio of uridine metabolite to parent cytidine.</p></div></div></div><div class="NLM_p">Compound <b>2c</b> had a poor oral bioavailability in monkeys with <i>F</i>% ≈ 3 based on PK data collected up to 4 h post oral dose, and its <i>C</i><sub>max</sub> was only 37.2 ng/mL at an oral dose of 5 mg/kg. A prodrug strategy was employed to improve the oral bioavailability. A number of ester prodrugs of <b>2c</b> as shown in Schemes <a class="ref internalNav" href="#sch7" aria-label="7">7</a>–<a class="ref internalNav" href="#sch9" aria-label="9">9</a> were tested for their PK properties in hamsters. On the basis of good oral bioavailability, stability, and solubility, the prodrugs <b>71</b>, <b>73</b>, and <b>81</b> were selected for further profiling in monkeys. Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> lists the PK properties in hamsters, rats, and monkeys following oral administration of the prodrugs at 5 mg/kg <b>2c</b> equivalent dose. All three prodrugs had good blood exposures to the parent nucleoside <b>2c</b>. In monkeys, <i>C</i><sub>max</sub> was increased >13-fold and oral bioavailability was ≥40% when dosed with the prodrugs in comparison to oral dose of <b>2c</b>. Although good oral bioavailability was obtained for <b>73</b> at 5 mg/kg <b>2c</b> equivalent dose, the relatively lower aqueous solubility of this prodrug, as encountered during formulation, was estimated to limit the absorption at high dose levels typically used in preclinical toxicity studies. The 3′-valine prodrug <b>81</b> had excellent aqueous solubility, as demonstrated during formulation test with various vehicles. However, this prodrug had a poor stability in aqueous solution. The prodrug <b>71</b> had excellent stability profiles in formulations (>24 h storage stability in 0.5% methylcellulose aqueous formulation at rt) and simulated gastric and intestinal fluids (half-life >2 h). Its solubility was adequate to support oral administration in solutions with relatively low percentage of organic solvent and in aqueous suspensions. High levels of NMP and NTP were obtained following oral administration of <b>71</b> to monkeys. Consequently, <b>71</b> was selected as the candidate for further development.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Properties of <b>2c</b> Prodrugs in Hamsters, Rats, and Monkeys Following Oral Administration of <b>71</b>, <b>81</b>, or <b>73</b> at 5 mg/kg <b>2c</b> Equivalent Dose</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>inf</sub> (h·ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>%</th><th class="colsep0 rowsep0" align="center">lung NMP (nM)</th><th class="colsep0 rowsep0" align="center">lung NTP (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hamster</td><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">445</td><td class="colsep0 rowsep0" align="char" char=".">4.18</td><td class="colsep0 rowsep0" align="char" char=".">1231</td><td class="colsep0 rowsep0" align="char" char=".">38.2</td><td class="colsep0 rowsep0" align="center">ND<a class="ref internalNav" href="#tbl6-fn1" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">460</td><td class="colsep0 rowsep0" align="char" char=".">3.90</td><td class="colsep0 rowsep0" align="char" char=".">1722</td><td class="colsep0 rowsep0" align="char" char=".">53.4</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">747</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td><td class="colsep0 rowsep0" align="char" char=".">2267</td><td class="colsep0 rowsep0" align="char" char=".">70.3</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="char" char=".">703</td><td class="colsep0 rowsep0" align="char" char=".">3.82</td><td class="colsep0 rowsep0" align="char" char=".">2593</td><td class="colsep0 rowsep0" align="char" char=".">97.2</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">728</td><td class="colsep0 rowsep0" align="char" char=".">4.10</td><td class="colsep0 rowsep0" align="char" char=".">2280</td><td class="colsep0 rowsep0" align="char" char=".">85.5</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="char" char=".">1.50</td><td class="colsep0 rowsep0" align="char" char=".">37.3</td><td class="colsep0 rowsep0" align="char" char=".">1.28</td><td class="colsep0 rowsep0" align="char" char=".">85.1</td><td class="colsep0 rowsep0" align="char" char=".">2.86</td><td class="colsep0 rowsep0" align="center">254<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">185<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="char" char=".">2.00</td><td class="colsep0 rowsep0" align="char" char=".">500</td><td class="colsep0 rowsep0" align="char" char=".">4.89</td><td class="colsep0 rowsep0" align="char" char=".">1295</td><td class="colsep0 rowsep0" align="char" char=".">43.5</td><td class="colsep0 rowsep0" align="center">679<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">1479<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">541</td><td class="colsep0 rowsep0" align="char" char=".">4.45</td><td class="colsep0 rowsep0" align="char" char=".">1240</td><td class="colsep0 rowsep0" align="char" char=".">41.6</td><td class="colsep0 rowsep0" align="center">861<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">915<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="char" char=".">1.50</td><td class="colsep0 rowsep0" align="char" char=".">571</td><td class="colsep0 rowsep0" align="char" char=".">5.87</td><td class="colsep0 rowsep0" align="char" char=".">1185</td><td class="colsep0 rowsep0" align="char" char=".">39.8</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Lungs taken at 4 h postdose.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Lungs taken at 12 h postdose.</p></div><div class="footnote" id="tbl6-fn1"><sup>c</sup><p class="last">ND: not determined.</p></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of 4′-substituted cytidine analogues have been synthesized and tested in anti-RSV assays. A number of 2′-deoxy-2′-fluoro-4′-susbstituted cytidine nucleosides demonstrated potent inhibition of the RSV replicon with a wide selectivity window, and their 5′-triphosphates effectively inhibited RSV polymerase with high selectivity with respect to host polymerases. These active nucleosides represent first-in-class antiviral agents against RSV infection. Compound <b>2c</b>, which had an EC<sub>50</sub> of 0.15 μM in the RSV replicon assay and an IC<sub>50</sub> of 0.02 μM for its corresponding 5′-triphosphate in the RSV polymerase assay, was selected for clinical development. A series of <b>2c</b> ester prodrugs were prepared and evaluated for bioavailability and other drug-like properties. Compound <b>71</b>, the 3′,5′-di-<i>O</i>-isobutyryl prodrug of <b>2c</b>, was selected for clinical development. Compound <b>71</b> given orally was efficacious against RSV infection in adult volunteers in a phase 2 RSV challenge study, with far superior virological outcomes when compared to the RSV fusion inhibitor GS-5806. Currently, compound <b>71</b> is under phase 2 clinical evaluation for the treatment of RSV infection in hospitalized infants aged 1–12 months.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All commercially obtained solvents and reagents were used as received. All solvents used for chemical reactions were anhydrous grade unless specifically indicated. Structures of the target compounds in this work were assigned by use of NMR and MS spectroscopy. The purities of all nucleosides and prodrugs were >95% as determined on an Agilent 1200 HPLC, XTerra 3.5 μm 4.6 mm × 150 mm MS C18 column, using 0.04 (v/v) TFA in water and 0.02 (v/v) TFA in acetonitrile as mobile phase. The purities of all nucleotides were >95%, determined on an Agilent 1100 HPLC, 50 mM TEAA in water, and 50 mM TEAA in acetonitrile as mobile phase. <sup>1</sup>H NMR spectra were recorded on a Bruker Advance III (400 MHz) or a Varian 400MR (400 MHz) NMR spectrometer. Chemical shifts are reported in parts per million (ppm, δ) using residual solvent line as an internal reference. Splitting patterns are reported as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), or br s (broad singlet). Coupling constants (<i>J</i>) are reported in hertz (Hz). Mass spectrometric analyses for nucleosides were performed on an Agilent 1200 HPLC with Agilent 6110/6140/1956C MSD mass spectrometer using ESI as ionization, Phenomenex Luna C18 5 μm, 5.0 mm × 20 mm column; mobile phase: 0.04%(v/v) TFA in water and 0.02%(v/v) TFA in acetonitrile, 40 °C, flow rate 0.4 mL/min. Mass spectrometric analyses for nucleotides were performed on an Agilent 1100 HPLC with API 2000 LC-MS/MS system using ESI as ionization, Synergi 75 mm × 2.0 mm, 4 μm Hydro-RP80 Å column, 50 mM TEAA in water, and 50 mM in acetonitrile, flow rate 0.4 mL/min. Workup procedures for most of chemical reactions are the same or similar, therefore, unless specifically indicated, the workup refers to the following procedure: the reaction mixture at 0 °C is quenched with water, diluted with ethyl acetate or dichloromethane, washed with 5% sodium bicarbonate and then with brine, dried over anhydrous sodium sulfate, filtered, and concentrated to dryness. Unless necessary, the word “workup” will not be mentioned for a reaction if it follows the procedure described above. Purification on silica gel refers to a flash chromatography on a silica gel column.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. MS and <sup>31</sup>P NMR of NTPs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">NTP</th><th class="colsep0 rowsep0" align="center" char=".">MS <i>m</i>/<i>e</i> (M – 1)<sup>−</sup></th><th class="colsep0 rowsep0" align="center"><sup>31</sup>P NMR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">542.9</td><td class="colsep0 rowsep0" align="left">–6.54 (d), −12.26 (d), −22.34 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">523.4</td><td class="colsep0 rowsep0" align="left">–5.54 (d), −11.88 (d), −21.11 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">523.3</td><td class="colsep0 rowsep0" align="left">–5.36 (br s), −11.70 (br s), 23.30 (br s)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1d</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">525.3</td><td class="colsep0 rowsep0" align="left">–9.95 (br s), −12.33 (d), 23.04 (br s)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">498.1</td><td class="colsep0 rowsep0" align="left">–10.90 (d), −11.82 (d), −23.30 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">516.1</td><td class="colsep0 rowsep0" align="left">–10.80 (d), −11.87 (d), −23.30 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">532.1</td><td class="colsep0 rowsep0" align="left">–5.08 (d), −11.30 (d), −20.43 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2d</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">575.7</td><td class="colsep0 rowsep0" align="left">–8.94 (d), −11.87 (d), −22.95 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2e</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">510.0</td><td class="colsep0 rowsep0" align="left">–5.34 (br s), −11.39 (d), 20.41 (br s)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2f</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">512.1</td><td class="colsep0 rowsep0" align="left">–7.62 (br s), −11.30 (br s), 21.88 (br s)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2g</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">508.3</td><td class="colsep0 rowsep0" align="left">–5.66 (d), −11.97 (d), −21.07 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2h</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">526.1</td><td class="colsep0 rowsep0" align="left">–10.62 (d), −11.49 (d), −23.26 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2i</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">526.1</td><td class="colsep0 rowsep0" align="left">–6.39 (d), −11.58 (d), −22.48 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2j</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">524.4</td><td class="colsep0 rowsep0" align="left">–10.62 (d), −11.87 (d), −23.31 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2k</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">543.9</td><td class="colsep0 rowsep0" align="left">–10.89 (d), −11.84 (d), −23.29 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2l</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">514.0</td><td class="colsep0 rowsep0" align="left">–10.66 (d), −11.93 (d), −23.23 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">532.7</td><td class="colsep0 rowsep0" align="left">–10.72 (d), −11.68 (d), −22.29 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">550.3</td><td class="colsep0 rowsep0" align="left">–10.92 (d), −11.88 (d), −23.22 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">529.8</td><td class="colsep0 rowsep0" align="left">–10.48 (br s), −13.47 (d), 23.35 (t)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b>-<b>TP</b></td><td class="colsep0 rowsep0" align="char" char=".">529.8</td><td class="colsep0 rowsep0" align="left">–10.72 (br s), −11.79 (d), 23.21 (br s)</td></tr></tbody></table></div></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 3′-<i>O</i>-(<i>tert</i>-Butyldimethylsilyl)-5′-<i>O</i>-(<i>tert</i>-butyldiphenylsilyl)-2′-deoxy-2′-fluoro-4′-hydroxymethyluridine (<b>10</b>)</h3><div class="NLM_p">A solution of <b>4</b> (100 g, 406 mmol) and DMTrCl (165 g, 488 mmol) in pyridine (750 mL) was stirred at rt overnight. After quenching with MeOH and workup, the crude product was dissolved in DCM (500 mL), and imidazole (44.3 g, 650 mmol) and TBSCl (91.9 g, 610 mmol) were added. The mixture was stirred at rt overnight. After workup, the crude (236 g, 357 mmol) was dissolved in 80% AcOH (500 mL) and kept at rt for 15 h. Chromatography on silica gel with 1–2% MeOH in DCM gave 131 g (89%) of <b>5</b> as a slightly yellow solid.</div><div class="NLM_p last">A mixture of <b>5</b> (131 g, 364 mmol) and IBX (121 g, 433 mmol) in CH<sub>3</sub>CN (1200 mL) was refluxed for 3 h and then cooled to 0 °C. Precipitate was filtered and the filtrate concentrated to give the crude 5′<b>-</b>aldehyde (121 g), which was dissolved in 1,4-dioxane (1000 mL), and 37% formaldehyde (81 mL, 1.35 mol) and 2 M NaOH (254 mL, 508 mmol) were added. The mixture was stirred at rt for 2 h and then neutralized with AcOH to pH 7. To the solution were added ethanol (400 mL) and then sodium borohydride (51.2 g, 1.35 mol). The mixture was stirred at rt for 30 min and quenched with saturated aq NH<sub>4</sub>Cl. Chromatography on silica gel with 1–3% MeOH in DCM gave 51.4 g of <b>7</b> (36%) as a white solid. A solution of <b>7</b> (51.4 g, 132 mmol), DMTrCl (49.1 g, 145 mmol), and pyridine (80 mL) in anhydrous DCM (400 mL) was stirred at rt for 14 h, then quenched with MeOH (30 mL). Solvent was evaporated, and the residue was purified on silica gel with 1–3% MeOH in DCM to give <b>8</b> as a yellow foam (57.4 g, 63%). Then compound <b>8</b> (57.4 g, 82.8 mmol) was converted, via intermediates <b>9</b> by the same procedure described for <b>5</b>, to 37.6 g (72%) of <b>10</b> as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.76 (d, <i>J</i> = 4.0 Hz, 1H), 7.70 (dd, <i>J</i> = 1.6 Hz, 8.0 Hz, 2H), 7.66–7.64 (m, 2H), 7.48–7.37 (m, 6H), 6.12 (dd, <i>J</i> = 2.8 Hz, 16.8 Hz, 1H), 5.22 (d, <i>J</i> = 8.0 Hz, 1H), 5.20–5.05 (m, 1H), 4.74 (dd, <i>J</i> = 5.6 Hz, 17.6 Hz, 1H), 4.16 (d, <i>J</i> = 12.0 Hz, 1H), 3.87–3.80 (m, 2H), 3.56 (d, <i>J</i> = 12.0 Hz, 1H), 1.16 (s, 9H), 0.92 (s, 9H), 0.14 (s, 6H).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2′-Deoxy-2′-fluoro-4′-methylcytidine (<b>2a</b>)</h3><div class="NLM_p last">A mixture of <b>10</b> (3.2 g, 5.0 mmol), Ph<sub>3</sub>P (5.2 g, 20 mmol), iodine (2.6 g, 10.2 mmol), and imidazole (1.4 g, 20 mmol) in THF (40 mL) was stirred at 80 °C for 14 h, then cooled to rt and quenched with saturated aq Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>. Chromatography on silica gel with 20–50% EtOAc in petroleum ether gave the 4′-iodomethyl derivative (1.6 g, 43%) as a white solid. A mixture of the iodo derivative (1.4 g, 2.0 mmol), Et<sub>3</sub>N (55 μL, 0.4 mmol), and 10% Pd/C in EtOH (20 mL) under H<sub>2</sub> (balloon) was stirred at rt overnight. Then the catalyst was filtered off and the filtrate was concentrated. Chromatography on silica gel with 20%–50% EtOAc in petroleum ether gave 1.1 g (95%) of <b>11</b> as a white solid.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Method A: A Representative Procedure for Conversion of Uridine to Cytidine</h3><div class="NLM_p last">A solution of <b>11</b> (650 mg, 1.1 mmol), DMAP (270 mg, 2.2 mmol), TPSCl (664 mg, 2.2 mol), and Et<sub>3</sub>N (222 mg, 2.2 mmol) in CH<sub>3</sub>CN (20 mL) was stirred at rt overnight. Then aqueous ammonia was added, and the resulting mixture stirred at rt for 2 h. Solvent was removed and the residue purified on silica gel with 1–10% MeOH in DCM to give <b>15</b> (430 mg) as a syrup. A solution of <b>15</b> (430 mg, 0.7 mmol) and NH<sub>4</sub>F (97 mg, 2.1 mmol) in MeOH (10 mL) was refluxed for 14 h. Solvent was removed and the residue purified on silica gel with 5–10% MeOH in DCM to give 65 mg (35%) of <b>2a</b> as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.10 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 6.03 (dd, <i>J</i> = 2.0 Hz, 16.8 Hz, 1H, H-1′), 5.87 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 4.98 (m, 1H, H-2′), 4.37 (dd, <i>J</i> = 5.2 Hz, 21.6 Hz, 1H, H-3′), 3.63 (d, <i>J</i> = 12.0 Hz, 1H, H-5′a), 3.56 (d, <i>J</i> = 12.0 Hz, 1H, H-5′b), 1.23 (d, <i>J</i> = 0.8 Hz, 3H, CH<sub>3</sub>). MS, <i>m</i>/<i>e</i> 260.1 (M + 1)<sup>+</sup>, 519.1 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4′-Chloromethyl-2′-deoxy-2′-fluorocytidine (<b>2c</b>)</h3><div class="NLM_p last">A mixture of <b>10</b> (1.60 g, 2.5 mmol), Ph<sub>3</sub>P (1.3 g, 5.0 mmol), and CCl<sub>4</sub> (0.76g, 5.0 mmol) in DCE (20 mL) was heated at 130 °C under microwave irradiation under nitrogen for 40 min. After removal of solvent, the residue was purified on silica gel with 2–10% EtOAc in petroleum ether to give 1.1 g (69%) of <b>12</b> as a white solid. Compound <b>12</b> (800 mg, 1.3 mmol) was converted by method A to <b>2c</b> (153 mg, 42%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.77 (d, <i>J</i> = 7.4 Hz, 1H, H-6), 7.24 (d, <i>J</i> = 12.9 Hz, 2H, NH<sub>2</sub>), 6.09 (dd, <i>J</i> = 4.7 Hz, 4.9 Hz, 1H, H-1′), 5.86 (d, <i>J</i> = 5.5 Hz, 1H, 3′-OH), 5.72 (d, <i>J</i> = 7.4 Hz, 1H, H-5), 5.30 (t, <i>J</i> = 5.1 Hz, 1H, 5′-OH), 5.09 (ddd, <i>J</i> = 4.7 Hz, 5.1 Hz, 53.6 Hz, 1H, H-2′), 4.39 (ddd, <i>J</i> = 5.1 Hz, 5.5 Hz, 7.1 Hz, 1H, H-3′), 3.73 (d, <i>J</i> = 1.2 Hz, 2H, CH<sub>2</sub>Cl), 3.65 (dd, <i>J</i> = 5.1 Hz, 11.3 Hz, 1H, H-5′a), 3.56 (dd, <i>J</i> = 5.1 Hz, 11.3 Hz, 1H, H-5′b). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 166 (C-4), 155 (C-2), 141 (C-6), 95 (C-5), 93 (C-2′), 86.5 (C-1′), 85.9 (C-4′), 70 (C-3′), 62 (C-5′), 46 (<u class="uu">C</u>H<sub>2</sub>Cl). <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −202 (m). MS, <i>m</i>/<i>e</i> 293.9 (M + 1)<sup>+</sup>, 586.8 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2′-Deoxy-2′-fluoro-4′-vinylcytidine (<b>2e</b>)</h3><div class="NLM_p last">To a solution of <b>10</b> (11.8 g, 18.8 mmol) in DCM (100 mL) was added Dess–Martin periodinane (16.3 g, 37.6 mmol) at 0 °C under nitrogen. The mixture was stirred at rt for 2.5 h. Chromatography on silica gel with 20% EtOAc in hexanes gave the 4′-formyl derivative (10.1 g). To a stirred mixture of Ph<sub>3</sub>PCH<sub>3</sub>Br (15.7 g, 48.5 mmol) in THF (100 mL) at −78 °C under nitrogen was added <i>n</i>-butyllithium (2.5 M in hexanes, 19.4 mL), and the mixture was stirred at 0 °C for 30 min. A solution of the 4′-formyluridine (10.1 g, 16.2 mmol) in THF (70 mL) was added dropwise at 0 °C under nitrogen. The mixture was stirred at rt for 1.5 h, then quenched with aq NH<sub>4</sub>Cl. Chromatography on silica gel with 20% EtOAc in hexanes gave 8.3 g (71%) of <b>13</b> as a white solid. Compound <b>2e</b> (82 mg, 63%) as a white solid was prepared from <b>13</b> via <b>17</b> according to method A. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.11 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 5.99–6.08 (m, 2H, H-1′, C<u class="uu">H</u>═CH<sub>2</sub>), 5.88 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 5.47 (dd, <i>J</i> = 1.4 Hz, 17.4 Hz, 1H, −CH═C<u class="uu">H</u><sub>2</sub>), 5.26 (dd, <i>J</i> = 1.4 Hz, 11.0 Hz, 1H, −CH═C<u class="uu">H</u><sub>2</sub>), 4.90 (m, 1H, H-2′), 4.52 (dd, <i>J</i> = 5.0 Hz, 23.0 Hz, 1H, H-3′), 3.65 (d, <i>J</i> = 12.4 Hz, 1H, H-5′a), 3.54 (d, <i>J</i> = 12.4 Hz, 1H, H-5′b). MS: <i>m</i>/<i>e</i> 272.0 (M + 1)<sup>+</sup>, 543.0 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2′-Deoxy-4′-ethyl-2′-fluorocytidine (<b>2f</b>)</h3><div class="NLM_p last">A mixture of <b>17</b> (5.9 g, 9.5 mmol) and 10% Pd/C (1.5 g) in methanol (100 mL) under hydrogen (balloon) was stirred at rt for 2 h. The same workup as described for <b>11</b> gave 5.4 g of crude <b>18</b>, which was desilylated by the procedure in method A to give 1.6 g (69%) of <b>2f</b> as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.08 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 6.07 (dd, <i>J</i> = 3.2 Hz, 15.6 Hz, 1H, H-1′), 5.88 (d, <i>J</i> = 7.2 Hz, 1H, H-5), 5.04 (ddd, <i>J</i> = 3.2 Hz, 5.2 Hz, 54.0 Hz, 1H, H-2′), 4.45 (dd, <i>J</i> = 5.2 Hz, 17.2 Hz, 1H, H-3′), 3.76 (d, <i>J</i> = 12.0 Hz, 1H, H-5′a), 3.57 (d, <i>J</i> = 12.0 Hz, 1H, H-5′b), 1.82, 1.62 (2m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>), 0.95 (t, <i>J</i> = 7.6 Hz, 3H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">3</u></sub>). MS, <i>m</i>/<i>e</i> 274.0 (M + 1)<sup>+</sup>, 547.0 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4′-Cyclopropyl-2′-deoxy-2′-fluorocytidine (<b>2j</b>)</h3><div class="NLM_p last">A solution of <b>13</b> (3.0 g, 4.8 mmol), BzCl (1.3 g, 9.6 mmol), DMAP (1.1 g, 9.6 mmol), and Et<sub>3</sub>N (4 mL) in DCM (50 mL) was stirred at rt for 2 h. Chromatography on silica gel with 25% EtOAc in petroleum ether gave 2.8 g (80%) of the <i>N</i><sup>3</sup>-benzoyl derivative as a solid. To a suspension of the <i>N</i><sup>3</sup>-benzoyl derivative (2.6 g, 3.6 mmol) and Pd(OAc)<sub>2</sub> (100 mg) in DCM (50 mL) was added a solution of diazomethane in ether (350 mL) generated by a standard procedure. The mixture was stirred at rt overnight, then quenched with AcOH. The crude product was dissolved in saturated ammonia in MeOH (100 mL) and kept at rt overnight. After evaporation, the residue was purified on silica gel with 25% EtOAc in petroleum ether to give 800 mg (35%) of <b>14</b> as a yellow solid. Compound <b>2j</b> (50 mg, 24%) as a white solid was prepared from <b>14</b> according to method A. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.13 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 6.01 (dd, <i>J</i> = 2.6 Hz, 15.8 Hz, 1H, H-1′), 5.85 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 4.96 (ddd, <i>J</i> = 2.6 Hz, 5.4 Hz, 53.6 Hz, 1H, H-2′), 4.52 (dd, <i>J</i> = 5.4 Hz, 19.8 Hz, 1H, H-3′), 3.66 (s, 2H, H-5′a, H-5′b), 0.98 (m, 1H, C<u class="uu">H</u>(CH<sub>2</sub>)<sub>2</sub>), 0.54–0.30 (m, 4H, CH(C<u class="uu">H</u><sub>2</sub>)<sub>2</sub>). MS, <i>m</i>/<i>e</i> 285.8 (M + 1)<sup>+</sup>, 570.8 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2′-Deoxy-2′-fluoro-4′-fluoromethylcytidine (<b>2b</b>)</h3><div class="NLM_p">To a solution of <b>9</b> (3.1 g, 4.5 mmol) in DMF (30 mL) were added K<sub>2</sub>CO<sub>3</sub> (1.24 g, 9.03 mmol) and PMBCl (1.40 g, 9.03 mmol). The mixture was stirred at rt overnight. Chromatography on silica gel with 10–20% EtOAc in petroleum ether gave 2.36 g (75%) of the <i>N</i><sup>3</sup>-(4-methoxybenzyl) derivative. A solution of the <i>N</i><sup>3</sup>-PMB derivative (11.0 g, 10.47 mmol) and TBAF (8.2 g, 31.4 mmol) in THF (100 mL) stood at rt for 5 h. Then solvent was removed and the residue purified on silica gel with 15–50% EtOAc in petroleum ether to give 6.0 g (82%) of <b>20</b>. To a stirred solution of <b>20</b> (500 mg, 0.72 mmol) in DMF (10 mL) were added sodium hydride (51.5 mg, 2.14 mmol) and then benzyl bromide (365 mg, 2.14 mmol) at 0 °C. The mixture was stirred at rt overnight. The crude product was purified on silica gel with 10–20% EtOAc in petroleum ether to give 496 mg (79%) of the 3′,5′-<i>O</i>-dibenzyl derivative of <b>20</b>. A solution of the dibenzyl intermediate (2.5 g, 2.84 mmol) in 80% AcOH (25 mL) stood at rt overnight. Chromatography on silica gel with 15–50% EtOAc in petroleum ether gave 1.2 g (73%) of the 4′-hydroxymethyl intermediate as a white solid. To a stirred solution of DAST (1.39 g, 8.68 mmol) in toluene (15 mL) at −78 °C was added dropwise a solution of the 4′-hydroxymethyl intermediate (1.0 g, 1.73 mmol) in toluene. The mixture was stirred at −78 °C for 30 min and then warmed to 60 °C gradually and stirred overnight at this temperature. After cooling, the mixture was poured into saturated Na<sub>2</sub>CO<sub>3</sub> solution. The crude was purified on silica gel with 10–50% EtOAc in petroleum ether to give <b>21 (</b>449 mg, 45%) as a white solid.</div><div class="NLM_p last">A mixture of <b>21</b> (1.20 g, 2.07 mmol) and CAN (3.41 g, 6.23 mmol) in CH<sub>3</sub>CN and water (3:1 v/v, 10 mL) was stirred at rt overnight. Chromatography on silica gel with EtOAc in petroleum (1:10 to 1:2) gave <b>22</b> (475 mg, 50%) as a solid. By method A, <b>22</b> (780 mg, 1.7 mmol) was converted to 2′-deoxy-3′,5′-<i>O-</i>dibenzyl-2′-fluoro-4′-fluoromethylcytidine. A mixture of the crude cytidine, MMTrCl (2.02 g, 6.6 mmol) and AgNO<sub>3</sub> (1.11 g, 6.6 mmol) in DCM (15 mL) was stirred at rt overnight. Chromatography on silica gel with 10–35% EtOAc in petroleum ether gave <b>23</b> as a white solid (520 mg, 40%). A mixture of <b>23</b> (520 mg, 0.71 mmol), ammonium formate (2.0 g, 31.7 mmol), and 10% Pd/C (1.0 g) in acetone was refluxed for 12 h. Then the catalyst was filtered off and the filtrate concentrated. Chromatography on silica gel with 1–15% MeOH in DCM gave 270 mg (68%) of the debenzylated product. A solution of the debenzylated intermediate (130 mg, 0.24 mmol) in 80% formic acid (20 mL) was stirred at 50 °C for 12 h, then solvent was evaporated and the residue coevaporated with toluene. Chromatography on silica gel with 10% MeOH in DCM gave 45 mg (72%) of <b>2b</b> as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.00 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 6.13 (dd, <i>J</i> = 3.6 Hz, 16.0 Hz, 1H, H-1′), 5.89 (d, <i>J</i> = 7.2 Hz, 1H, H-5), 5.19 (ddd, <i>J</i> = 3.6 Hz, 5.2 Hz, 53.6 Hz, 1H, H-2′), 4.60 (s, 1H, H-3′), 4.54 (m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>F), 3.84 (dd, <i>J</i> = 2.0 Hz, 12.0 Hz, 1H, H-5′a), 3.75 (dd, <i>J</i> = 2.0 Hz, 12.0 Hz, 1H, H-5′b). MS, <i>m</i>/<i>e</i> 277.8 (M + 1)<sup>+</sup>, 554.8 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 4′-Bromomethyl-2′-deoxy-2′-fluorocytidine (<b>2d</b>)</h3><div class="NLM_p last">A solution of <b>4</b> (50 g, 203 mmol) and TBDPS-Cl (83.7 g, 304 mmol) in pyridine (200 mL) was stirred overnight. Workup gave 94 g of crude 2′-deoxy-2′-fluoro-5′-<i>O</i>-TBDPS-uridine. To a solution of the 5′-<i>O</i>-TBDPS-uridine in DCM (300 mL) were added silver nitrate (66 g, 388 mmol), collidine (235 mL, 1.78 mol), and MMTrCl (239 g, 777 mmol). The mixture was stirred at rt overnight. Precipitate was filtered through Celite, and filtrate was diluted with MTBE and washed successively with 1 M citric acid, brine, and 5% sodium bicarbonate. The crude 3′-<i>O</i>-MMTr intermediate was dissolved in THF (250 mL), and TBAF (60 g, 233 mmol) added and kept at rt for 2 h. After evaporation, chromatography on silica gel with 15–50% EtOAc in petroleum ether gave 91 g (86%) of <b>26</b> as a white foam. By the similar procedure as described for conversion of <b>5</b> to <b>7</b>, compound <b>26</b> (13.5 g, 26 mmol) was converted to <b>29</b> (9.2 g, 63%) as a white foam.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Method B: A Representative Procedure for Preparation of 4′-Substituted Uridines via 2,5′-Anhydrouridines <b>35</b>–<b>37</b></h3><div class="NLM_p last">Compound <b>29</b> (23 g, 42.0 mmol) was coevaporated with toluene, then dissolved in DCM (250 mL) and pyridine (20 mL) and cooled to −35 °C when triflic anhydride (24.9 g, 88.1 mmol) was added dropwise. The reaction mixture was stirred at this temperature for 40 min. After workup, the residue was purified on silica gel with 10–50% EtOAc in petroleum ether to give 30 g (88%) of <b>32</b> as a foam. To a solution of <b>32</b> (4.2 g, 5.17 mmol) in DMF (50 mL) at 0 °C was added NaH (60% in mineral oil, 227 mg, 5.7 mmol) and kept for 2 h. Then LiBr (1.34 g, 15.5 mmol) was added and the mixture stirred at rt overnight. Chromatography on silica gel with 10% EtOAc in petroleum ether gave 2 g (66%) of the 4′-bromomethyl-2,5′-annhydrouridine as a yellowish solid. To a solution of the 4′-bromomethyl intermediate (1.74 g, 2.9 mmol) in THF (20 mL) at 0 °C was added 1 M NaOH (3.2 mL) and stirred at 0 °C for 2 h. Chromatography on silica gel with 20% EtOAc in petroleum ether gave <b>38</b> (1.6 g, 90%) as a yellow solid. Compound <b>38</b> (2.3 g, 3.76 mmol) was tritylated by the procedure used in preparation of <b>26</b> to give 2.4 g (73%) of <b>42</b>, which was converted to 1.5 g (62%) of the corresponding cytidine according to method A. The cytidine derivative (1.35 g, 1.5 mmol) was dissolved in 80% AcOH (40 mL) and stirred at 60 °C for 2 h. After evaporation, chromatography on silica gel with 5% MeOH in DCM gave 180 mg (35%) of <b>2d</b> as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.00 (d, <i>J</i> = 7.2 Hz, 1H, H-6), 6.12 (dd, <i>J</i> = 3.6 Hz, 15.6 Hz, 1H, H-1′), 5.88 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 5.10 (dd, <i>J</i> = 4.8 Hz, 53.2 Hz, 1H, H-2′), 4.59 (dd, <i>J</i> = 5.2 Hz, 16.4 Hz, 1H, H-3′), 3.95 (d, <i>J</i> = 11.6 Hz, 1H, C<u class="uu">H</u><sub>2</sub>Br), 3.76 (d, <i>J</i> = 11.6 Hz, 1H, C<u class="uu">H</u><sub>2</sub>Br), 3.70 (d, <i>J</i> = 11.4 Hz, 1H, H-5′a), 3.63 (d, <i>J</i> = 11.4 Hz, 1H, H-5′b). MS, <i>m</i>/<i>e</i> 337.9 (M + 1)<sup>+</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2′-Deoxy-2′-fluoro-4′-methylthiomethylcytidine (<b>2k</b>)</h3><div class="NLM_p last">According to method B, <b>32</b> (3.0 g, 3.69 mmol) was converted to <b>35</b>, then, to the stirred reaction mixture in DMF was added NaSMe (9.0 g, 0.13 mol) and 15-crown-5 (4.87 g, 22.1 mmol) at 0 °C under nitrogen. The reaction mixture was stirred at rt for 2 h. Chromatography on silica gel with EtOAc in petroleum ether (2:5) gave 1.23 g (59%) of <b>39</b> as a white foam. Compound <b>39</b> (1.34 g, 2.3 mmol) was converted to 1.29 g (66%) of <b>43</b>, and 828 mg (0.97 mmol) of <b>43</b> was further converted to <b>2k</b> (127 mg, 43%) as a white solid by the same method as described for <b>2d</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.05 (d, <i>J</i> = 7.2 Hz, 1H, H-6), 6.11 (dd, <i>J</i> = 3.2 Hz, 15.6 Hz, 1H, mH-1′), 5.87 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 5.05 (ddd, <i>J</i> = 3.6 Hz, 4.8 Hz, 53.6 Hz, 1H, H-2′), 4.47 (dd, <i>J</i> = 5.0 Hz, 17.4 Hz, 1H, H-3′), 4.00 (d, <i>J</i> = 12.0 Hz, 1H, H-5′a) 3.67 (d, <i>J</i> = 12.0 Hz, 1H, H-5′b), 2.94 (d, <i>J</i> = 14.4 Hz, 1H, C<u class="uu">H</u><sub>2</sub>SCH<sub>3</sub>), 274 (d, <i>J</i> = 14.4 Hz, 1H, C<u class="uu">H</u><sub>2</sub>SCH<sub>3</sub>), 2.15 (s, 3H, SCH<sub>3</sub>). MS, <i>m</i>/<i>e</i> 305.8 (M + 1)<sup>+</sup>, 610.7 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4′-Chloromethyl-2′-deoxy-2′-fluoro-arabinocytidine (<b>3a</b>)</h3><div class="NLM_p last">2′-Deoxy-2′-fluoro-arabinouridine (<b>24</b>, 8.67 g, 35.2 mmol) was converted to <b>27</b> (15.0 g, 82%) as a white solid by the same procedure as described for <b>26</b>. Compound <b>30</b> (9.6 g, 56%) was prepared from <b>27</b> (11 g, 21.1 mmol) according to the procedure as described for <b>29</b>. Compound <b>30</b> was converted to 3.75 g (58%) of <b>40</b> as a foam according to method B, with LiCl as the nucleophile for anhydro-ring opening. Compound <b>40</b> (3.75 g, 6.6 mmol) was converted to <b>44</b> (2.7 g, 60%) by the standard silylation procedure as used for <b>26</b>. The uridine <b>44</b> (2.25 g, 3.3 mmol) was converted to its corresponding cytidine (2.0 g, 88%) according to method A. Then the 3′,5′-protected cytidine intermediate (2.6 g, 3.82 mmol) was converted to the <i>N</i><sup>4</sup>-MMTr derivative by the same procedure used for <b>26</b>. After removal of the 5′-<i>O</i>-TBS by TBAF, <i>N</i><sup>4</sup>,3′-<i>O</i>-bis(4-methoxytrityl)-4′-chloromethyl-2′-deoxy-2′-fluoro-arabinocytidine (1.9 g, 64%) was obtained, part (1.5 g, 1.53 mmol) of which was detritylated by the same procedure used for <b>2d</b>. The crude was purified on silica gel with 5% MeOH in DCM to give <b>3a</b> (320 mg, 70%) as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.82 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 6.34 (dd, <i>J</i> = 3.0 Hz, 17.4 Hz, 1H, H-1′), 5.89 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 5.16 (d, <i>J</i> = 52.8 Hz, 1H, H-2′), 4.46 (d, <i>J</i> = 16.8 Hz, 1H, H-3′), 3.74–3.90 (m, 4H, CH<sub>2</sub>Cl, H-5′a, H5′b). MS, <i>m</i>/<i>e</i> 293.9 (M + 1)<sup>+</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4′-Chloromethyl-2′-deoxy-2′,2′-difluorocytidine (<b>3b</b>)</h3><div class="NLM_p">A solution of 2′-deoxy-2′,2′-difluorocytidine hydrochloride (30 g, 100 mmol) and BzCl (56.0 g, 400 mmol) in pyridine (300 mL) was stirred at rt overnight. Chromatography on silica gel with EtOAc in petroleum ether gave the 3′,5′-<i>O</i>-<i>N</i><sup>4</sup>-tribenzoylated derivative (55.0 g), which was dissolved in 80% AcOH, then refluxed overnight. Chromatography on silica gel with 20–35% EtOAc in hexanes gave 39.2 g of 3′,5′-<i>O</i>-dibenzoyl-2′-deoxy-2′,2′-difluorouridine as a white solid, which was dissolved in saturated methanolic ammonia and kept at rt overnight. After evaporation, the residue was purified on silica gel with 2–5% MeOH in DCM to give 21 g (70%) of <b>25</b><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> as a white solid.</div><div class="NLM_p last">Compound <b>45</b> was prepared from <b>25</b> according to the same procedure as described for <b>44</b> from <b>24</b>. The uridine <b>45</b> (1.24 g, 1.78 mmol) was converted to its corresponding cytidine (1.0 g, 81%) according method A. The 3′-<i>O</i>-MMTr cytidine was dissolved in 80% formic acid (10 mL) and kept at rt overnight. Chromatography on silica gel with 5% MeOH in DCM gave <b>3b</b> (264 mg, 49%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), δ 7.61 (d, <i>J</i> = 7.4 Hz, 1H, H-6), 7.37, 7.32 (2 br s, 2H, NH<sub>2</sub>), 6.62 (d, <i>J</i> = 5.9 Hz, 1H, 3′-OH), 6.26 (t, <i>J</i> = 8.6 Hz, 1H, H-1′), 5.76 (d, <i>J</i> = 7.4 Hz, 1H, H-5), 5.44 (br, 1H, 5′-OH), 4.42 (m, 1H, H-3′), 3.81 (d, <i>J</i> = 12.1 Hz, 1H, CH<sub>2</sub>Cl), 3.71 (d, <i>J</i> = 12.5 Hz, 1H, CH<sub>2</sub>Cl), 3.68, 3.54 (2 m, 2H, H5′a, H5′b). MS, <i>m</i>/<i>e</i> 311.9 (M + 1)<sup>+</sup>, 623.0 (2 M + 1)<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2′-Deoxy-4′-ethynyl-2′-fluorocytidine (<b>2g</b>)</h3><div class="NLM_p last">Compound <b>46</b> (10 g, 40.8 mmol) was converted to 21.4 g (66%) of <b>47</b> by the same procedure as described for <b>26</b> with an exception that 4 equiv of each of MMTrCl, AgNO<sub>3</sub>, and collidine were used in the tritylation step. By the similar procedure as described for <b>7</b>, compound <b>47</b> (4.0 g, 5.1 mmol) was converted to the diol <b>48</b> (2.5 g, 60%) as a yellowish solid. To a solution of <b>48</b> (4.0 g, 4.9 mmol) in pyridine (20 mL) at 0 °C was added dropwise a solution of TBSCl in pyridine (1.0 M, 5.9 mL). The mixture was stirred at rt overnight. Chromatography on silica gel with 1% MeOH in DCM gave the silylated crude product (3.2 g), which was tritylated at the 5-OH by the same procedure as described for <b>26</b>. The resulting <i>N</i><sup>4</sup>,3′,5′-<i>O</i>-tris-MMTr intermediate (3.3 g) was desilylated by a similar procedure used for <b>26</b>. Chromatography on silica gel with 1% MeOH in DCM gave a mixture of two major products, which were separated by preparative HPLC (CH<sub>3</sub>CN and 0.1% HCOOH in water) to give 1.5 g (28%) of <b>49</b> as a white solid. Compound <b>49</b> (1.5 g, 1.22 mmol) was converted to the 4′-(2-chlorovinyl) Wittig product (1.1 g) by a similar procedure as described for <b>13</b> except that Ph<sub>3</sub>PCH<sub>3</sub>Br was replaced by Ph<sub>3</sub>P(ClCH<sub>2</sub>)Br. To a solution of the Wittig product in THF (40 mL) at −78 °C was added dropwise <i>n</i>-BuLi (2.5 M, 6 mL). The mixture was stirred at −78 °C for 5 h and then quenched with water. Chromatography on silica gel with 2% MeOH in DCM gave 910 mg (61%) of <b>50</b>, which was dissolved in 80% AcOH (50 mL) and kept at 40 °C overnight. Purification by RP HPLC (CH<sub>3</sub>CN and 0.1% HCOOH in water) gave 101 mg (45%) of <b>2g</b> as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.90 (d, <i>J</i> = 7.2 Hz, 1H H-6), 6.04 (d, <i>J</i> = 19.6 Hz, 1H, H-1′), 5.87 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 5.00 (dd, <i>J</i> = 5.2 Hz, 53.6 Hz, 1H, H-2′), 4.47 (dd, <i>J</i> = 5.2 Hz, 22.8 Hz, 1H, H-3′), 3.86 (d, <i>J</i> = 12.4 Hz, 1H, H-5′a), 3.73 (d, <i>J</i> = 12.4 Hz, 1H, H-5′b), 3.08 (s, 1H, −CCH). MS, <i>m</i>/<i>e</i> 270.09 (M + 1)<sup>+</sup>, 539.17 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4′-Allyl-2′-deoxy-2′-fluorocytidine (<b>2h</b>)</h3><div class="NLM_p">To a stirred suspension of <b>4</b> (20.0 g, 81.3 mmol), imidazole (15.9 g, 234.0 mmol), PPh<sub>3</sub> (53.5 g, 203.3 mmol), and pyridine (90 mL) in anhydrous THF (360 mL) at 0 °C was added dropwise a solution of iodine (41.3 g, 162.6 mmol) in THF (350 mL). The mixture was stirred at rt overnight, then quenched with aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (150 mL). Chromatography on silica gel with 1–10% MeOH in DCM gave 22.1 g of the 5′-iodo product as a white solid, which was then dissolved in THF (200 mL) and cooled to 0 °C. DBU (14.2 g, 93.1 mmol) in THF (50 mL) was added, then the mixture was stirred at 60 °C for 6 h. Chromatography on silica gel with 1–3% MeOH in DCM gave 8.7 g (47%) of <b>51</b><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> as a white solid, part (3.2 g, 14.0 mmol) of which was converted to the 3′-<i>O</i>-TBS derivative (3.4 g, 71%) by the same procedure as described for <b>5</b>. To a stirred solution of the 3′-<i>O</i>-TBS product (250 mg, 0.73 mmol) in DCM (20 mL) at −40 °C was added the DMDO in acetone (30 mL) generated by a standard procedure.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The resulting solution was stirred at rt for 2 h, then concentrated to give the crude <b>52</b>. To a stirred solution of the crude <b>52</b> (from 2 × 250 mg of <b>51</b>, 1.46 mmol) in DCM (50 mL) at −40 °C was added allyltrimethylsilane (760 mg, 6.7 mmol) and SnCl<sub>4</sub> (1.2 g, 4.5 mmol). The mixture was then warmed to and stirred at 0 °C for 1 h. The crude product was purified on silica gel with 20–50% EtOAc in petroleum ether to give <b>53</b> (120 mg, 41%) as a white foam.</div><div class="NLM_p last">Compound <b>53</b> (270 mg, 0.68 mmol) was converted to <b>54</b> (280 mg, 0.54 mmol) by the same procedure as described for <b>5</b>. According to method A, <b>54</b> was converted via <b>55</b> to <b>2h</b> (54 mg, 35%) as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.13 (d, <i>J</i> = 8.4 Hz, 1H, H-6), 6.12 (dd, <i>J</i> = 3.2 Hz, 12.0 Hz, 1H, H-1′), 5.97–5.87 (m, 2H, H-5, −C<u class="uu">H</u>═CH<sub>2</sub>), 5.06 (ddd, <i>J</i> = 3.2 Hz, 5.2 Hz, 53.6 Hz, 1H, H-2′), 5.04–5.11 (m, 2H, −CH═C<u class="uu">H</u><sub>2</sub>), 4.45 (dd, <i>J</i> = 5.2 Hz, 17.6 Hz, 1H, H-3′), 3.71 (d, <i>J</i> = 11.6 Hz, 1H, H-5′a), 3.54 (d, <i>J</i> = 11.6 Hz, 1H, H-5′b), 2.57 (dd, <i>J</i> = 6.6 Hz, 14.6 Hz, 1H, −C<u class="uu">H</u><sub>2</sub>CH═CH<sub>2</sub>), 2.36 ((dd, <i>J</i> = 8.2 Hz, 14.6 Hz, 1H, −C<u class="uu">H</u><sub>2</sub>CH═CH<sub>2</sub>)). MS, <i>m</i>/<i>e</i> 286.0 (M + 1)<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2′-Deoxy-2′-fluoro-4′-propylcytidine (<b>2i</b>)</h3><div class="NLM_p last">Compound <b>55</b> (270 mg, 0.5 mmol) was converted to the <i>N</i><sup>4</sup>-MMTr derivative by the same procedure as described for <b>26</b> to give <b>56</b> (300 mg, 76%). A mixture of <b>56</b> (250 mg, 0.3 mmol) and 10% Pd/C (500 mg) in MeOH was stirred under hydrogen (balloon) overnight. After filtration and evaporation, chromatography on silica gel with 30% EtOAc in petroleum ether gave <b>57</b> (210 mg), which was desilylated by the same procedure used for <b>26</b> to give 111 mg (74%) of <b>58</b> as a white foam. Compound <b>58</b> (81 mg, 0.14 mmol) was detritylated by the same procedure as described for <b>3b</b> to give <b>2i</b> (27 mg, 65%) as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.05 (d, <i>J</i> = 7.6 Hz, 1H, mH-6), 6.06 (dd, <i>J</i> = 3.2 Hz, 16.0 Hz, 1H, H-1′), 5.87 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 5.03 (ddd, <i>J</i> = 3.4 Hz, 5.4 Hz, 54.0 Hz, 1H, H-2′), 4.43 (dd, <i>J</i> = 5.6 Hz, 17.2 Hz, 1H, H-3′), 3.75 (d, <i>J</i> = 12.0 Hz, 1H, H-5′a), 3.56 (d, <i>J</i> = 12.0 Hz, 1H, H-5′b), 1.74, 1.57 (2m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>CH<sub>3</sub>), 1.34–1.52 (m, 2H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>), 0.94 (t, <i>J</i> = 7.2 Hz, 3H, CH<sub>2</sub>CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">3</u></sub>). MS, <i>m</i>/<i>e</i> 288.2 (M + 1)<sup>+</sup>, 575.4 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2′-Deoxy-2′-fluoro-4′-methoxycytidine (<b>2l</b>)</h3><div class="NLM_p last">To a solution of <b>51</b> (5.23 g, 23.1 mmol) and PbCO<sub>3</sub> (12.7 g, 46.3 mmol) in MeOH (100 mL) at 0 °C was added dropwise iodine (11.7 g, 46.3 mmol) in MeOH (10 mL), the mixture was stirred at rt overnight, then quenched with Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>. Chromatography on silica gel with 1–5% MeOH in DCM gave 5.6 g (72%) of <b>59</b> as a white solid, which was dissolved in pyridine (20 mL). Then BzCl (2.9 g, 20.9 mmol) was added and the resulting mixture stirred at rt for 10 h. Chromatography on silica gel with 20–40% EtOAc in petroleum ether gave 4.9 g of <b>60</b> as a white foam, which was heated with BzONa (14.4 g, 100 mmol) and 15-crown-5 (22.0 g, 100 mmol) in DMF (200 mL) at 60–70 °C for 3 days. Chromatography on silica gel with 20–60% EtOAc in petroleum ether gave 2.3 g (35%) of <b>61</b>. The uridine <b>61</b> (2.3 g, 4.8 mmol) was converted to the cytidine product (1.2 g) according to method A, which was further benzoylated on the cytosine base by the same procedure used for <b>60</b> to give the <i>N</i><sup>4</sup>-Bz derivative <b>62</b> (460 mg, 15%). The latter was dissolved in saturated methanolic ammonia (100 mL) and kept at rt overnight. After evaporation, the residue was purified by RP HPLC (0.1% formic acid in water/acetonitrile) to give <b>2l</b> (145 mg, 79%) as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.88 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 6.03 (d, <i>J</i> = 18.6 Hz, 1H, H-1′), 5.87 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 4.86–5.00 (m, 1H, H-2′), 4.49 (dd, <i>J</i> = 5.8 Hz, 22.8 Hz, 1H, H-3′), 3.90 (d, <i>J</i> = 12.0 Hz, 1H, H-5′a), 3.66 (d, <i>J</i> = 12.0 Hz, 1H, H-5′b), 3.41 (s, 3H, OC<u class="uu">H</u><sub><u class="uu">3</u></sub>). MS, <i>m</i>/<i>e</i> 276.0 (M + 1)<sup>+</sup>, 551.1 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4′-Chloromethylcytidine (<b>3d</b>)</h3><div class="NLM_p last">Compound <b>63</b>, prepared by a procedure similar to the published,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> was converted to <b>65</b> in 17% yield by a multistep procedure as described for <b>40</b>. Compound <b>65</b> (3.0 g, 8.37 mmol) was converted to the 5′-<i>O</i>-Bz product (3.0 g, 77%) by the same procedure used for <b>60</b>. The 5′-<i>O</i>-Bz intermediate (2.0 g, 4.33 mmol) was converted to the cytidine <b>66</b> according to method A. Chromatography on silica gel with EtOAc/petroleum ether (1:1) gave pure <b>66</b> (1.0 g, 50%) as a colorless syrup, which was deprotected with 80% formic acid (3 mL) at 40 °C and then with NH<sub>3</sub>/MeOH to give 250 mg (40%) of <b>3d</b> as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.93 (d, <i>J</i> = 7.2 Hz, 1H, H-6), 5.97 (d, <i>J</i> = 6.8 Hz, 1H, H-1′), 5.91 (d, <i>J</i> = 7.2 Hz, 1H, H-5), 4.39 (m, 1H, H-2′), 4.26 (d, <i>J</i> = 5.6 Hz, 1H, H-3′), 3.80 (m, 4H, CH<sub>2</sub>Cl, H-5′a, H-5′b). MS, <i>m</i>/<i>e</i> 291.9 (M + 1)<sup>+</sup>, 583.1 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4′-Chloromethyl-arabinocytidine (<b>3c</b>)</h3><div class="NLM_p last">A solution of <b>65</b> (0.5 g, 1.4 mmol) in 80% formic acid (20 mL) was heated at 50 °C for 8 h. Chromatography on silica gel with 5% MeOH in EtOAc gave 306 mg (75%) of 4′-chloromethyluridine. A mixture of 4′-chloromethyluridine (1.16 g, 3.96 mmol), diphenyl carbonate (1.03 g, 4.76 mmol), and sodium hydrogen carbonate (20 mg, 0.23 mmol) in DMF (50 mL) was stirred at 100 °C under nitrogen until the conversion was completed. Chromatography on silica gel with 30% EtOAc in petroleum ether gave 0.86 g (80%) of <b>67</b>. To a solution of <b>67</b> (1.0 g, 3.65 mmol) in EtOH and water (15 mL, 9:1) was added NaOH (0.45 g, 11.3 mmol), then stirred at rt overnight. Chromatography on silica gel with EtOAc gave 0.8 g (75%) of 4′-chloromethyl-arabinouridine. A mixture of 4′-chloromethyl-arabinouridine (50 mg, 0.17 mmol), AgNO<sub>3</sub> (300 mg, 1.8 mmol), imidazole (300 mg, 4.4 mmol), and TBSCl (300 mg, 2 mmol in DMF (1 mL) was stirred at 100 °C for 5 h. Chromatography on silica gel with 5% EtOAc in petroleum ether gave the 2′,3′,5′-tris-<i>O</i>-TBS derivative (87 mg, 80%). The tris-<i>O</i>-TBS-arabinouridine (200 mg, 0.32 mmol) was converted to the corresponding cytidine according to method A. The crude was purified on silica gel with 20% EtOAc in petroleum ether to give 130 mg (65%) of <b>68</b> as a colorless syrup. A solution of <b>68</b> (100 mg, 0.158 mmol), 2,4,6-trimethylpyridine (600 mg, 4.95 mmol), AgNO<sub>3</sub> (600 mg, 3.55 mmol), and DMTrCl (120 mg, 0.32 mmol) in DCM (0.5 mL) was stirred at rt for 5 h. A usual workup and chromatography on silica (5% EtOAc in PE) gave an <i>N</i><sup>4</sup>-(4-methoxytruityl) product (130 mg, 65%) as a colorless syrup. A solution of the product (100 mg, 0.106 mmol) and NH<sub>4</sub>F (0.1 g, 2.78 mmol) in MeOH (3 mL) was refluxed overnight. A usual workup and chromatography on silica gel (EtOAc in petroleum ether 2:1) gave 4′-chloromethyl-<i>N</i><sup>4</sup>-(4-methoxytrityl)arabinocytidine (54 mg, 85%) as a syrup. A solution of latter (100 mg, 0.17 mmol) in 80% TFA in water (5 mL) was stirred at 50 °C for 3 h, then TFA was removed by evaporation. The residue was washed with DCM to give <b>3c</b> (27 mg, 55%) as a white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD), δ = 7.89 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 6.17 (d, <i>J</i> = 3.6 Hz, 1H, H-1′), 5.80 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 4.22 (t, <i>J</i> = 2.8 Hz, 1H, H-2′), 4.10 (d, <i>J</i> = 2.4 Hz, 1H, H-3′), 3.89–3.75 (m, 4H, CH<sub>2</sub>Cl, H-5′a, H-5′b). MS, <i>m</i>/<i>e</i> 292.0 (M + 1)<sup>+</sup>, 583.1 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4′-Chloromethyl-2′-deoxy-3′,5′-di-<i>O</i>-isobutyryl-2′-fluorocytidine (<b>71</b>)</h3><div class="NLM_p last">Compound <b>69</b> was prepared from <b>16</b> by a similar approach as conversion of <b>55</b> to <b>58</b>. A mixture of <b>69</b> (170 mg, 0.3 mmol) and isobutyric anhydride (0.1 mL; 0.6 mmol) in pyridine (3 mL) was stirred at rt overnight. Chromatography on silica gel with 30–100% EtOAc in hexanes gave the 3′,5′-di-<i>O</i>-isobutyryl product (180 mg), which was dissolved in 80% formic acid (5 mL) and heated at 35–40 °C for 3 h. After evaporation, the residue was purified on silica gel with 4–10% MeOH in DCM to give <b>71</b> (75 mg, 59%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.68 (d, <i>J</i> = 7.4 Hz, 1H, H-6), 7.40 (s, 2H, NH<sub>2</sub>), 5.92 (dd, <i>J</i> = 2.2 Hz, 21.7 Hz, 2.4 Hz, 1H, H-1′), 5.73 (m, 2H, H-5, H-3′), 5.57 (ddd, <i>J</i> = 2.4 Hz, 5.7 Hz, 53.6 Hz, 1H, H-2′), 4.26 (d, <i>J</i> = 11.3 Hz, 1H, H-5′a), 4.25 (d, <i>J</i> = 11.3 Hz, 1H, H-5′b), 3.86 (d, <i>J</i> = 12.1 Hz, 1H, C<u class="uu">H</u><sub>2</sub>Cl), 3.80 (d, <i>J</i> = 12.1 Hz, 1H, C<u class="uu">H</u><sub>2</sub>Cl), 2.66 (sept, <i>J</i> = 7.0 Hz, 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 2.58 (sept, <i>J</i> = 7.0 Hz, 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 1.14 (d, <i>J</i> = 7.0 Hz, 6H, CH(C<u class="uu">H</u><sub><u class="uu">3</u></sub><u class="uu">)</u><sub><u class="uu">2</u></sub>), 1.09, 1.08 (2d, <i>J</i> = 7.0 Hz, 6H, CH(C<u class="uu">H</u><sub><u class="uu">3</u></sub><u class="uu">)</u><sub><u class="uu">2</u></sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 167 (C-4), 176 (<u class="uu">C</u>OCH(CH<sub>3</sub>)<sub>2</sub>), 175 (<u class="uu">C</u>OCH(CH<sub>3</sub>)<sub>2</sub>), 156 (C-2), 144 (C-6), 95 (C-5), 93 (C-1′), 92 (C-2′), 83 (C-4′), 72 (C-3′), 64 (C-5′), 44 (<u class="uu">C</u>H<sub>2</sub>Cl), 33 (2<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub>), 19 (2CH(<u class="uu">C</u>H<sub>3</sub>)<sub>2</sub>). <sup>19</sup>F NMR (DMSO-<i>d</i><sub>6</sub>) δ −193.49 (ddd, <i>J</i> = 16.2 Hz, 21.0 Hz, 53.1 Hz). MS, <i>m</i>/<i>e</i> 434.2 (M+1)<sup>+</sup>, 867.5 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 4′-Chloromethyl-2′-deoxy-3′,5′-di-<i>O</i>-propionyl-2′-fluorocytidine (<b>70</b>)</h3><div class="NLM_p last">As a white solid, <b>70</b> was prepared from <b>69</b> and propionic anhydride in 60% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.61 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 7.32 (br s, 2H, NH<sub>2</sub>), 5.85 (dd, <i>J</i> = 2.5 Hz, 21.6 Hz, 1H, H-1′), 5.72 (dd, <i>J</i> = 5.7 Hz, 16.4 Hz, 1H, H-3′), 5.68 (d, <i>J</i> = 7.3 Hz, 1H, H-5), 5.50 (ddd, <i>J</i> = 2.5 Hz, 5.7 Hz, 53.6 Hz, 1H, H-2′), 4.27 (d, <i>J</i> = 11.3 Hz, 1H, H-5′a), 4.16 (d, <i>J</i> = 11.5 Hz, 1H, H-5′b), 3.83 (d, <i>J</i> = 12.1 Hz, 1H, CH<sub>2</sub>Cl), 3.75 (d, <i>J</i> = 12.1 Hz, 1H, CH<sub>2</sub>Cl), 2.37 (m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>), 2.29 (m, 2H, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>), 1.01 (t, <i>J</i> = 7.5 Hz, 3H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">3</u></sub>), 0.95 (t, <i>J</i> = 7.5 Hz, 3H, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">3</u></sub>). MS, <i>m</i>/<i>e</i> 404.2 (M – 1)<sup>−</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4′-Chloromethyl-2′-deoxy-3′,5′-di-<i>O</i>-pentanoyl-2′-fluorocytidine (<b>72</b>)</h3><div class="NLM_p last">As a white solid, <b>72</b> was prepared from <b>69</b> and valeric anhydride in 61% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.64 (d, <i>J</i> = 7.4 Hz, 1H, H-6), 7.36 (br s, 2H, NH<sub>2</sub>), 5.90 (dd, <i>J</i> = 2.4 Hz, 21.4 Hz, 1H, H-1′), 5.75–5.70 (m, 2H, H-5, H-3′), 5.54 (ddd, <i>J</i> = 2.6 Hz, 5.6 Hz, 53.5 Hz, 1H, H-2′), 4.27 (d, <i>J</i> = 11.4 Hz, 1H, H-5′a), 4.21 (d, <i>J</i> = 11.4 Hz, 1H, H-5′b), 3.86 (d, <i>J</i> = 12.1 Hz, 1H, CH<sub>2</sub>Cl), 3.78 (d, <i>J</i> = 12.1 Hz, 1H, CH<sub>2</sub>Cl), 2.39 (m, 2H, COC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 2.31 (m, 2H, COC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.50, 1.27 (2m, 2 × 4H, 2 CH<sub>2</sub>(C<u class="uu">H</u><sub><u class="uu">2</u></sub><u class="uu">)</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>), 0.84 (m, 6H, 2 CH<sub>3</sub>). MS, <i>m</i>/<i>e</i> 462.3 (M + 1)<sup>+</sup>, 923.5 (2M + 1)<sup>+</sup>.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4′-Chloromethyl-2′-deoxy-3′,5′-di-<i>O</i>-hexanoyl-2′-fluorocytidine (<b>73</b>)</h3><div class="NLM_p last">As a white solid, <b>73</b> was prepared from <b>69</b> and hexanoic anhydride in 43% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.2 (br s, 1H, NH<sub>2</sub>), 7.32 (d, <i>J</i> = 7.2 Hz, 1H, H-6), 6.8 (br s, 1H, NH<sub>2</sub>), 5.96 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 5.67 (dd, <i>J</i> = 1.8 Hz, 20.2 Hz, 1H, H-1′), 5.60 (dd, <i>J</i> = 5.2 Hz, 17.6 Hz, 1H, H-3′), 5.45 (ddd, <i>J</i> = 1.8 Hz, 5.4 Hz, 53.2 Hz, 1H, H-2′), 4.39 (d, <i>J</i> = 12.0 Hz, 1H, H-5′a), 4.32 (d, <i>J</i> = 11.6 Hz, 1H, H-5′b), 3.78 (d, <i>J</i> = 12.0 Hz, 1H, CH<sub>2</sub>Cl), 3.72 (d, <i>J</i> = 12.4 Hz, 1H, CH<sub>2</sub>Cl), 2.34 (m, 2H, COCH<sub>2</sub>), 2.26 (m, 2H, COCH<sub>2</sub>), 1.58, 1.24 (2m, 4H, 8H, 2 CH<sub>2</sub>(C<u class="uu">H</u><sub><u class="uu">2</u></sub><u class="uu">)</u><sub><u class="uu">3</u></sub>CH<sub>3</sub>), 0.83 (m, 6H, 2 CH<sub>3</sub>). MS, <i>m</i>/<i>e</i> 488.3 (M – 1)<sup>−</sup>.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 4′-Chloromethyl-2′-deoxy-2′-fluoro-3′-<i>O</i>-octanoylcytidine (<b>76</b>), 4′-Chloromethyl-2′-deoxy-2′-fluoro-5′-<i>O</i>-octanoylcytidine (<b>75</b>), and 4′-Chloromethyl-2′-deoxy-3′,5′-di-<i>O</i>-octanoyl-2′-fluorocytidine (<b>74</b>)</h3><div class="NLM_p">To a solution of <b>69</b> (1.26 g, 2.1 mmol) in pyridine (15 mL) were added <i>n</i>-octanoic acid (0.34 mL, 2.1 mmol), DCC (60% in xylene; 0.81 mL, 2.1 mmol), and DMAP (52 mg; 0.42 mmol). The resulting mixture was stirred at rt for 6 h, then the precipitate filtered. The crude was purified on silica gel with 30–100% EtOAc in hexanes to give three acylated products with increasing polarity: 0.57, 0.18, and 0.2 g. A portion of each was treated with 80% formic acid by the same procedure as for <b>71</b> to give the detritylated products. <b>76</b> (44 mg, 9%, 2 steps): <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.74 (d, <i>J</i> = 7.5 Hz, 1H, H-6), 7.34, 7.30 (2 br s, 2H, NH<sub>2</sub>), 6.04 (dd, <i>J</i> = 4.6 Hz, 18.1 Hz, 1H, H-1′), 5.74 (d, <i>J</i> = 7.4 Hz, 1H, H-5), 5.57 (dd, <i>J</i> = 5.5 Hz, 10.1 Hz, 1H, H-3′), 5.42 (m, 1H, H-2′), 5.39 (t, <i>J</i> = 5.4 Hz, 1H, 5′-OH), 3.82 (d, <i>J</i> = 11.7 Hz, 1H, CH<sub>2</sub>Cl), 3.72 (d, <i>J</i> = 11.7 Hz, 1H, CH<sub>2</sub>Cl), 3.66 (m, 1H, H-5′a), 3.57 (m, 1H, H-5′b), 2.38 (m, 2H, COC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.54, 1.23 (2m, 2H, 8H, COCH<sub>2</sub>(C<u class="uu">H</u><sub><u class="uu">2</u></sub><u class="uu">)</u><sub><u class="uu">5</u></sub>CH<sub>3</sub>), 0.83 (m, 3H, CH<sub>3</sub>). MS, <i>m</i>/<i>e</i> 418.2 (M – 1)<sup>−</sup>.</div><div class="NLM_p"><b>75</b> (60 mg, 9%, 2 steps): <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.57 (d, <i>J</i> = 7.4 Hz, 1H, H-6), 7.30, 7.27 (2 br s, 2H, NH<sub>2</sub>), 6.03–5.95 (m, 2H, H-1′, 3′-OH), 5.72 (d, <i>J</i> = 7.4 Hz, 1H, H-5), 5.23 (ddd, <i>J</i> = 3.9 Hz, 5.2 Hz, 53.4 Hz, 1H, H-2′), 4.51 (dt, <i>J</i> = 5.5 Hz, 15.4 Hz, 1H, H-3′), 4.29 (d, <i>J</i> = 11.6 Hz, 1H, H-5′a), 4.16 (d, <i>J</i> = 11.6 Hz, 1H, H-5′b), 3.78 (m, 2H, CH<sub>2</sub>Cl), 2.32 (m, 2H, COC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.49, 1.21 (m, 2H, 8H, COCH<sub>2</sub>(C<u class="uu">H</u><sub><u class="uu">2</u></sub><u class="uu">)</u><sub><u class="uu">5</u></sub>CH<sub>3</sub>), 0.82 (m, 3H, CH<sub>3</sub>). MS, <i>m</i>/<i>e</i> 418 (M – 1)<sup>−</sup>.</div><div class="NLM_p last"><b>74</b> (53 mg, 24%, 2 steps): <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.66 (d, <i>J</i> = 7.4 Hz, 1H, H-6), 7.43, 7.39 (2 br s, 2H, NH<sub>2</sub>), 5.90 (dd, <i>J</i> = 2.5 Hz, 21.6 Hz, 1H, H-1′), 5.73 (m, 2H, H-5, H-3′), 5.54 (ddd, <i>J</i> = 2.5 Hz, 5.7 Hz, 53.4 Hz, 1H, H-2′), 4.26 (d, <i>J</i> = 11.4 Hz, 1H, H-5′a), 4.21 (d, <i>J</i> = 11.4 Hz, 1H, H-5′b), 3.85 (d, <i>J</i> = 12.1 Hz, 1H, CH<sub>2</sub>Cl), 3.77 (d, <i>J</i> = 12.1 Hz, 1H, CH<sub>2</sub>Cl), 2.38 (m, 2H, COC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 2.30 (m, 2H, COC<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.50, 1.21 (2m, 4H, 16H, 2 COCH<sub>2</sub>(C<u class="uu">H</u><sub><u class="uu">2</u></sub><u class="uu">)</u><sub><u class="uu">5</u></sub>CH<sub>3</sub>), 0.83 (m, 6H, 2 CH<sub>3</sub>). MS, <i>m</i>/<i>e</i> 544.3 (M – 1)<sup>−</sup>.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4′-Chloromethyl-2′-deoxy-2′-fluoro-5′-<i>O</i>-(<span class="smallcaps smallerCapital">l</span>-valinyl)cytidine Dihydrochloride (<b>79</b>)</h3><div class="NLM_p last">Compound <b>32</b> (30 g, 36.9 mmol) was converted to 21.3 g (67%) of <b>78</b> as a yellow foam by a similar procedure as described for <b>3a</b>. To a solution of Boc-<span class="smallcaps smallerCapital">l</span>-valine (160 mg, 0.74 mmol) and Et<sub>3</sub>N (140 μL, 1.0 mmol) in THF was added <b>78</b> (395 mg, 0.44 mmol). The mixture was concentrated, coevaporated with pyridine and then with toluene, and redissolved in THF (4 mL). DIPEA (0.38 mL, 2.2 mmol), BOP-Cl (0.28 g, 1.1 mmol), and 3-nitro-1,2,4-triazole (0.13 g, 1.1 mmol) were added successively. The reaction mixture was stirred at rt for 1 h. Chromatography on silica gel with 0.5% Et<sub>3</sub>N and 20–100% EtOAc in hexanes gave the 5′-<i>O</i>-valinyl product (0.39 g, 81%), 0.37 g of which was dissolved in 80% formic acid (10 mL) and kept at rt for 3 h. After evaporation, the residue was suspended in EtOAc (1.5 mL) and mixed with 4 M HCl in dioxane (1.5 mL). The precipitate was collected and purified by RP HPLC (0.5 M formic acid in acetonitrile/water). The resulting formic acid salt was converted to the dihydrochloride salt (<b>79</b>) (63 mg, 40%) as a white solid by suspending in EtOAc (2 mL) and treatment with 4 M HCl in dioxane (2 mL). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.6 (br, 1H, NH), 8.54, 6.22 (2 br s, 3H, H, 2NH<sub>2</sub>), 7.95 (d, J = 7.8 Hz, 1H, H-6), 6.14 (d, <i>J</i> = 7.8 Hz, 1H, H-5), 6.00 (dd, <i>J</i> = 4.8 Hz, 17.2 Hz, 1H, H-1′), 5.39 (ddd, <i>J</i> = 3.7 Hz, 5.1 Hz, 52.8 Hz, 1H, H-2′), 4.58 (dd, <i>J</i> = 5.5 Hz, 15.9 Hz, 1H, H-3′), 4.44 (d, <i>J</i> = 11.7 Hz, 1H, H-5′a), 4.37 (d, <i>J</i> = 11.9 Hz, 1H, H-5′b), 3.94 (m, 1H, C<u class="uu">H</u>NH<sub>2</sub>), 3.90 (d, <i>J</i> = 12.4 Hz, 1H, CH<sub>2</sub>Cl), 3.83 (d, <i>J</i> = 12.4 Hz, 1H, CH<sub>2</sub>Cl), 2.18 (m, 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 0.95 (m, 6H, CH(C<u class="uu">H</u><sub><u class="uu">3</u></sub><u class="uu">)</u><sub><u class="uu">2</u></sub>). MS, <i>m</i>/<i>e</i> 391.2 (M – 1)<sup>−</sup>.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4′-Chloromethyl-2′-deoxy-2′-fluoro-5′-<i>O</i>-isobutyrylcytidine (<b>80</b>)</h3><div class="NLM_p last">As a white solid, <b>80</b> was prepared in 65% yield from <b>78</b> by the same procedure as described for <b>71</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.58 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 7.28, 7.30 (2 br s, 2H, NH<sub>2</sub>), 6.00 (br s, 1H, 3′-OH), 5.96 (dd, <i>J</i> = 3.6 Hz, 18.0 Hz, 1H, H-1′), 5.73 (d, <i>J</i> = 7.4 Hz, 1H, H-5), 5.24 (ddd, <i>J</i> = 3.7 Hz, 5.3 Hz, 53.6 Hz, 1H, H-2′), 4.55 (dd, <i>J</i> = 5.1 Hz, 15.9 Hz, 1H, H-3′), 4.29 (d, <i>J</i> = 11.7 Hz, 1H, H-5′a), 4.16 (d, <i>J</i> = 11.7 Hz, 1H, H-5′b), 3.80 (m, 2H, CH<sub>2</sub>Cl), 2.58 (sept, <i>J</i> = 7.0 Hz 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 1.08 (d, <i>J</i> = 7.0 Hz, 3H, CH<sub>3</sub>), 1.07 (d, <i>J</i> = 7.0 Hz, 3H, CH<sub>3</sub>). MS, <i>m</i>/<i>e</i> 364.2 (M + 1)<sup>+</sup>.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4′-Chloromethyl-2′-deoxy-2′-fluoro-3′-<i>O</i>-(<span class="smallcaps smallerCapital">l</span>-valinyl)cytidine Dihydrochloride (<b>81</b>)</h3><div class="NLM_p last">A solution of <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-valine (0.41 g, 1.9 mmol) and CDI (0.31 g, 1.9 mmol) in THF (9 mL) was stirred at rt for 1.5 h and then at 40 °C for 20 min, The resulting solution was added to a stirred solution of <b>2c</b> (0.42 g, 1.43 mmol), DMAP (25 mg, 0.2 mmol), and Et<sub>3</sub>N (4 mL) in DMF (8 mL) at 80 °C.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The mixture was stirred at 80 °C for 1 h, then cooled and concentrated. Chromatography on silica gel with 2–10% MeOH in DCM gave the crude valinyl derivative, which was further purified by RP-HPLC (MeOH/water) to give 0.25 g (35%) of the 3′-<i>O</i>-valinyl product. A solution of the 3′-<i>O</i>-valinyl intermediate (0.12 g; 0.24 mmol) in EtOAc (0.6 mL) was mixed with 4 M HCl in dioxane (0.6 mL) and shaken for 20 min. A white precipitate was filtered, washed with diethyl ether, and dried to give 95 mg (85%) of <b>81</b> as a dihydrochloride salt. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.8, 8.7 (2 br s, 1H, 4H, NH<sub>2</sub>, NH<sub>3</sub><sup>+</sup>), 8.13 (d, <i>J</i> = 8.0 Hz, 1H, H-6), 6.18 (d, <i>J</i> = 8.0 Hz, 1H, H-5), 6.13 (dd, <i>J</i> = 3.0 Hz, 17.4 Hz, 1H, H-1′), 5.68–5.52 (m, 2H, H-2, H-3′), 4.06 (d, <i>J</i> = 12.0 Hz, 1H, H-5′a), 3.96 (br s, 1H, C<u class="uu">H</u>NH<sub>2</sub>), 3.88 (d, <i>J</i> = 12.0 Hz, 1H, H-5′b), 3.69 (s, 2H, CH<sub>2</sub>Cl), 2.24 (m, 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 0.97 (m, 6H, CH(C<u class="uu">H</u><sub><u class="uu">3</u></sub><u class="uu">)</u><sub><u class="uu">2</u></sub>). MS, <i>m</i>/<i>e</i> 391.1 (M – 1)<sup>−</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 4′-Chloromethyl-2′-deoxy-2′-fluoro-3′-<i>O</i>-isobutyrylcytidine (<b>84</b>)</h3><div class="NLM_p last">Compound <b>7</b> was converted to <b>82</b> in 62% yield by a similar procedure as described for <b>40</b>. Compound <b>83</b> was prepared in 29% yield from <b>82</b> via the 5′-<i>O</i>-tritylation, conversion to cytidine, and then desilylation by using similar procedures in the synthesis of <b>3a</b>. Compound <b>84</b> was prepared from <b>83</b> in 56% yield by the similar procedure as described for <b>71</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.75 (d, <i>J</i> = 7.2 Hz, 1H, H-6), 7.35, 7.31 (2 br s, 2H, NH<sub>2</sub>), 6.07 (dd, <i>J</i> = 4.8 Hz, 17.2 Hz, 1H, H-1′), 5.75 (d, <i>J</i> = 7.6 Hz, 1H, H-5), 5.55 (dd, <i>J</i> = 5.6 Hz, 9.2 Hz, 1H, H-3′), 5.43 (dt, <i>J</i> = 5.2 Hz, 52.9 Hz, 1H, H-2′), 5.43 (t, <i>J</i> = 5.4 Hz, 1H, 5′-OH), 3.84 (d, <i>J</i> = 11.6 Hz, 1H, CH<sub>2</sub>Cl), 3.74 (d, <i>J</i> = 11.6 Hz, 1H, CH<sub>2</sub>Cl), 3.68 (dd, <i>J</i> = 5.2 Hz, 11.6 Hz, 1H, H-5′a), 3.57 (dd, <i>J</i> = 5.2 Hz, 11.6 Hz, 1H, H-5′b), 2.64 (sept, <i>J</i> = 7.2 Hz, 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 1.12 (d, <i>J</i> = 7.2 Hz, 6H, CH(C<u class="uu">H</u><sub><u class="uu">3</u></sub><u class="uu">)</u><sub><u class="uu">2</u></sub>). MS, <i>m</i>/<i>e</i> 362.1 (M – 1)<sup>−</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4′-Chloromethyl-2′-deoxy-2′-fluoro-3′-<i>O</i>-dodecanoylcytidine (<b>85</b>)</h3><div class="NLM_p last"><b>85</b> was prepared from <b>83</b> in 70% yield by the same procedure as described for <b>71</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.77 (d, <i>J</i> = 7.6 Hz, 1H, H-6), 7.36, 7.33 (2 br s, 2H, NH<sub>2</sub>), 6.07 (dd, <i>J</i> = 4.6 Hz, 17.3 Hz, 1H, H-1′), 5.77 (d, <i>J</i> = 7.5 Hz, 1H, H_5), 5.60 (dd, <i>J</i> = 5.5 Hz, 10.1 Hz, 1H, H-3′), 5.55 (ddd, <i>J</i> = 4.9 Hz, 5.3 Hz, 53.2 Hz, 1H, H-2′), 5.43 (t, <i>J</i> = 5.5 Hz, 1H, 5′-OH), 3.85 (d, <i>J</i> = 11.7 Hz, 1H, CH<sub>2</sub>Cl), 3.75 (d, <i>J</i> = 11.7 Hz, 1H, CH<sub>2</sub>Cl), 3.69 (dd, <i>J</i> = 5.8 Hz, 11.5 Hz, 1H, H-5′a), 3.60 (dd, <i>J</i> = 5.4 Hz, 11.5 Hz, 1H, H-5′b), 2.41 (m, 2 H, COCH<sub>2</sub>), 1.56 (m, 2H, COCH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>), 1.24 (m, 16H, (C<u class="uu">H</u><sub><u class="uu">2</u></sub><u class="uu">)</u><sub><u class="uu">8</u></sub>CH<sub>3</sub>), 0.85 (m, 3H, CH<sub>3</sub>). MS, <i>m</i>/<i>e</i> 474.3 (M – 1)<sup>−</sup>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Synthesis of Nucleoside 5′-Triphosphates</h3><div class="NLM_p last">Dry nucleoside (0.05 mmol) was dissolved in dry PO(OMe)<sub>3</sub> (0.7 mL). <i>N</i>-Methylimidazole (9 μL, 0.11 mmol) was added, followed by addition of POCl<sub>3</sub> (9 μL, 0.11 mmol) at rt, and the mixture was kept for 20–40 min. The reaction was monitored on LCMS by appearance of the corresponding nucleoside 5′-monophosphate. After completion of the conversion, tetrabutylammonium salt of pyrophosphate (150 mg) was added, followed by DMF (0.5 mL) to get a homogeneous solution. After 1.5 h at rt, the reaction mixture was diluted with water (10 mL) and loaded on ÄKTApurifier equipped with HiLoad 16/10 with Q Sepharose High Performance. Separation was done in a linear gradient of NaCl from 0 to 1 M in 50 mM TRIS-buffer (pH 7.5). The fractions containing NTP were combined and concentrated. Desalting was done on RP HPLC on Synergy 4 μm Hydro-RP column (Phenominex). A linear gradient of methanol from 0 to 30% in 50 mM triethylammonium acetate buffer (pH 7.5) was used. The fractions containing NTP were combined, concentrated, and lyophilized three times to remove the TEAA buffer. Concentration of aqueous solutions of NTP was measured based on UV absorption on a GE NanoVue plus UV spectrometer. MS and <sup>31</sup>P NMR data of the synthesized NTPs are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> RSV Polymerase Inhibition Assay</h3><div class="NLM_p last">Cell fractionation and extraction of RSV RNP complex was performed as described.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Unless otherwise specified, nucleoside triphosphate (NTP) concentrations were around their <i>K</i><sub>m</sub> value: 0.1 μM CTP and 1 μM ATP, 2 μM UTP, and 500 μM GTP. The radioactive tracer was either 10 μCi [α-<sup>33</sup>P]rCTP (CTP competitive mode) or 15 μCi [α-<sup>33</sup>P]rGTP (non-CTP competitive mode) together with 0.1 μM GTP. The reaction was initiated with the addition of 1.5 μL of the RSV cell extract and incubated for 2 h at 30 °C in a final volume of 30 μL. The reaction was stopped by adding 25 μL of Tris-sodium-EDTA buffer containing 10 mM Tris-HCl pH 8, 150 mM NaCl, and 100 mM EDTA. Processing of samples included elution through a G-50 spin column (GE Healthcare), phenol–chloroform extraction, and ethanol precipitation. Air-dried RNA samples were reconstituted in 20 μL of TBE urea gel loading buffer (Invitrogen) and run through a 6% TBE urea PAGE gel for 1 h at 190 V. The gel was dried and exposed to a phosphor-screen that was scanned with a Storm 860 phosphorImager (Molecular Dynamics).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> DdDp Assay with Polymerases α, β, and γ</h3><div class="NLM_p last">The DdDp activity was measured with 4 U/mL recombinant DNA polymerase α, 0.5 U/mL recombinant DNA polymerase β, or 2.5 U/mL DNA polymerase γ, 62 μg/mL activated calf thymus DNA, 50 mM Tris-HCl (pH 8.0), 60 mM KCl, 5 mM MgCl<sub>2</sub>, 4 mM dithiothreitol (DTT), 2 μM dCTP, 2 μM dATP, 2 μM dGTP, 2.5 μCi <sup>3</sup>H-dTTP (about 0.5 μM from a 2.5 μCi/μL stock, cat. no. NET520A), and 0.1% kinase stabilizer at 30 °C for 2 h. DNA polymerase α, β, and γ assays were performed in 96-well polymerase chain reaction (PCR) plates in a final reaction volume of 50 μL. The reaction was stopped by transferring 50 μL of the reaction mixture from the 96-well v-bottom plate into a 96-well Multiscreen plate (Millipore, cat. no. MABVN0B50) containing 60 μL of 4 °C 20% (w/v) trichloroacetic acid (TCA). The tritiated high molecular weight transcription products were precipitated at 4 °C for 40 min. The plates were subsequently washed with 3 × 200 μL of 10% (w/v) TCA and 200 μL of ethanol. After the addition of 50 μL of Microscint 20, the precipitated high molecular weight DNA products were measured in a Trilux Microbeta microplate scintillation reader.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> DdRp Assay with RNA Polymerase II</h3><div class="NLM_p last">The RNA polymerase II-mediated in vitro transcription was performed with commercially available HeLa cell nuclear extract (Promega, cat. no. E3110). The DNA template used in the RNA polymerase II-mediated in vitro transcription is a 1188 base pair DNA fragment containing the Cytomegalovirus (CMV) Immediate Early Promoter (Promega, cat. no. E3621). The CMV Immediate Early Promoter-containing DNA fragment gives a 363 nucleotide (nt) runoff transcript product mediated by RNA polymerase II. The standard reactions were carried out at 30 °C with 4 μL of nuclear extract (8.7 units, one unit is defined as the amount of extract required for the incorporation of 50 fmol of nucleotide into the 363 nucleotide runoff transcript under the manufacturer′s assay conditions), 75 ng of the CMV promoter-containing DNA template, 400 μM UTP, 40 μM CTP, 400 μM GTP, 20 μCi [α-<sup>33</sup>P]ATP, or [α-<sup>32</sup>P]ATP (3000 Ci/mmol, 10 mCi/mL), 3 mM MgCl<sub>2</sub>, 44 mM KCl, 5.6 mM HEPES, pH 7.9, 6.4 mM Tris-Cl, pH 7.8, 0.22 mM DTT, 9.6% (v/v) glycerol, and 1 U/μL RNaseIn (Ambion, cat. no. 2694) for 30 min at standard conditions or otherwise as specifically indicated. The reaction was initiated by the addition of the nuclear extract and stopped by adding 25 μL of 1× Tris-sodium-EDTA (TSE) buffer (150 mM NaCl, 10 mM Tris-HCl, pH 8.0, 100 mM EDTA). The remaining free nucleotides in the reactions were removed by passing through ProbeQuant G50 columns (GE Healthcare, cat. no. 27–5335–01). After the addition of 175 μL of stop solution (0.3 M Tris-HCl, pH 7.4, 0.3 M sodium acetate, 0.5% (w/v) sodium dodecyl sulfate (SDS), 2 mM EDTA, 30 μg/mL tRNA), the protein was removed by phenol/chloroform extraction. Finally, 45 μg of glycoblue (Ambion, cat. no. 9515) and 500 μL of ethanol were added and the in vitro transcript was precipitated on dry ice for 60 min and subsequently pelleted by centrifuging at 13000 rpm for 20 min. The dried pellets were suspended in nuclease-free H<sub>2</sub>O and an equal volume of 2× TBE urea gel loading buffer (Invitrogen). RNA products were resolved by electrophoresis on 6% Novex TBE-Urea polyacrylamide gels (Invitrogen). Quantification of the radiolabeled band was performed using a Storm 860 PhosphoImager and ImageQuant 5.2 software.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Nucleotide Incorporation by Human Mitochondrial RNA Polymerase</h3><div class="NLM_p last">Human mitochondrial RNA polymerase was obtained as recombinant enzyme from INDIGO Biosciences. The two oligonucleotides required for the human mitochondrial RNA polymerase assay were custom-ordered from Dharmacon and contain the following sequence: (primer) 5′-UUUUGCCGCGCC-3′ and (template) 3′-CGGCGCGGGTACTAAGGG-5′. The DdRp assay with human mitochondrial RNA polymerase was performed under single turnover conditions where enzyme concentration is in excess of the primer/template. Therefore, the <sup>33</sup>P-RNA/DNA primer/template was used at a concentration of 100 nM, together with 320 nM enzyme. The standard 10 μL reactions were carried out at 30 °C for 1 min with 100 μM of each NTP, 10 mM MgCl<sub>2</sub>, 50 mM NaCl, 40 mM Tris, pH 7.5, and 1 mM DTT. The reaction was stopped by adding 20 μL of formamide loading dye containing 50 mM EDTA. RNA products were resolved by electrophoresis on 22.5% TBE-urea polyacrylamide sequencing gels. Quantification of the radiolabeled band was performed using a TYPHOON PhosphorImager and ImageQuant 5.2 software.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> RSV Replicon Assay</h3><div class="NLM_p last">Nucleosides and nucleoside prodrugs were assayed in RSV Replicon subgenomic 395 HeLa, which was licensed from Apath (Brooklyn, NY, USA) and was originally developed by Dr. Mark Peeples of Center for Vaccines & Immunity, the Research Institute at Nationwide Children’s Hospital in Columbus, Ohio.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The 395 HeLa cells were cultured in Dulbecco′s Modified Eagle Medium (DMEM) containing 4500 mg/L <span class="smallcaps smallerCapital">d</span>-glucose, <span class="smallcaps smallerCapital">l</span>-glutamine, and 110 mg/L sodium pyruvate (Invitrogen, Cat. no. 11995-040). The medium was further supplemented with 10% (v/v) fetal bovine serum (FBS) (Mediatech, cat. no. 35-010-CV), 1% (v/v) penicillin/streptomycin (Mediatech, cat. no. 30-002-CI), and 10 μg/mL of Blasticidin (BSD) (Invivogen, cat. no. ant-bl-1). Cells were maintained at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere. On the first day, 5000 RSV replicon cells per well were plated in a 96-well plate. On the following day, each compound was serially diluted (1:3) up to nine distinct concentrations and dosed to the cells.). Cells were incubated with compounds for 7 days at 37 °C in a 5% CO<sub>2</sub> atmosphere. The <i>Renilla</i> Luciferase Assay System (Promega, cat. no. E2820) was used to measure anti-RSV replicon activity. Cell viability assay plates were set up in the same format as in the replicon assay. CellTiter-Glo Luminescent Cell Viability Assay (Promega, cat. no. G7572) was used to measure cell viability.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> NTP Formation in Vitro</h3><div class="NLM_p last">The in vitro NTP formation experiments were conducted in A549 (human lung epithelial cell), HEp-2 (human epithelial cell), NHBE (normal human bronchial epithelial cell), and human nasal epithelial cell lines. The cryopreserved primary NHBE cells were purchased from Lonza (Walkersville, MD) and human normal nasal epithelial cells were from Applied Biological Materials (Richmond, BC, Canada). The A549 and HEp2 cell lines were purchased from American Type Culture Collection (Manassas, VA). All cell lines were maintained and cultured at Alios BioPharma. The cells were plated in 96-well plates at 0.2–0.5 million cells/well with their corresponding media and incubated in a cell culture incubator at 37 °C, 5% CO<sub>2</sub>, for 1–4 days before use, as recommended by the cell suppliers. In each experiment, the medium concentration of the test compound was 50 μM and the incubation was carried out for 24 h at 37 °C, 5% CO<sub>2</sub>. At the end of the incubation, the medium was removed and the cells were washed with cold 0.9% sodium chloride in water. The cells were lysed with methanol/water (70/30), and the extracted supernatant was dried down and reconstituted in 1 mM ammonium phosphate before subjected to LC/MS/MS analysis for the determination of the corresponding NTP. The concentrations of the NTPs were normalized by the cells numbers in each well and thus expressed as pmol/million cells.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> In Vivo Pharmacokinetic Studies</h3><div class="NLM_p last">The in vivo pharmacokinetic studies were conducted at Wuxi AppTec. Male Syrian Golden hamsters, male Sprague–Dawley rats, and non-naïve male cynomolgus monkeys were used in the in vivo pharmacokinetic studies. The animals (<i>N</i> = 3 for hamsters and rats and <i>N</i> = 2 for each of the monkey PK study) were fasted overnight before administered intravenously with <b>2f</b>, <b>2c</b>, or <b>2b</b> or orally with <b>71</b>, <b>81</b>, or <b>73</b>. The study compounds were formulated as solutions in PEG400-based vehicles. IV PK studies were conducted at 5 mg/kg and for oral PK studies the prodrugs were administered at 5 mg/kg parent nucleoside equivalent doses. Blood samples were typically collected at various time points up to 24 h post dose for hamster and rat studies and up to 12 h for monkey studies. K<sub>2</sub>EDTA was used as the anticoagulant. Following an immediate plasma protein precipitation treatment, the supernatant of the blood samples was analyzed for analyte concentrations using a LC/MS/MS method. Pharmacokinetic parameters of the test compounds were obtained by conducting a noncompartmental PK analysis of the blood concentration–time profiles of compounds using WinNonlin software (v5.2) by Pharsight (Mountain View, CA). For lung tissue collection, animals were anesthetized with either isoflurane or pentobarbital after the terminal blood collection. Lung tissue was removed immediately and flash-frozen into liquid nitrogen to prevent any ex vivo degradation of the phosphorylated metabolites. The frozen tissue was homogenized in an extraction solution in a sample tube set in a dry ice/ethanol bath to maintain cold temperature. The supernatant of the lung extracts was subjected to LC/MS/MS analysis for the concentrations NMP and NTP.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm5017279" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guangyi Wang</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#06617167686146676a6f6975646f69766e67746b672865696b"><span class="__cf_email__" data-cfemail="721505131c1532131e1b1d01101b1d021a13001f135c111d1f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leo Beigelman</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#48242a2d212f2d2425292608292421273b2a21273820293a2529662b2725"><span class="__cf_email__" data-cfemail="2c404e49454b4940414d426c4d4045435f4e45435c444d5e414d024f4341">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerome Deval</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Hong</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natalia Dyatkina</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marija Prhavc</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua Taylor</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy Fung</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhinan Jin</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah K. Stevens</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vladimir Serebryany</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jyanwei Liu</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingling Zhang</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuen Tam</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sushmita M. Chanda</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David B. Smith</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julian A. Symons</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence M. Blatt</span> - <span class="hlFld-Affiliation affiliation">Alios BioPharma, Inc., 260 East Grand Avenue, South San Francisco, California 94080, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2433e7360-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64427" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64427" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Hans Maag, an independent consultant, for many helpful chemistry discussions, Martin Moore of the Department of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine, for helpful discussions throughout this project, and Mark Peeples of The Ohio State University for his help in development of the RSV replicon assay, licensed from Apath LLC. We also thank Caroline Williams, Alios BioPharma, for her assistance in recording and interpreting 2D NMRs.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> Abbreviations Used</h2><tr><td class="NLM_term">IBX</td><td class="NLM_def"><p class="first last">2-iodoxybenzoic acid</p></td></tr><tr><td class="NLM_term">DMTrCl</td><td class="NLM_def"><p class="first last">4,4′-dimethoxytrityl chloride</p></td></tr><tr><td class="NLM_term">MMTrCl</td><td class="NLM_def"><p class="first last">4-methoxytrityl chloride</p></td></tr><tr><td class="NLM_term">TBDPSCl</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldiphenylchlorosilane</p></td></tr><tr><td class="NLM_term">DMP</td><td class="NLM_def"><p class="first last">Dess–Martin periodinane</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TPSCl</td><td class="NLM_def"><p class="first last">2,4,6-triisopropylbenzenesulfonyl chloride</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34702" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34702" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Borchers, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershwin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershwin, L. J.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus—a comprehensive review</span> <span class="citation_source-journal">Clin. Rev. Allergy Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1007%2Fs12016-013-8368-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=23575961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSqtb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=331-379&author=A.+T.+Borchersauthor=C.+Changauthor=M.+E.+Gershwinauthor=L.+J.+Gershwin&title=Respiratory+syncytial+virus%E2%80%94a+comprehensive+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory Syncytial Virus-A Comprehensive Review</span></div><div class="casAuthors">Borchers, Andrea T.; Chang, Christopher; Gershwin, M. Eric; Gershwin, Laurel J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Reviews in Allergy & Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-379</span>CODEN:
                <span class="NLM_cas:coden">CRAIF2</span>;
        ISSN:<span class="NLM_cas:issn">1080-0549</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Respiratory syncytial virus (RSV) is amongst the most important pathogenic infections of childhood and is assocd. with significant morbidity and mortality.  Although there have been extensive studies of epidemiol., clin. manifestations, diagnostic techniques, animal models and the immunobiol. of infection, there is not yet a convincing and safe vaccine available.  The major histopathol. characteristics of RSV infection are acute bronchiolitis, mucosal and submucosal edema, and luminal occlusion by cellular debris of sloughed epithelial cells mixed with macrophages, strands of fibrin, and some mucin.  There is a single RSV serotype with two major antigenic subgroups, A and B. Strains of both subtypes often co-circulate, but usually one subtype predominates.  In temperate climates, RSV infections reflect a distinct seasonality with onset in late fall or early winter.  It is believed that most children will experience at least one RSV infection by the age of 2 years.  There are several key animal models of RSV.  These include a model in mice and, more importantly, a bovine model; the latter reflects distinct similarity to the human disease.  Importantly, the prevalence of asthma is significantly higher amongst children who are hospitalized with RSV in infancy or early childhood.  However, there have been only limited investigations of candidate genes that have the potential to explain this increase in susceptibility.  An atopic predisposition appears to predispose to subsequent development of asthma and it is likely that subsequent development of asthma is secondary to the pathogenic inflammatory response involving cytokines, chemokines and their cognate receptors.  Numerous approaches to the development of RSV vaccines are being evaluated, as are the use of newer antiviral agents to mitigate disease.  There is also significant attention being placed on the potential impact of co-infection and defining the natural history of RSV.  Clearly, more research is required to define the relationships between RSV bronchiolitis, other viral induced inflammatory responses, and asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz4EZ4rD5YZLVg90H21EOLACvtfcHk0lgoRr22nsZA-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSqtb7L&md5=dc062b5f24682fc2f57bcd00f5233a49</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs12016-013-8368-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12016-013-8368-9%26sid%3Dliteratum%253Aachs%26aulast%3DBorchers%26aufirst%3DA.%2BT.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DGershwin%26aufirst%3DM.%2BE.%26aulast%3DGershwin%26aufirst%3DL.%2BJ.%26atitle%3DRespiratory%2520syncytial%2520virus%25E2%2580%2594a%2520comprehensive%2520review%26jtitle%3DClin.%2520Rev.%2520Allergy%2520Immunol.%26date%3D2013%26volume%3D45%26spage%3D331%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Tawar, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquerroy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varela, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damier-Piolle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagné, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLellan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedouelle, H.</span><span> </span><span class="NLM_article-title">Crystal structure of a nucleocapsid-like nucleoprotein–RNA complex of respiratory syncytial virus</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2009&pages=1279-1283&author=R.+G.+Tawarauthor=S.+Duquerroyauthor=C.+Vonrheinauthor=P.+F.+Varelaauthor=L.+Damier-Piolleauthor=N.+Castagn%C3%A9author=K.+MacLellanauthor=H.+Bedouelle&title=Crystal+structure+of+a+nucleocapsid-like+nucleoprotein%E2%80%93RNA+complex+of+respiratory+syncytial+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTawar%26aufirst%3DR.%2BG.%26aulast%3DDuquerroy%26aufirst%3DS.%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DVarela%26aufirst%3DP.%2BF.%26aulast%3DDamier-Piolle%26aufirst%3DL.%26aulast%3DCastagn%25C3%25A9%26aufirst%3DN.%26aulast%3DMacLellan%26aufirst%3DK.%26aulast%3DBedouelle%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520a%2520nucleocapsid-like%2520nucleoprotein%25E2%2580%2593RNA%2520complex%2520of%2520respiratory%2520syncytial%2520virus%26jtitle%3DScience%26date%3D2009%26volume%3D326%26spage%3D1279%26epage%3D1283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piedimonte, G.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus prevention and therapy: past, present, and future</span> <span class="citation_source-journal">Pediatr. Pulmonol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1002%2Fppul.21377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=21438168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ps1Ciug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=324-347&author=M.+Wrightauthor=G.+Piedimonte&title=Respiratory+syncytial+virus+prevention+and+therapy%3A+past%2C+present%2C+and+future"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus prevention and therapy: past, present, and future</span></div><div class="casAuthors">Wright Melvin; Piedimonte Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Pediatric pulmonology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">324-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the most common respiratory pathogen in infants and young children worldwide.  More than 50 years after its discovery, and despite relentless attempts to identify pharmacological therapies to improve the clinical course and outcomes of this disease, the most effective therapy remains supportive care.  Although the quest for a safe and effective vaccine remains unsuccessful, pediatricians practicing during the past decade have been able to protect at least the more vulnerable patients with safe and effective passive prophylaxis.  This review summarizes the history, microbiology, epidemiology, pathophysiology, and clinical manifestations of this infection in order to provide the reader with the background information necessary to fully appreciate the many challenges presented by the clinical management of young children with bronchiolitis.  The last part of this article attempts an evidence-based review of the pharmacologic strategies currently available and those being evaluated, intentionally omitting highly experimental approaches not yet tested in clinical trials and, therefore, not likely to become available in the foreseeable future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoHpmXTQa9F3qj_yg7twvpfW6udTcc2eZTaaLDfu4EQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ps1Ciug%253D%253D&md5=0b2cf1bd2f7393c702cfd31d1a849ff2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fppul.21377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fppul.21377%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%26aulast%3DPiedimonte%26aufirst%3DG.%26atitle%3DRespiratory%2520syncytial%2520virus%2520prevention%2520and%2520therapy%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DPediatr.%2520Pulmonol.%26date%3D2011%26volume%3D46%26spage%3D324%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Piedimonte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M. K.</span><span> </span><span class="NLM_article-title">Alternative mechanisms for respiratory syncytial virus (RSV) infection and persistence: could RSV be transmitted through the placenta and persist into developing fetal lungs?</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1016%2Fj.coph.2014.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=24810284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSlt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=82-88&author=G.+Piedimonteauthor=M.+K.+Perez&title=Alternative+mechanisms+for+respiratory+syncytial+virus+%28RSV%29+infection+and+persistence%3A+could+RSV+be+transmitted+through+the+placenta+and+persist+into+developing+fetal+lungs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative mechanisms for respiratory syncytial virus (RSV) infection and persistence: could RSV be transmitted through the placenta and persist into developing fetal lungs?</span></div><div class="casAuthors">Piedimonte, Giovanni; Perez, Miriam K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-88</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Respiratory syncytial virus (RSV) represents the most common respiratory pathogen obsd. worldwide in infants and young children and may play a role in the inception of recurrent wheezing and asthma in childhood.  We discuss herein the recent hypothesis that RSV vertically transmitted from the mother to the fetus in utero causes persistent structural and functional changes in the developing lungs of the offspring, thereby predisposing to postnatal airway obstruction.  A no. of observations in humans support the notion that extrapulmonary tissues may be infected hematogenously by RSV and harbor this virus allowing the persistence of latent infection.  More recent data from animal models suggest that RSV can be transmitted across the placenta from the respiratory tract of the mother to that of the fetus, and persist in the lungs both during development, as well as during adulthood.  Vertical RSV infection is assocd. with dysregulation of crucial neurotrophic pathways during ontogenesis, leading to aberrant parasympathetic innervation and airway hyperreactivity after postnatal reinfection.  These new data challenge the current paradigm that acquisition of RSV infection occurs only after birth and shift attention to the prenatal effects of the virus, with the potential to result in more severe and lasting consequences by interfering with crucial developmental processes.  The most immediate implication is that prophylactic strategies targeted to the mother-fetus dyad may reduce the incidence of postviral sequelae like childhood wheezing and asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw69INmVAwVrVg90H21EOLACvtfcHk0lhdIYYQ2fzI9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSlt7jN&md5=7314f36462331ceaec2ea4f27ea433c0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2014.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2014.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DPiedimonte%26aufirst%3DG.%26aulast%3DPerez%26aufirst%3DM.%2BK.%26atitle%3DAlternative%2520mechanisms%2520for%2520respiratory%2520syncytial%2520virus%2520%2528RSV%2529%2520infection%2520and%2520persistence%253A%2520could%2520RSV%2520be%2520transmitted%2520through%2520the%2520placenta%2520and%2520persist%2520into%2520developing%2520fetal%2520lungs%253F%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2014%26volume%3D16%26spage%3D82%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ohmit, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moler, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monto, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, A. S.</span><span> </span><span class="NLM_article-title">Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection</span> <span class="citation_source-journal">J. Clin. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1016%2F0895-4356%2896%2900137-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=8780603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A280%3ADyaK28znsVeisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1996&pages=963-967&author=S.+E.+Ohmitauthor=F.+W.+Molerauthor=A.+S.+Montoauthor=A.+S.+Khan&title=Ribavirin+utilization+and+clinical+effectiveness+in+children+hospitalized+with+respiratory+syncytial+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection</span></div><div class="casAuthors">Ohmit S E; Moler F W; Monto A S; Khan A S</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical epidemiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">963-7</span>
        ISSN:<span class="NLM_cas:issn">0895-4356</span>.
    </div><div class="casAbstract">Ribavirin was approved in early 1986 for treatment of illness associated with respiratory syncytial virus (RSV) infection in hospitalized children; however, the value of its use remains controversial.  This investigation was undertaken to describe ribavirin utilization and to evaluate the effectiveness of ribavirin in reducing the period of hospitalization.  All children with laboratory-confirmed RSV infection, hospitalized over seven epidemic periods at a single institution, were identified.  Characteristics from the medical records of the 768 children and their course of hospitalization were evaluated as determinants of treatment with ribavirin.  Very young age as well as diagnoses of congenital heart disease, certain pulmonary conditions, and failure to thrive were all significantly related to increased likelihood of treatment.  Children requiring intensive care were likely to be treated; however, the most critically ill children, those who required mechanical ventilation, were not treated.  Although these results were in keeping with treatment guidelines for the use of ribavirin, actual utilization declined significantly over the course of the evaluation.  The effect of ribavirin treatment on the duration of hospitalization among children with community-acquired infection was evaluated in a multivariate model, which controlled for the effects of underlying conditions, measures of illness severity, and epidemic year.  This analysis failed to demonstrate a benefit for ribavirin in reducing length of stay; in fact, ribavirin treatment was significantly associated with prolonged hospitalization.  It was not likely that the explanation for ribavirin's association with prolonged hospitalization was that the most seriously ill children were treated; however, it was not possible to determine whether this association was due to an adverse effect of treatment or resulted from a perceived need to complete the course of therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVAZQffUn-JQqdek-gHSrIfW6udTcc2eZdSVUL0t5CNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28znsVeisA%253D%253D&md5=011155b5b2b5c092f5d163f5e54ba8b4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0895-4356%2896%2900137-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0895-4356%252896%252900137-0%26sid%3Dliteratum%253Aachs%26aulast%3DOhmit%26aufirst%3DS.%2BE.%26aulast%3DMoler%26aufirst%3DF.%2BW.%26aulast%3DMonto%26aufirst%3DA.%2BS.%26aulast%3DKhan%26aufirst%3DA.%2BS.%26atitle%3DRibavirin%2520utilization%2520and%2520clinical%2520effectiveness%2520in%2520children%2520hospitalized%2520with%2520respiratory%2520syncytial%2520virus%2520infection%26jtitle%3DJ.%2520Clin.%2520Epidemiol.%26date%3D1996%26volume%3D49%26spage%3D963%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wyde, P. R.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus (RSV) disease and prospects for its control</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=63-79&author=P.+R.+Wyde&title=Respiratory+syncytial+virus+%28RSV%29+disease+and+prospects+for+its+control"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyde%26aufirst%3DP.%2BR.%26atitle%3DRespiratory%2520syncytial%2520virus%2520%2528RSV%2529%2520disease%2520and%2520prospects%2520for%2520its%2520control%26jtitle%3DAntiviral%2520Res.%26date%3D1998%26volume%3D39%26spage%3D63%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ding, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulabaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaccardi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feld, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazumyan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raifeld, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonia Nikitenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gluzman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Hara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellestad, G. A.</span><span> </span><span class="NLM_article-title">Novel and specific respiratory syncytial virus inhibitors that target virus fusion</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2671</span><span class="NLM_x">–</span> <span class="NLM_lpage">2675</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980239e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADyaK1cXksVKrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2671-2675&author=W.+D.+Dingauthor=B.+Mitsnerauthor=G.+Krishnamurthyauthor=A.+Aulabaughauthor=C.+D.+Hessauthor=J.+Zaccardiauthor=M.+Cutlerauthor=B.+Feldauthor=A.+Gazumyanauthor=Y.+Raifeldauthor=A.+Antonia+Nikitenkoauthor=S.+A.+Langauthor=Y.+Gluzmanauthor=B.+O%E2%80%99Haraauthor=G.+A.+Ellestad&title=Novel+and+specific+respiratory+syncytial+virus+inhibitors+that+target+virus+fusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and Specific Respiratory Syncytial Virus Inhibitors That Target Virus Fusion</span></div><div class="casAuthors">Ding, Wei-dong; Mitsner, Boris; Krishnamurthy, Girija; Aulabaugh, Ann; Hess, Cynthia D.; Zaccardi, Joe; Cutler, Mark; Feld, Boris; Gazumyan, Anna; Raifeld, Yuri; Nikitenko, Antonia; Lang, Stanley A.; Gluzman, Yakov; O'Hara, Bryan; Ellestad, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2671-2675</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A screening program was initiated to look for inhibitors of respiratory syncytial virus (RSV).  An active lead [I, R = SO2N(CH2CH2CONH2)2 throughout, X = CH:CH] (II) was identified from a 20,000 compd. library with a high-throughput screen using a whole virus cell-based assay.  The synthesis and SAR of a class of RSV inhibitors based on the stilbene II and the somewhat more active biphenyl analog I (X = bond) was described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPHEbXWr2MDbVg90H21EOLACvtfcHk0lhFQCbisCbbKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksVKrsrY%253D&md5=0f7f809cf71c10c25b48b700f07f03a8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm980239e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980239e%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DW.%2BD.%26aulast%3DMitsner%26aufirst%3DB.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DHess%26aufirst%3DC.%2BD.%26aulast%3DZaccardi%26aufirst%3DJ.%26aulast%3DCutler%26aufirst%3DM.%26aulast%3DFeld%26aufirst%3DB.%26aulast%3DGazumyan%26aufirst%3DA.%26aulast%3DRaifeld%26aufirst%3DY.%26aulast%3DAntonia%2BNikitenko%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DS.%2BA.%26aulast%3DGluzman%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Hara%26aufirst%3DB.%26aulast%3DEllestad%26aufirst%3DG.%2BA.%26atitle%3DNovel%2520and%2520specific%2520respiratory%2520syncytial%2520virus%2520inhibitors%2520that%2520target%2520virus%2520fusion%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2671%26epage%3D2675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeremans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willebrords, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacrampe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyde, P. R.</span><span> </span><span class="NLM_article-title">Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1016%2Fj.antiviral.2003.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=14638397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1eqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=209-219&author=K.+Andriesauthor=M.+Moeremansauthor=T.+Geversauthor=R.+Willebrordsauthor=C.+Sommenauthor=J.+Lacrampeauthor=F.+Janssensauthor=P.+R.+Wyde&title=Substituted+benzimidazoles+with+nanomolar+activity+against+respiratory+syncytial+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus</span></div><div class="casAuthors">Andries, Koen; Moeremans, Marc; Gevers, Tom; Willebrords, Rudy; Sommen, Cois; Lacrampe, Jean; Janssens, Frans; Wyde, Philip R.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-219</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A cell-based assay was used to discover compds. inhibiting respiratory syncytial virus (RSV)-induced fusion in HeLa/M cells.  A lead compd. was identified and subsequent synthesis of >300 analogs led to the identification of JNJ 2408068 (R170591), a low mol. wt. (MW 395) benzimidazole deriv. with an EC50 (0.16 nM) against some lab. strains almost 100,000 times better than that of ribavirin (15 μM).  Antiviral activity was confirmed for subgroup A and B clin. isolates of human RSV and for a bovine RSV isolate.  The compd. did not inhibit the growth of representative viruses from other Paramyxovirus genera, i.e. HPIV2 and Mumps Virus (genus Rubulavirus), HPIV3 (genus Respirovirus), Measles virus (genus Morbillivirus) and hMPV.  Efficacy in cytopathic effect inhibition assays correlated well with efficacy in virus yield redn. assays.  A concn. of 10 nM reduced RSV prodn. 1000-fold in multi-cycle expts., irresp. of the multiplicity of infection.  Time of addn. studies pointed to a dual mode of action: inhibition of virus-cell fusion early in the infection cycle and inhibition of cell-cell fusion at the end of the replication cycle.  Two resistant mutants were raised and shown to have single point mutations in the F-gene (S398L and D486N).  JNJ 2408068 was also shown to inhibit the release of proinflammatory cytokines IL-6, IL-8 and Rantes from RSV-infected A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH25-cUfGD5LVg90H21EOLACvtfcHk0lhFQCbisCbbKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1eqs7c%253D&md5=2fbf116384f9775d4c371a134f8e1d92</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2003.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2003.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DMoeremans%26aufirst%3DM.%26aulast%3DGevers%26aufirst%3DT.%26aulast%3DWillebrords%26aufirst%3DR.%26aulast%3DSommen%26aufirst%3DC.%26aulast%3DLacrampe%26aufirst%3DJ.%26aulast%3DJanssens%26aufirst%3DF.%26aulast%3DWyde%26aufirst%3DP.%2BR.%26atitle%3DSubstituted%2520benzimidazoles%2520with%2520nanomolar%2520activity%2520against%2520respiratory%2520syncytial%2520virus%26jtitle%3DAntiviral%2520Res.%26date%3D2003%26volume%3D60%26spage%3D209%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bonfanti, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doublet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queguiner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willebrords, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuyts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Remoortere, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span> </span><span class="NLM_article-title">Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701284j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=875-896&author=J.-F.+Bonfantiauthor=C.+Meyerauthor=F.+Doubletauthor=J.+Fortinauthor=P.+Mullerauthor=L.+Queguinerauthor=T.+Geversauthor=P.+Janssensauthor=H.+Szelauthor=R.+Willebrordsauthor=P.+Timmermanauthor=K.+Wuytsauthor=P.+van+Remoortereauthor=F.+Janssensauthor=P.+Wigerinckauthor=K.+Andries&title=Selection+of+a+respiratory+syncytial+virus+fusion+inhibitor+clinical+candidate.+2.+Discovery+of+a+morpholinopropylaminobenzimidazole+derivative+%28TMC353121%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm701284j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701284j%26sid%3Dliteratum%253Aachs%26aulast%3DBonfanti%26aufirst%3DJ.-F.%26aulast%3DMeyer%26aufirst%3DC.%26aulast%3DDoublet%26aufirst%3DF.%26aulast%3DFortin%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DP.%26aulast%3DQueguiner%26aufirst%3DL.%26aulast%3DGevers%26aufirst%3DT.%26aulast%3DJanssens%26aufirst%3DP.%26aulast%3DSzel%26aufirst%3DH.%26aulast%3DWillebrords%26aufirst%3DR.%26aulast%3DTimmerman%26aufirst%3DP.%26aulast%3DWuyts%26aufirst%3DK.%26aulast%3Dvan%2BRemoortere%26aufirst%3DP.%26aulast%3DJanssens%26aufirst%3DF.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DAndries%26aufirst%3DK.%26atitle%3DSelection%2520of%2520a%2520respiratory%2520syncytial%2520virus%2520fusion%2520inhibitor%2520clinical%2520candidate.%25202.%2520Discovery%2520of%2520a%2520morpholinopropylaminobenzimidazole%2520derivative%2520%2528TMC353121%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D875%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus entry inhibitors targeting the F protein</span> <span class="citation_source-journal">Viruses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.3390%2Fv5010211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=23325327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=211-225&author=Z.+Sunauthor=Y.+Panauthor=S.+Jiangauthor=L.+Lu&title=Respiratory+syncytial+virus+entry+inhibitors+targeting+the+F+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus entry inhibitors targeting the F protein</span></div><div class="casAuthors">Sun, Zhiwu; Pan, Yanbin; Jiang, Shibo; Lu, Lu</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">211-225</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Human respiratory syncytial virus (RSV) is the main viral cause of respiratory tract infection in infants as well as some elderly and high-risk adults with chronic pulmonary disease and the severely immunocompromised.  So far, no specific anti-R SV therapeutics or effective anti-RSV vaccines have been reported.  Only one humanized monoclonal antibody, Palivizumab, has been approved for use in high-risk infants to prevent RSV infection.  Ribavirin is the only drug licensed for therapy of RSV infection, but its clin. use is limited by its nonspecific anti-RSV activity, toxic effect, and relatively high cost.  Therefore, development of novel effective anti-RSV therapeutics is urgently needed.  The RSV envelope glycoprotein F plays an important role in RSV fusion with, and entry into, the host cell and, consequently, serves as an attractive target for developing RSV entry inhibitors.  This article reviews advances made in studies of the structure and function of the F protein and the development of RSV entry inhibitors targeting it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPOeEk3HJ9DbVg90H21EOLACvtfcHk0lh1b4UgduQ_iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yqtLY%253D&md5=845867182964c18a459de59ed022f6d1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3390%2Fv5010211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv5010211%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DL.%26atitle%3DRespiratory%2520syncytial%2520virus%2520entry%2520inhibitors%2520targeting%2520the%2520F%2520protein%26jtitle%3DViruses%26date%3D2013%26volume%3D5%26spage%3D211%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">DeVincenzo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaglioni-Weinlich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambkin-Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Riordan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toback, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, J. W.</span><span> </span><span class="NLM_article-title">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1056%2FNEJMoa1401184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=25140957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=711-722&author=J.+P.+DeVincenzoauthor=R.+J.+Whitleyauthor=R.+L.+Mackmanauthor=C.+Scaglioni-Weinlichauthor=L.+Harrisonauthor=E.+Farrellauthor=S.+McBrideauthor=R.+Lambkin-Williamsauthor=R.+Jordanauthor=Y.+Xinauthor=S.+Ramanathanauthor=T.+O%E2%80%99Riordanauthor=S.+A.+Lewisauthor=X.+Liauthor=S.+L.+Tobackauthor=S.+L.+Linauthor=J.+W.+Chien&title=Oral+GS-5806+activity+in+a+respiratory+syncytial+virus+challenge+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span></div><div class="casAuthors">DeVincenzo, John P.; Whitley, Richard J.; Mackman, Richard L.; Scaglioni-Weinlich, Cecilia; Harrison, Lisa; Farrell, Eric; McBride, Stephen; Lambkin-Williams, Robert; Jordan, Robert; Xin, Yan; Ramanathan, Srini; O'Riordan, Thomas; Lewis, Sandra A.; Li, Xiaoming; Toback, Seth L.; Lin, Shao-Lee; Chien, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">711-722, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Respiratory syncytial virus (RSV) is a common cause of infant hospitalizations and is increasingly recognized as a cause of considerable morbidity and mortality.  No accepted antiviral treatment exists.  Methods: We conducted a double-blind, placebo-controlled study of GS-5806, an oral RSV-entry inhibitor, in healthy adults who received a clin. challenge strain of RSV intranasally.  Participants were monitored for 12 days.  At the time of a pos. test for RSV infection or 5 days after inoculation, whichever occurred first, participants were randomly assigned to receive GS-5806 or placebo in one of seven sequential cohorts.  Cohorts 1 to 4 received a first dose of 50 mg of GS-5806 and then 25 mg daily for the next 4 days, cohort 5 received a first dose of 50 mg and then 25 mg daily for the next 2 days, cohort 6 received one 100-mg dose, and cohort 7 received a first dose of 10 mg and then 5 mg daily for the next 4 days.  Dose selection for cohorts 5, 6, and 7 occurred after an interim anal. of data for cohorts 1 to 4.  The primary end point was the area under the curve (AUC) for the viral load, which was assessed after administration of the first dose through the 12th day after inoculation.  Secondary end points were mucus wt. and symptom scores.  Results: Among the 54 participants in cohorts 1 to 4 who were infected with RSV, active treatment was assocd. with a lower viral load (adjusted mean, 250.7 vs. 757.7 log10 plaque-forming-unit equiv. [PFUe] × hours per mL; P<0.001), lower total mucus wt. (mean, 6.9 g vs. 15.1 g; P = 0.03), and a lower AUC for the change from baseline in symptom scores (adjusted mean, -20.2 vs. 204.9 × hours; P = 0.005).  The results were similar in cohorts 5, 6, and 7.  Adverse events, including low neutrophil counts and increased levels of alanine aminotransferase, were more common among participants receiving GS-5806.  Conclusions: Treatment with GS-5806 reduced the viral load and the severity of clin. disease in a challenge study of healthy adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqxDrIVO5aQLVg90H21EOLACvtfcHk0lh1b4UgduQ_iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O&md5=72276739a80d55a732269359e338fb95</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1401184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1401184%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%2BP.%26aulast%3DWhitley%26aufirst%3DR.%2BJ.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DScaglioni-Weinlich%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DL.%26aulast%3DFarrell%26aufirst%3DE.%26aulast%3DMcBride%26aufirst%3DS.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DRamanathan%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Riordan%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DToback%26aufirst%3DS.%2BL.%26aulast%3DLin%26aufirst%3DS.%2BL.%26aulast%3DChien%26aufirst%3DJ.%2BW.%26atitle%3DOral%2520GS-5806%2520activity%2520in%2520a%2520respiratory%2520syncytial%2520virus%2520challenge%2520study%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D711%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">DeVincenzo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambkin-Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cehelsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nochur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walshe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gollob, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaishnaw, A.</span><span> </span><span class="NLM_article-title">A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">8800</span><span class="NLM_x">–</span> <span class="NLM_lpage">8805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=8800-8805&author=J.+DeVincenzoauthor=R.+Lambkin-Williamsauthor=T.+Wilkinsonauthor=J.+Cehelskyauthor=S.+Nochurauthor=E.+Walsheauthor=R.+Meyersauthor=J.+Gollobauthor=A.+Vaishnaw&title=A+randomized%2C+double-blind%2C+placebo-controlled+study+of+an+RNAi-based+therapy+directed+against+respiratory+syncytial+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26aulast%3DWilkinson%26aufirst%3DT.%26aulast%3DCehelsky%26aufirst%3DJ.%26aulast%3DNochur%26aufirst%3DS.%26aulast%3DWalshe%26aufirst%3DE.%26aulast%3DMeyers%26aufirst%3DR.%26aulast%3DGollob%26aufirst%3DJ.%26aulast%3DVaishnaw%26aufirst%3DA.%26atitle%3DA%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%2520of%2520an%2520RNAi-based%2520therapy%2520directed%2520against%2520respiratory%2520syncytial%2520virus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D8800%26epage%3D8805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Liuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawetz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCollum, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudette, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massariol, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scouten, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeleau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulrez Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span> </span><span class="NLM_article-title">Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">13105</span><span class="NLM_x">–</span> <span class="NLM_lpage">13115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1128%2FJVI.79.20.13105-13115.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=16189012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWisbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=13105-13115&author=M.+Liuzziauthor=S.+W.+Masonauthor=M.+Cartierauthor=C.+Lawetzauthor=R.+S.+McCollumauthor=N.+Dansereauauthor=G.+Bolgerauthor=N.+Lapeyreauthor=Y.+Gaudetteauthor=L.+Lagaceauthor=M.-J.+Massariolauthor=F.+Doauthor=P.+Whiteheadauthor=L.+Lamarreauthor=E.+Scoutenauthor=J.+Bordeleauauthor=S.+Landryauthor=J.+Rancourtauthor=G.+Gulrez+Fazalauthor=B.+Simoneau&title=Inhibitors+of+respiratory+syncytial+virus+replication+target+cotranscriptional+mRNA+guanylylation+by+viral+RNA-dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase</span></div><div class="casAuthors">Liuzzi, Michel; Mason, Stephen W.; Cartier, Mireille; Lawetz, Carol; McCollum, Robert S.; Dansereau, Nathalie; Bolger, Gordon; Lapeyre, Nicole; Gaudette, Yvon; Lagace, Lisette; Massariol, Marie-Josee; Do, Florence; Whitehead, Paul; Lamarre, Lyne; Scouten, Erika; Bordeleau, Josee; Landry, Serge; Rancourt, Jean; Fazal, Gulrez; Simoneau, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">13105-13115</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is a major cause of respiratory illness in infants, immunocompromised patients, and the elderly.  New antiviral agents would be important tools in the treatment of acute RSV disease.  RSV encodes its own RNA-dependent RNA polymerase that is responsible for the synthesis of both genomic RNA and subgenomic mRNAs.  The viral polymerase also cotranscriptionally caps and polyadenylates the RSV mRNAs at their 5' and 3' ends, resp.  The authors have previously reported the discovery of the first nonnucleoside transcriptase inhibitor of RSV polymerase through high-throughput screening.  Here the authors report the design of inhibitors that have improved potency both in vitro and in antiviral assays and that also exhibit activity in a mouse model of RSV infection.  The authors have isolated virus with reduced susceptibility to this class of inhibitors.  The mutations conferring resistance mapped to a novel motif within the RSV L gene, which encodes the catalytic subunit of RSV polymerase.  This motif is distinct from the catalytic region of the L protein and bears some similarity to the nucleotide binding domain within nucleoside diphosphate kinases.  These findings lead to the hypothesis that this class of inhibitors may block synthesis of RSV mRNAs by inhibiting guanylylation of viral transcripts.  The authors show that short transcripts produced in the presence of inhibitor in vitro do not contain a 5' cap but, instead, are triphosphorylated, confirming this hypothesis.  These inhibitors constitute useful tools for elucidating the mol. mechanism of RSV capping and represent valid leads for the development of novel anti-RSV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIoHs26iOUQ7Vg90H21EOLACvtfcHk0lg3CX1gEjuWwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWisbjN&md5=46e93fff53e2d22c832f5949fe967ef8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.20.13105-13115.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.20.13105-13115.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DMason%26aufirst%3DS.%2BW.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DLawetz%26aufirst%3DC.%26aulast%3DMcCollum%26aufirst%3DR.%2BS.%26aulast%3DDansereau%26aufirst%3DN.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DLapeyre%26aufirst%3DN.%26aulast%3DGaudette%26aufirst%3DY.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DMassariol%26aufirst%3DM.-J.%26aulast%3DDo%26aufirst%3DF.%26aulast%3DWhitehead%26aufirst%3DP.%26aulast%3DLamarre%26aufirst%3DL.%26aulast%3DScouten%26aufirst%3DE.%26aulast%3DBordeleau%26aufirst%3DJ.%26aulast%3DLandry%26aufirst%3DS.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DGulrez%2BFazal%26aufirst%3DG.%26aulast%3DSimoneau%26aufirst%3DB.%26atitle%3DInhibitors%2520of%2520respiratory%2520syncytial%2520virus%2520replication%2520target%2520cotranscriptional%2520mRNA%2520guanylylation%2520by%2520viral%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D13105%26epage%3D13115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sudo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shintani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, Y.</span><span> </span><span class="NLM_article-title">YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=125-131&author=K.+Sudoauthor=Y.+Miyazakiauthor=N.+Kojimaauthor=M.+Kobayashiauthor=H.+Suzukiauthor=M.+Shintaniauthor=Y.+Shimizu&title=YM-53403%2C+a+unique+anti-respiratory+syncytial+virus+agent+with+a+novel+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudo%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DY.%26aulast%3DKojima%26aufirst%3DN.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DShimizu%26aufirst%3DY.%26atitle%3DYM-53403%252C%2520a%2520unique%2520anti-respiratory%2520syncytial%2520virus%2520agent%2520with%2520a%2520novel%2520mechanism%2520of%2520action%26jtitle%3DAntiviral%2520Res.%26date%3D2005%26volume%3D65%26spage%3D125%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Xiong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschenbrenner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiong-Yip, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moustakas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span> </span><span class="NLM_article-title">Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6789</span><span class="NLM_x">–</span> <span class="NLM_lpage">6793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6789-6793&author=H.+Xiongauthor=M.+Foulkauthor=L.+Aschenbrennerauthor=J.+Fanauthor=C.-L.+Tiong-Yipauthor=K.+D.+Johnsonauthor=D.+Moustakasauthor=P.+R.+Flemingauthor=D.+G.+Brownauthor=M.+Zhangauthor=D.+Fergusonauthor=D.+Wuauthor=Q.+Yu&title=Discovery+of+a+potent+respiratory+syncytial+virus+RNA+polymerase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DFoulk%26aufirst%3DM.%26aulast%3DAschenbrenner%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DTiong-Yip%26aufirst%3DC.-L.%26aulast%3DJohnson%26aufirst%3DK.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%26aulast%3DFleming%26aufirst%3DP.%2BR.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DQ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520respiratory%2520syncytial%2520virus%2520RNA%2520polymerase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6789%26epage%3D6793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Leyssen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyts, J.</span><span> </span><span class="NLM_article-title">The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1128%2FJVI.79.3.1943-1947.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=15650220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=1943-1947&author=P.+Leyssenauthor=J.+Balzariniauthor=E.+De+Clercqauthor=J.+Neyts&title=The+predominant+mechanism+by+which+ribavirin+exerts+its+antiviral+activity+in+vitro+against+flaviviruses+and+paramyxoviruses+is+mediated+by+inhibition+of+IMP+dehydrogenase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase</span></div><div class="casAuthors">Leyssen, Pieter; Balzarini, Jan; De Clercq, Erik; Neyts, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1943-1947</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">It is not yet clear to what extent depletion of intracellular GTP pools contributes to the antiviral activity of ribavirin.  Therefore, the antiviral activities of (i) ribavirin, (ii) its 5-ethynyl analog, 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR), and (iii) mycophenolic acid (MPA) (a compd. that inhibits only cellular IMP dehydrogenase activity) were studied on the replication of flaviviruses and paramyxoviruses.  In addn., the effects of these three compds. on intracellular GTP pools were assessed.  A linear correlation was obsd. over a broad concn. range between the antiviral activities of ribavirin, EICAR, and MPA and the effects of these compds. on GTP pool depletion.  When the 50% effective concns. (EC50s) for the antiviral activities of ribavirin, EICAR, and MPA were plotted against the resp. EC50 values for GTP pool depletion, a linear correlation was calcd.  These data provide compelling evidence that the predominant mechanism of action of ribavirin in vitro against flavi- and paramyxoviruses is based on inhibition of cellular IMP dehydrogenase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq--VWj2w0ZRrVg90H21EOLACvtfcHk0lg3CX1gEjuWwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCisro%253D&md5=be4ce47865e8b4dca75f473c17e3ad10</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.3.1943-1947.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.3.1943-1947.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLeyssen%26aufirst%3DP.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DNeyts%26aufirst%3DJ.%26atitle%3DThe%2520predominant%2520mechanism%2520by%2520which%2520ribavirin%2520exerts%2520its%2520antiviral%2520activity%2520in%2520vitro%2520against%2520flaviviruses%2520and%2520paramyxoviruses%2520is%2520mediated%2520by%2520inhibition%2520of%2520IMP%2520dehydrogenase%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D1943%26epage%3D1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, D. M.</span><span> </span><span class="NLM_article-title">Ribavirin in the treatment of chronic hepatitis C</span> <span class="citation_source-journal">J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1111%2Fj.1440-1746.2008.05398.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=18565019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFyls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=844-855&author=P.+Martinauthor=D.+M.+Jensen&title=Ribavirin+in+the+treatment+of+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin in the treatment of chronic hepatitis C</span></div><div class="casAuthors">Martin, Paul; Jensen, Donald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">844-855</span>CODEN:
                <span class="NLM_cas:coden">JGHEEO</span>;
        ISSN:<span class="NLM_cas:issn">0815-9319</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Background and Aim: Current practice guidelines recommend that individuals chronically infected with the hepatitis C virus (HCV) be treated with pegylated interferon plus ribavirin.  Ribavirin, however, is assocd. with serious adverse events (AE), esp. anemia.  We review its mechanism of action, its importance in treating chronic hepatitis C (CHC) patients, the AE assocd. with its use, and techniques used to lessen these AE.  Methods: Medline searches were performed using the keywords ribavirin and hepatitis, together with the keywords mechanism, anemia, liver transplant, renal function, pharmacokinetics, and dose redn.  Searches of abstrs. of recent Digestive Diseases Week, American Assocn. for the Study of Liver Diseases, and European Assocn. for the Study of Liver Diseases meetings were also performed.  Results: Ribavirin may be effective in treating CHC by affecting the virus or the host; for example by inducing viral mutations, blocking cellular enzymes, or affecting the host immune response.  Although the pegylated interferons are the primary drugs used to treat CHC, a combination with ribavirin is more effective than pegylated interferon alone.  Ribavirin-assocd. AE may be lessened by ribavirin dose redns. and by maintenance of the hematocrit.  Conclusions: Treatments of ribavirin toxicities, esp. anemia, can allow patients to continue full-dose combination therapy with peginterferon and ribavirin, enhancing their probability of attaining a sustained virol. response (SVR).  Treatment of CHC should be tailored to individual patients, esp. those with renal dysfunction, and should include agents that treat the side-effects of CHC treatment.  Monitoring of plasma ribavirin concns. during treatment may help in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopgTg12R89U7Vg90H21EOLACvtfcHk0lhJEukk50G1mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFyls7o%253D&md5=e01104f2f31f1134b8ca41d9fb133e5c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1746.2008.05398.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1746.2008.05398.x%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DD.%2BM.%26atitle%3DRibavirin%2520in%2520the%2520treatment%2520of%2520chronic%2520hepatitis%2520C%26jtitle%3DJ.%2520Gastroenterol.%2520Hepatol.%26date%3D2008%26volume%3D23%26spage%3D844%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Crotty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andino, R.</span><span> </span><span class="NLM_article-title">Ribavirin’s antiviral mechanism of action: lethal mutagenesis?</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1007%2Fs00109-001-0308-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=11907645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFOlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=86-95&author=S.+Crottyauthor=C.+Cameronauthor=R.+Andino&title=Ribavirin%E2%80%99s+antiviral+mechanism+of+action%3A+lethal+mutagenesis%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin's antiviral mechanism of action: Lethal mutagenesis?</span></div><div class="casAuthors">Crotty, Shane; Cameron, Craig; Andino, Raul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">86-95</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  Ribavirin, an antiviral drug discovered in 1972, is interesting and important for three reasons: (a) it exhibits antiviral activity against a broad range of RNA viruses; (b) it is currently used clin. to treat hepatitis C virus infections, respiratory syncytial virus infections, and Lassa fever virus infections; and (c) ribavirin's mechanism of action has remained unclear for many years.  Here we recount the history of ribavirin and review recent reports regarding ribavirin's mechanism of action, including our studies demonstrating that ribavirin is an RNA virus mutagen and ribavirin's primary antiviral mechanism of action against a model RNA virus is via lethal mutagenesis of the RNA virus genomes.  Implications for the development of improved versions of ribavirin and for the development of novel antiviral drugs are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0CTPDtNCY_LVg90H21EOLACvtfcHk0lhJEukk50G1mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFOlsrc%253D&md5=478924c4b358db2f39eabf02f112ffbb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00109-001-0308-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-001-0308-0%26sid%3Dliteratum%253Aachs%26aulast%3DCrotty%26aufirst%3DS.%26aulast%3DCameron%26aufirst%3DC.%26aulast%3DAndino%26aufirst%3DR.%26atitle%3DRibavirin%25E2%2580%2599s%2520antiviral%2520mechanism%2520of%2520action%253A%2520lethal%2520mutagenesis%253F%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2002%26volume%3D80%26spage%3D86%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Andrei, C.; De Clercq, E.; Snoeck, R.; Viral, D. N. A.</span><span> </span><span class="NLM_article-title">Polymerase Inhibitors</span>. In  <span class="citation_source-book">Viral Genome Replication</span>; <span class="NLM_contrib-group">Cameron, C. E.; Gotte, M.; Raney, K.</span>, Eds.; <span class="NLM_publisher-name">Springer Science and Business Media</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Chapter 22.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1007%2Fb135974_22" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+Andrei&author=E.+De+Clercq&author=R.+Snoeck&author=D.+N.+A.+Viralauthor=C.+E.+Cameron&author=M.+Gotte&author=K.+Raney&title=Viral+Genome+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fb135974_22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252Fb135974_22%26sid%3Dliteratum%253Aachs%26aulast%3DAndrei%26aufirst%3DC.%26atitle%3DPolymerase%2520Inhibitors%26btitle%3DViral%2520Genome%2520Replication%26aulast%3DCameron%26aufirst%3DC.%2BE.%26pub%3DSpringer%2520Science%2520and%2520Business%2520Media%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Nelson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferenci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herring, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pockros, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G.</span><span> </span><span class="NLM_article-title">Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients</span> <span class="citation_source-journal">Ann. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=22166557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFWmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=15-31&author=D.+R.+Nelsonauthor=S.+Zeuzemauthor=P.+Andreoneauthor=P.+Ferenciauthor=R.+Herringauthor=D.+M.+Jensenauthor=P.+Marcellinauthor=P.+J.+Pockrosauthor=M.+Rodr%C3%ADguez-Torresauthor=L.+Rossaroauthor=V.+K.+Rustgiauthor=T.+Sepeauthor=M.+Sulkowskiauthor=I.+R.+Thomasonauthor=E.+M.+Yoshidaauthor=A.+Chanauthor=G.+Hill&title=Balapiravir+plus+peginterferon+alfa-2a+%2840KD%29%2Fribavirin+in+a+randomized+trial+of+hepatitis+C+genotype+1+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients</span></div><div class="casAuthors">Nelson, David R.; Zeuzem, Stefan; Andreone, Pietro; Ferenci, Peter; Herring, Robert; Jensen, Donald M.; Marcellin, Patrick; Pockros, Paul J.; Rodriguez-Torres, Maribel; Rossaro, Lorenzo; Rustgi, Vinod K.; Sepe, Thomas; Sulkowski, Mark; Thomason, Isaac R.; Yoshida, Eric M.; Chan, Anna; Hill, George</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hepatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-31</span>CODEN:
                <span class="NLM_cas:coden">AHNEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1665-2681</span>.
    
            (<span class="NLM_cas:orgname">Mexican Association of Hepatology</span>)
        </div><div class="casAbstract">Balapiravir (R1626, RG1626) is the prodrug of a nucleoside analog inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).  This phase 2, double-blind international trial evaluated the optimal treatment regimen of balapiravir plus peginterferon alfa-2a (40KD)/ribavirin.  Treatment-naive genotype 1 patients (N = 516) were randomized to one of seven treatment groups in which they received balapiravir 500, 1000, or 1500 mg twice daily, peginterferon alfa-2a (40KD) 180 or 90 μg/wk and ribavirin 1000/1200 mg/day or peginterferon alfa-2a (40KD)/ribavirin.  The planned treatment duration with balapiravir was reduced from 24 to 12 wk due to safety concerns.  The percentage of patients with undetectable HCV RNA was consistently higher in all balapiravir groups from week 2 to 12.  However, high rates of dose modifications and discontinuations of one/all study drugs compromised the efficacy assessment and resulted in similar sustained virol. response rates in the balapiravir groups (range 32-50%) and the peginterferon alfa-2a (40KD)/ribavirin group (43%).  Balapiravir was discontinued for safety reasons in 28-36% of patients (most often for lymphopenia) and the percentage of patients with serious adverse events (esp. hematol., infection, ocular events) was dose related.  Serious hematol. adverse events (particularly neutropenia, lymphopenia) were more common in balapiravir recipients.  Two deaths in the balapiravir/peginterferon alfa-2a/ribavirin combination groups were considered possibly related to study medication.  Further development of balapiravir for the treatment of chronic hepatitis C has been halted because of the unacceptable benefit to risk ratio revealed in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRO0zUfNS5ILVg90H21EOLACvtfcHk0lhJEukk50G1mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFWmtQ%253D%253D&md5=cc59339beba23a752f77cc3c7e5d0c3c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BR.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DAndreone%26aufirst%3DP.%26aulast%3DFerenci%26aufirst%3DP.%26aulast%3DHerring%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DD.%2BM.%26aulast%3DMarcellin%26aufirst%3DP.%26aulast%3DPockros%26aufirst%3DP.%2BJ.%26aulast%3DRodr%25C3%25ADguez-Torres%26aufirst%3DM.%26aulast%3DRossaro%26aufirst%3DL.%26aulast%3DRustgi%26aufirst%3DV.%2BK.%26aulast%3DSepe%26aufirst%3DT.%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DThomason%26aufirst%3DI.%2BR.%26aulast%3DYoshida%26aufirst%3DE.%2BM.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DG.%26atitle%3DBalapiravir%2520plus%2520peginterferon%2520alfa-2a%2520%252840KD%2529%252Fribavirin%2520in%2520a%2520randomized%2520trial%2520of%2520hepatitis%2520C%2520genotype%25201%2520patients%26jtitle%3DAnn.%2520Hepatol.%26date%3D2012%26volume%3D11%26spage%3D15%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">DeVincenzo, J.; Fathi, H.; McClure, M.; Westland, C.; Chanda, S.; Lambkin-Williams, R.; Smith, P.; Harrison, L.; Symons, J.; Scaglioni-Weinlich, C.; Zhang, Q.; Nieforth, K.; Beigelman, L.; Blatt, L.; Fry, J.</span><span> </span><span class="NLM_article-title">Treatment with oral ALS-008176, a nucleoside analog, rapidly reduces RSV viral load and clinical disease severity in a healthy volunteer challenge study</span>. <span class="NLM_conf-name">IDWeek</span>, <span class="NLM_conf-loc">Philadelphia, PA</span>, <span class="NLM_conf-date">October 8-12, 2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DeVincenzo%2C+J.%3B+Fathi%2C+H.%3B+McClure%2C+M.%3B+Westland%2C+C.%3B+Chanda%2C+S.%3B+Lambkin-Williams%2C+R.%3B+Smith%2C+P.%3B+Harrison%2C+L.%3B+Symons%2C+J.%3B+Scaglioni-Weinlich%2C+C.%3B+Zhang%2C+Q.%3B+Nieforth%2C+K.%3B+Beigelman%2C+L.%3B+Blatt%2C+L.%3B+Fry%2C+J.+Treatment+with+oral+ALS-008176%2C+a+nucleoside+analog%2C+rapidly+reduces+RSV+viral+load+and+clinical+disease+severity+in+a+healthy+volunteer+challenge+study.+IDWeek%2C+Philadelphia%2C+PA%2C+October+8-12%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%26atitle%3DTreatment%2520with%2520oral%2520ALS-008176%252C%2520a%2520nucleoside%2520analog%252C%2520rapidly%2520reduces%2520RSV%2520viral%2520load%2520and%2520clinical%2520disease%2520severity%2520in%2520a%2520healthy%2520volunteer%2520challenge%2520study" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomgren, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granycome, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laxton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrett, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span> </span><span class="NLM_article-title">Design, synthesis and antiviral properties of 4′-substituted ribonucleosides as inhibitors of hepatitis C virus placation: The discovery of R1479</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2570</span><span class="NLM_x">–</span> <span class="NLM_lpage">2576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2570-2576&author=D.+B.+Smithauthor=J.+A.+Martinauthor=K.+Klumppauthor=S.+J.+Bakerauthor=P.+A.+Blomgrenauthor=R.+Devosauthor=C.+Granycomeauthor=J.+Hangauthor=C.+J.+Hobbsauthor=W.-R.+Jiangauthor=C.+Laxtonauthor=S.+Le+Pogamauthor=V.+Levequeauthor=H.+Maauthor=G.+Maileauthor=J.+H.+Merrettauthor=A.+Pichotaauthor=K.+Sarmaauthor=M.+Smithauthor=S.+Swallowauthor=J.+Symonsauthor=D.+Veseyauthor=I.+Najeraauthor=N.+Cammack&title=Design%2C+synthesis+and+antiviral+properties+of+4%E2%80%B2-substituted+ribonucleosides+as+inhibitors+of+hepatitis+C+virus+placation%3A+The+discovery+of+R1479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBlomgren%26aufirst%3DP.%2BA.%26aulast%3DDevos%26aufirst%3DR.%26aulast%3DGranycome%26aufirst%3DC.%26aulast%3DHang%26aufirst%3DJ.%26aulast%3DHobbs%26aufirst%3DC.%2BJ.%26aulast%3DJiang%26aufirst%3DW.-R.%26aulast%3DLaxton%26aufirst%3DC.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMerrett%26aufirst%3DJ.%2BH.%26aulast%3DPichota%26aufirst%3DA.%26aulast%3DSarma%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%2520and%2520antiviral%2520properties%2520of%25204%25E2%2580%25B2-substituted%2520ribonucleosides%2520as%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520placation%253A%2520The%2520discovery%2520of%2520R1479%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2570%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaynov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sund, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinho, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltseva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkenstock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunnar Johansson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span> </span><span class="NLM_article-title">The design, synthesis and antiviral activity of 4′-azidocytidine analogues against hepatitis C virus replication: the discovery of 4′-azidoarabinocytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800981y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=219-223&author=D.+B.+Smithauthor=G.+Kalaynovauthor=C.+Sundauthor=A.+Winqvistauthor=P.+Pinhoauthor=T.+Maltsevaauthor=V.+Morissonauthor=S.+Rajyaguruauthor=S.+Le+Pogamauthor=I.+Najeraauthor=K.+Benkenstockauthor=X.-X.+Zhouauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+Gunnar+Johanssonauthor=K.+Klumppauthor=M.+Smith&title=The+design%2C+synthesis+and+antiviral+activity+of+4%E2%80%B2-azidocytidine+analogues+against+hepatitis+C+virus+replication%3A+the+discovery+of+4%E2%80%B2-azidoarabinocytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm800981y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800981y%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalaynov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DC.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DPinho%26aufirst%3DP.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DMorisson%26aufirst%3DV.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DBenkenstock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGunnar%2BJohansson%26aufirst%3DN.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520design%252C%2520synthesis%2520and%2520antiviral%2520activity%2520of%25204%25E2%2580%25B2-azidocytidine%2520analogues%2520against%2520hepatitis%2520C%2520virus%2520replication%253A%2520the%2520discovery%2520of%25204%25E2%2580%25B2-azidoarabinocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D219%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalayanov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sund, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltseva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V. J-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ann C. Kaiser, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span> </span><span class="NLM_article-title">The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4′-azidocytidine against hepatitis C virus replication: the discovery of 4′-azido-2′-deoxy-2′-fluorocytidine and 4′-azido-2′-dideoxy-2′,2′-difluorocytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2971</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801595c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2971-2978&author=D.+B.+Smithauthor=G.+Kalayanovauthor=C.+Sundauthor=A.+Winqvistauthor=T.+Maltsevaauthor=V.+J-P.+Levequeauthor=S.+Rajyaguruauthor=S.+Le+Pogamauthor=I.+Najeraauthor=K.+Benkestockauthor=X.-X.+Zhouauthor=A.+C.+Ann+C.+Kaiserauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+G.+Johanssonauthor=K.+Klumppauthor=M.+Smith&title=The+design%2C+synthesis%2C+and+antiviral+activity+of+monofluoro+and+difluoro+analogues+of+4%E2%80%B2-azidocytidine+against+hepatitis+C+virus+replication%3A+the+discovery+of+4%E2%80%B2-azido-2%E2%80%B2-deoxy-2%E2%80%B2-fluorocytidine+and+4%E2%80%B2-azido-2%E2%80%B2-dideoxy-2%E2%80%B2%2C2%E2%80%B2-difluorocytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm801595c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801595c%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalayanov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DC.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DLeveque%26aufirst%3DV.%2BJ-P.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DAnn%2BC.%2BKaiser%26aufirst%3DA.%2BC.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DJohansson%26aufirst%3DN.%2BG.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520design%252C%2520synthesis%252C%2520and%2520antiviral%2520activity%2520of%2520monofluoro%2520and%2520difluoro%2520analogues%2520of%25204%25E2%2580%25B2-azidocytidine%2520against%2520hepatitis%2520C%2520virus%2520replication%253A%2520the%2520discovery%2520of%25204%25E2%2580%25B2-azido-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluorocytidine%2520and%25204%25E2%2580%25B2-azido-2%25E2%2580%25B2-dideoxy-2%25E2%2580%25B2%252C2%25E2%2580%25B2-difluorocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2971%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Nomura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, A.</span><span> </span><span class="NLM_article-title">Nucleosides and Nucleotides. 185. Synthesis and biological activities of 4′α-<i>C</i>-branched-chain sugar pyrimidine nucleosides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2901</span><span class="NLM_x">–</span> <span class="NLM_lpage">2908</span><div class="note"><p class="first last">25-1</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm990050i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2901-2908&author=M.+Nomuraauthor=S.+Shutoauthor=M.+Tanakaauthor=T.+Sasakiauthor=S.+Moriauthor=S.+Shigetaauthor=A.+Matsuda&title=Nucleosides+and+Nucleotides.+185.+Synthesis+and+biological+activities+of+4%E2%80%B2%CE%B1-C-branched-chain+sugar+pyrimidine+nucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm990050i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990050i%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DM.%26aulast%3DShuto%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DShigeta%26aufirst%3DS.%26aulast%3DMatsuda%26aufirst%3DA.%26atitle%3DNucleosides%2520and%2520Nucleotides.%2520185.%2520Synthesis%2520and%2520biological%2520activities%2520of%25204%25E2%2580%25B2%25CE%25B1-C-branched-chain%2520sugar%2520pyrimidine%2520nucleosides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2901%26epage%3D2908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">O-Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eugui, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRoberts, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheyden, J. P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurz, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, K. A. M.</span><span> </span><span class="NLM_article-title">4′-Substituted nucleosides as inhibitors of HIV: an unusual oxetane derivative</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1992&pages=41-44&author=C.+O-Yangauthor=W.+Kurzauthor=E.+M.+Euguiauthor=M.+J.+McRobertsauthor=J.+P.+H.+Verheydenauthor=L.+J.+Kurzauthor=K.+A.+M.+Walker&title=4%E2%80%B2-Substituted+nucleosides+as+inhibitors+of+HIV%3A+an+unusual+oxetane+derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO-Yang%26aufirst%3DC.%26aulast%3DKurz%26aufirst%3DW.%26aulast%3DEugui%26aufirst%3DE.%2BM.%26aulast%3DMcRoberts%26aufirst%3DM.%2BJ.%26aulast%3DVerheyden%26aufirst%3DJ.%2BP.%2BH.%26aulast%3DKurz%26aufirst%3DL.%2BJ.%26aulast%3DWalker%26aufirst%3DK.%2BA.%2BM.%26atitle%3D4%25E2%2580%25B2-Substituted%2520nucleosides%2520as%2520inhibitors%2520of%2520HIV%253A%2520an%2520unusual%2520oxetane%2520derivative%26jtitle%3DTetrahedron%2520Lett.%26date%3D1992%26volume%3D33%26spage%3D41%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span> </span><span class="NLM_article-title">Synthesis and anti-HIV activity of 2′-deoxy-2′-fluoro-4′-<i>C</i>-ethynyl nucleoside analogs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4053</span><span class="NLM_x">–</span> <span class="NLM_lpage">4056</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4053-4056&author=Q.+Wangauthor=Y.+Liauthor=C.+Songauthor=K.+Qianauthor=C.-H.+Chenauthor=K.-H.+Leeauthor=J.+Chang&title=Synthesis+and+anti-HIV+activity+of+2%E2%80%B2-deoxy-2%E2%80%B2-fluoro-4%E2%80%B2-C-ethynyl+nucleoside+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DLee%26aufirst%3DK.-H.%26aulast%3DChang%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520anti-HIV%2520activity%2520of%25202%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluoro-4%25E2%2580%25B2-C-ethynyl%2520nucleoside%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4053%26epage%3D4056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Haraguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span> </span><span class="NLM_article-title">Ring opening of 4′,5′-epoxynucleosides: a novel stereoselective entry to 4′-<i>C</i>-branched nucleosides</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1402</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol020259h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=1399-1402&author=K.+Haraguchiauthor=S.+Takedaauthor=H.+Tanaka&title=Ring+opening+of+4%E2%80%B2%2C5%E2%80%B2-epoxynucleosides%3A+a+novel+stereoselective+entry+to+4%E2%80%B2-C-branched+nucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fol020259h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol020259h%26sid%3Dliteratum%253Aachs%26aulast%3DHaraguchi%26aufirst%3DK.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DH.%26atitle%3DRing%2520opening%2520of%25204%25E2%2580%25B2%252C5%25E2%2580%25B2-epoxynucleosides%253A%2520a%2520novel%2520stereoselective%2520entry%2520to%25204%25E2%2580%25B2-C-branched%2520nucleosides%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D1399%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Richards, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheyden, J. P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span> </span><span class="NLM_article-title">Synthesis of 4’-methoxyadenosine and related compounds</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1982&pages=315-330&author=C.+M.+Richardsauthor=J.+P.+H.+Verheydenauthor=J.+G.+Moffat&title=Synthesis+of+4%E2%80%99-methoxyadenosine+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DC.%2BM.%26aulast%3DVerheyden%26aufirst%3DJ.%2BP.%2BH.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26atitle%3DSynthesis%2520of%25204%25E2%2580%2599-methoxyadenosine%2520and%2520related%2520compounds%26jtitle%3DCarbohydr.%2520Res.%26date%3D1982%26volume%3D100%26spage%3D315%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Brandl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birudaraj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micaela Reddy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfredson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrabee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadig, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washington, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span> </span><span class="NLM_article-title">Physicochemical properties of the nucleoside prodrug R1626 leading to high oral bioavailability</span> <span class="citation_source-journal">Drug Dev. Ind. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1080%2F03639040701836636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=18612909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVaisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2008&pages=683-691&author=M.+Brandlauthor=X.+Wuauthor=M.+Holperauthor=L.+Hongauthor=Z.+Jiaauthor=R.+Birudarajauthor=M.+Micaela+Reddyauthor=T.+Alfredsonauthor=T.+Tranauthor=S.+Larrabeeauthor=X.+Hadigauthor=K.+Sarmaauthor=C.+Washingtonauthor=G.+Hillauthor=D.+B.+Smith&title=Physicochemical+properties+of+the+nucleoside+prodrug+R1626+leading+to+high+oral+bioavailability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical Properties of the Nucleoside Prodrug R1626 Leading to High Oral Bioavailability</span></div><div class="casAuthors">Brandl, Michael; Wu, Xiaoyang; Holper, Marites; Hong, Lei; Jia, Zhongjiang; Birudaraj, Raj; Reddy, Micaela; Alfredson, Tom; Tran, Tony; Larrabee, Susan; Hadig, Xu; Sarma, Keshab; Washington, Carla; Hill, George; Smith, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development and Industrial Pharmacy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">683-691</span>CODEN:
                <span class="NLM_cas:coden">DDIPD8</span>;
        ISSN:<span class="NLM_cas:issn">0363-9045</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The nucleoside analog R1479 is a potent and highly selective inhibitor of NS5b-directed hepatitis C virus (HCV) RNA polymerase in vitro.  Because of its limited permeability, lipophilic prodrugs of R1479 were screened.  Selection of the prodrug involved optimization of soly., permeability, and stability parameters.  R1626 has dissocn. const., intrinsic soly., log partition coeff. (n-octanol water), and Caco-2 permeability of 3.62, 0.19 mg/mL, 2.45, and 14.95 × 10-6 cm/s, resp.  The hydrolysis of the prodrug is significantly faster in the Caco-2 expts. than in hydrolytic expts., suggesting that the hydrolysis is catalyzed by enzymes in the cellular membrane.  Using GastroPlus, the phys. properties of R1626 successfully predict the dose dependence of the pharmacokinetics in humans previously studied.  The program predicts that if the particle size of R1626 is less than 25 μm, it will be well absorbed.  Prodrugs with a soly. of greater than 100 μg/mL and permeability in the Caco-2 assay greater than 3 × 10-6 cm/s are expected to achieve a high fraction absorbed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn2JvGjiHPNLVg90H21EOLACvtfcHk0lgp-DI7nWuLAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVaisro%253D&md5=222ee77af8ae55778417c97296da6df6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F03639040701836636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03639040701836636%26sid%3Dliteratum%253Aachs%26aulast%3DBrandl%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHolper%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DBirudaraj%26aufirst%3DR.%26aulast%3DMicaela%2BReddy%26aufirst%3DM.%26aulast%3DAlfredson%26aufirst%3DT.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DLarrabee%26aufirst%3DS.%26aulast%3DHadig%26aufirst%3DX.%26aulast%3DSarma%26aufirst%3DK.%26aulast%3DWashington%26aufirst%3DC.%26aulast%3DHill%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26atitle%3DPhysicochemical%2520properties%2520of%2520the%2520nucleoside%2520prodrug%2520R1626%2520leading%2520to%2520high%2520oral%2520bioavailability%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2008%26volume%3D34%26spage%3D683%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amours, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommadossi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2′-<i>C</i>-methylcytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6614</span><span class="NLM_x">–</span> <span class="NLM_lpage">6620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6614-6620&author=C.+Pierraauthor=A.+Amadorauthor=S.+Benzariaauthor=E.+Cretton-Scottauthor=M.+D%E2%80%99Amoursauthor=J.+Maoauthor=S.+Mathieuauthor=A.+Moussaauthor=E.+G.+Bridgesauthor=D.+N.+Standringauthor=J.+P.+Sommadossiauthor=R.+Storerauthor=G.+Gosselin&title=Synthesis+and+pharmacokinetics+of+valopicitabine+%28NM283%29%2C+an+efficient+prodrug+of+the+potent+anti-HCV+agent+2%E2%80%B2-C-methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm0603623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603623%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amours%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DBridges%26aufirst%3DE.%2BG.%26aulast%3DStandring%26aufirst%3DD.%2BN.%26aulast%3DSommadossi%26aufirst%3DJ.%2BP.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520pharmacokinetics%2520of%2520valopicitabine%2520%2528NM283%2529%252C%2520an%2520efficient%2520prodrug%2520of%2520the%2520potent%2520anti-HCV%2520agent%25202%25E2%2580%25B2-C-methylcytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6614%26epage%3D6620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mason, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawetz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudette, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dô, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scouten, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liuzzi, M.</span><span> </span><span class="NLM_article-title">Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">4758</span><span class="NLM_x">–</span> <span class="NLM_lpage">4767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=4758-4767&author=S.+W.+Masonauthor=C.+Lawetzauthor=Y.+Gaudetteauthor=F.+D%C3%B4author=E.+Scoutenauthor=L.+Lagac%C3%A9author=B.+Simoneauauthor=M.+Liuzzi&title=Polyadenylation-dependent+screening+assay+for+respiratory+syncytial+virus+RNA+transcriptase+activity+and+identification+of+an+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DS.%2BW.%26aulast%3DLawetz%26aufirst%3DC.%26aulast%3DGaudette%26aufirst%3DY.%26aulast%3DD%25C3%25B4%26aufirst%3DF.%26aulast%3DScouten%26aufirst%3DE.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DLiuzzi%26aufirst%3DM.%26atitle%3DPolyadenylation-dependent%2520screening%2520assay%2520for%2520respiratory%2520syncytial%2520virus%2520RNA%2520transcriptase%2520activity%2520and%2520identification%2520of%2520an%2520inhibitor%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3D4758%26epage%3D4767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Deval, J.; Hong, J.; Wang, G.; Taylor, J.; Smith, L.; Fung, A.; Stevens, S.; Liu, H.; Jin, Z.; Dyatkina, N.; Prhavc, M.; Serebryany, V.; Jyanwei Liu, J.; Smith, D. B.; Yuen Tam, Y.; Zhang, Q.; Chanda, S. M.; Blatt, L. B.; Symons, J. A.; Beigelman, L.</span><span> </span><span class="NLM_article-title">ALS-8176 is an orally bioavailable nucleoside analog acting as a chain terminator of respiratory syncytial virus rna polymerase activity</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Deval%2C+J.%3B+Hong%2C+J.%3B+Wang%2C+G.%3B+Taylor%2C+J.%3B+Smith%2C+L.%3B+Fung%2C+A.%3B+Stevens%2C+S.%3B+Liu%2C+H.%3B+Jin%2C+Z.%3B+Dyatkina%2C+N.%3B+Prhavc%2C+M.%3B+Serebryany%2C+V.%3B+Jyanwei+Liu%2C+J.%3B+Smith%2C+D.+B.%3B+Yuen+Tam%2C+Y.%3B+Zhang%2C+Q.%3B+Chanda%2C+S.+M.%3B+Blatt%2C+L.+B.%3B+Symons%2C+J.+A.%3B+Beigelman%2C+L.+ALS-8176+is+an+orally+bioavailable+nucleoside+analog+acting+as+a+chain+terminator+of+respiratory+syncytial+virus+rna+polymerase+activity.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DDeval%26aufirst%3DJ.%26atitle%3DALS-8176%2520is%2520an%2520orally%2520bioavailable%2520nucleoside%2520analog%2520acting%2520as%2520a%2520chain%2520terminator%2520of%2520respiratory%2520syncytial%2520virus%2520rna%2520polymerase%2520activity" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Arnold, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smidansky, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireeva, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babusis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barauskus, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnatt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashlev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, C. E.</span><span> </span><span class="NLM_article-title">Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides</span> <span class="citation_source-journal">PLOS Pathogens</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=e1003030&author=J.+J.+Arnoldauthor=S.+D.+Sharmaauthor=J.+Y.+Fengauthor=A.+S.+Rayauthor=E.+D.+Smidanskyauthor=M.+L.+Kireevaauthor=A.+Choauthor=J.+Perryauthor=J.+E.+Velaauthor=Y.+Parkauthor=Y.+Xuauthor=Y.+Tianauthor=D.+Babusisauthor=O.+Barauskusauthor=B.+R.+Petersonauthor=A.+Gnattauthor=M.+Kashlevauthor=W.+Zhongauthor=E.+Craigauthor=C.+E.+Cameron&title=Sensitivity+of+mitochondrial+transcription+and+resistance+of+RNA+polymerase+II+dependent+nuclear+transcription+to+antiviral+ribonucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DJ.%2BJ.%26aulast%3DSharma%26aufirst%3DS.%2BD.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DSmidansky%26aufirst%3DE.%2BD.%26aulast%3DKireeva%26aufirst%3DM.%2BL.%26aulast%3DCho%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DVela%26aufirst%3DJ.%2BE.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DBarauskus%26aufirst%3DO.%26aulast%3DPeterson%26aufirst%3DB.%2BR.%26aulast%3DGnatt%26aufirst%3DA.%26aulast%3DKashlev%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DCraig%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DC.%2BE.%26atitle%3DSensitivity%2520of%2520mitochondrial%2520transcription%2520and%2520resistance%2520of%2520RNA%2520polymerase%2520II%2520dependent%2520nuclear%2520transcription%2520to%2520antiviral%2520ribonucleosides%26jtitle%3DPLOS%2520Pathogens%26date%3D2012%26volume%3D8%26spage%3De1003030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Malykhina, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yednak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivo, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeples, M. E.</span><span> </span><span class="NLM_article-title">A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">4792</span><span class="NLM_x">–</span> <span class="NLM_lpage">4801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1128%2FJVI.02399-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=21389127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Wlt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2011&pages=4792-4801&author=O.+Malykhinaauthor=M.+A.+Yednakauthor=P.+L.+Collinsauthor=P.+D.+Olivoauthor=M.+E.+Peeples&title=A+respiratory+syncytial+virus+replicon+that+is+noncytotoxic+and+capable+of+long-term+foreign+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression</span></div><div class="casAuthors">Malykhina, Olga; Yednak, Mark A.; Collins, Peter L.; Olivo, Paul D.; Peeples, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4792-4801</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) infection of most cultured cell lines causes cell-cell fusion and death.  Cell fusion is caused by the fusion (F) glycoprotein and is clearly cytopathic, but other aspects of RSV infection may also contribute to cytopathol.  To investigate this possibility, we generated an RSV replicon that lacks all three of its glycoprotein genes and so cannot cause cell-cell fusion or virus spread.  This replicon includes a green fluorescent protein gene and an antibiotic resistance gene to enable detection and selection of replicon-contg. cells.  Adaptive mutations in the RSV replicon were not required for replicon maintenance.  Cells contg. the replicon could be cloned and passaged many times in the absence of antibiotic selection, with 99% or more of the cells retaining the replicon after each cell division.  Transient expression of the F and G (attachment) glycoproteins supported the prodn. of virions that could transfer the replicon into most cell lines tested.  Since the RSV replicon is not toxic to these cultured cells and does not affect their rate of cell division, none of the 8 internal viral proteins, the viral RNA transcripts, or the host response to these mols. or their activities is cytopathic.  However, the level of replicon genome and gene expression is controlled in some manner well below that of complete virus and, as such, might avoid cytotoxicity.  RSV replicons could be useful for cytoplasmic gene expression in vitro and in vivo and for screening for compds. active against the viral polymerase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8hxZsD49u17Vg90H21EOLACvtfcHk0lhak6Juf8cFaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Wlt7fN&md5=e4eb52f351eca99dbe8366b493ff9aeb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1128%2FJVI.02399-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02399-10%26sid%3Dliteratum%253Aachs%26aulast%3DMalykhina%26aufirst%3DO.%26aulast%3DYednak%26aufirst%3DM.%2BA.%26aulast%3DCollins%26aufirst%3DP.%2BL.%26aulast%3DOlivo%26aufirst%3DP.%2BD.%26aulast%3DPeeples%26aufirst%3DM.%2BE.%26atitle%3DA%2520respiratory%2520syncytial%2520virus%2520replicon%2520that%2520is%2520noncytotoxic%2520and%2520capable%2520of%2520long-term%2520foreign%2520gene%2520expression%26jtitle%3DJ.%2520Virol.%26date%3D2011%26volume%3D85%26spage%3D4792%26epage%3D4801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Hertel, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tustin, J. M.</span><span> </span><span class="NLM_article-title">Synthesis of 2-deoxy-2,2-difluoro-<span class="smallcaps smallerCapital">d</span>-ribose and 2-deoxy-2,2-difluoro-<span class="smallcaps smallerCapital">d</span>-ribofuranosyl nucleosides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2406</span><span class="NLM_x">–</span> <span class="NLM_lpage">2409</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00246a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=2406-2409&author=L.+W.+Hertelauthor=J.+S.+Kroinauthor=J.+W.+Misnerauthor=J.+M.+Tustin&title=Synthesis+of+2-deoxy-2%2C2-difluoro-d-ribose+and+2-deoxy-2%2C2-difluoro-d-ribofuranosyl+nucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo00246a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00246a002%26sid%3Dliteratum%253Aachs%26aulast%3DHertel%26aufirst%3DL.%2BW.%26aulast%3DKroin%26aufirst%3DJ.%2BS.%26aulast%3DMisner%26aufirst%3DJ.%2BW.%26aulast%3DTustin%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%25202-deoxy-2%252C2-difluoro-d-ribose%2520and%25202-deoxy-2%252C2-difluoro-d-ribofuranosyl%2520nucleosides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D2406%26epage%3D2409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Martínez-Montero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleavey, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-Pintado, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindovska, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Götte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damha, M. J.</span><span> </span><span class="NLM_article-title">Rigid 2′,4′-difluororibonucleosides: synthesis, conformational analysis, and incorporation into nascent RNA by HCV polymerase</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">5627</span><span class="NLM_x">–</span> <span class="NLM_lpage">5635</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo500794v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=5627-5635&author=S.+Mart%C3%ADnez-Monteroauthor=G.+F.+Deleaveyauthor=A.+Kulkarniauthor=N.+Mart%C3%ADn-Pintadoauthor=P.+Lindovskaauthor=M.+Thomsonauthor=C.+Gonz%C3%A1lezauthor=M.+G%C3%B6tteauthor=M.+J.+Damha&title=Rigid+2%E2%80%B2%2C4%E2%80%B2-difluororibonucleosides%3A+synthesis%2C+conformational+analysis%2C+and+incorporation+into+nascent+RNA+by+HCV+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo500794v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo500794v%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Montero%26aufirst%3DS.%26aulast%3DDeleavey%26aufirst%3DG.%2BF.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DMart%25C3%25ADn-Pintado%26aufirst%3DN.%26aulast%3DLindovska%26aufirst%3DP.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DC.%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26aulast%3DDamha%26aufirst%3DM.%2BJ.%26atitle%3DRigid%25202%25E2%2580%25B2%252C4%25E2%2580%25B2-difluororibonucleosides%253A%2520synthesis%252C%2520conformational%2520analysis%252C%2520and%2520incorporation%2520into%2520nascent%2520RNA%2520by%2520HCV%2520polymerase%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D5627%26epage%3D5635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Murray, R. W.; Singh, M.</span><span> </span><span class="NLM_article-title">Synthesis of epoxides using dimethyldioxirane: <i>trans</i>-stilbene oxide</span>,  <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span><i>Coll. Vol.</i> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1988&pages=288&author=R.+W.+Murray&author=M.+Singh&title=Synthesis+of+epoxides+using+dimethyldioxirane%3A+trans-stilbene+oxide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DR.%2BW.%26atitle%3DSynthesis%2520of%2520epoxides%2520using%2520dimethyldioxirane%253A%2520trans-stilbene%2520oxide%26jtitle%3DOrg.%2520Synth.%26date%3D1988%26volume%3D9%26spage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Luzzio, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menes, M. E.</span><span> </span><span class="NLM_article-title">A facile route to pyrimidine-based nucleoside olefins: application to the synthesis of d4T (Stavudine)</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7267</span><span class="NLM_x">–</span> <span class="NLM_lpage">7272</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00103a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=7267-7272&author=F.+A.+Luzzioauthor=M.+E.+Menes&title=A+facile+route+to+pyrimidine-based+nucleoside+olefins%3A+application+to+the+synthesis+of+d4T+%28Stavudine%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo00103a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00103a017%26sid%3Dliteratum%253Aachs%26aulast%3DLuzzio%26aufirst%3DF.%2BA.%26aulast%3DMenes%26aufirst%3DM.%2BE.%26atitle%3DA%2520facile%2520route%2520to%2520pyrimidine-based%2520nucleoside%2520olefins%253A%2520application%2520to%2520the%2520synthesis%2520of%2520d4T%2520%2528Stavudine%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D7267%26epage%3D7272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 78 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Richard L. Mackman, Hon C. Hui, Michel Perron, Eisuke Murakami, Christopher Palmiotti, Gary Lee, Kirsten Stray, Lijun Zhang, Bindu Goyal, Kwon Chun, Daniel Byun, Dustin Siegel, Scott Simonovich, Venice Du Pont, Jared Pitts, Darius Babusis, Arya Vijjapurapu, Xianghan Lu, Cynthia Kim, Xiaofeng Zhao, Julie Chan, Bin Ma, Diane Lye, Adelle Vandersteen, Sarah Wortman, Kimberly T. Barrett, Maria Toteva, Robert Jordan, Raju Subramanian, John P. Bilello, <span class="NLM_string-name hlFld-ContribAuthor">Tomas Cihlar</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 5001-5017. <a href="https://doi.org/10.1021/acs.jmedchem.1c00071" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00071%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProdrugs%252Bof%252Ba%252B1%2525E2%252580%2525B2-CN-4-Aza-7%25252C9-dideazaadenosine%252BC-Nucleoside%252BLeading%252Bto%252Bthe%252BDiscovery%252Bof%252BRemdesivir%252B%252528GS-5734%252529%252Bas%252Ba%252BPotent%252BInhibitor%252Bof%252BRespiratory%252BSyncytial%252BVirus%252Bwith%252BEfficacy%252Bin%252Bthe%252BAfrican%252BGreen%252BMonkey%252BModel%252Bof%252BRSV%26aulast%3DMackman%26aufirst%3DRichard%2BL.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15012021%26date%3D09042021%26volume%3D64%26issue%3D8%26spage%3D5001%26epage%3D5017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zihua Zheng, Elisabetta Groaz, Robert Snoeck, Steven De Jonghe, Piet Herdewijn, <span class="NLM_string-name hlFld-ContribAuthor">Graciela Andrei</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of 4′-Substitution on the Activity of Gemcitabine and Its ProTide Against VZV and SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 88-92. <a href="https://doi.org/10.1021/acsmedchemlett.0c00485" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00485</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00485%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInfluence%252Bof%252B4%2525E2%252580%2525B2-Substitution%252Bon%252Bthe%252BActivity%252Bof%252BGemcitabine%252Band%252BIts%252BProTide%252BAgainst%252BVZV%252Band%252BSARS-CoV-2%26aulast%3DZheng%26aufirst%3DZihua%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D04092020%26date%3D07122020%26date%3D09122020%26volume%3D12%26issue%3D1%26spage%3D88%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guangyi Wang, Natalia Dyatkina, Marija Prhavc, Caroline Williams, Vladimir Serebryany, Yujian Hu, Yongfei Huang, Xiangyang Wu, Tongqian Chen, Wensheng Huang, Vivek K. Rajwanshi, Jerome Deval, Amy Fung, Zhinan Jin, Antitsa Stoycheva, Kenneth Shaw, Kusum Gupta, Yuen Tam, Andreas Jekle, David B. Smith, <span class="NLM_string-name hlFld-ContribAuthor">Leonid Beigelman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of AL-611 as an HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10380-10395. <a href="https://doi.org/10.1021/acs.jmedchem.0c00935" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00935%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnti-HCV%252BActivity%252Bof%252BSugar-Modified%252BGuanosine%252BAnalogues%25253A%252BDiscovery%252Bof%252BAL-611%252Bas%252Ban%252BHCV%252BNS5B%252BPolymerase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BHepatitis%252BC%26aulast%3DWang%26aufirst%3DGuangyi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01062020%26date%3D03092020%26date%3D20082020%26volume%3D63%26issue%3D18%26spage%3D10380%26epage%3D10395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sandrine Vendeville, Abdellah Tahri, Lili Hu, Samuel Demin, Ludwig Cooymans, Ann Vos, Leen Kwanten, Joke Van den Berg, Michael B. Battles, Jason S. McLellan, Anil Koul, Pierre Raboisson, Dirk Roymans, <span class="NLM_string-name hlFld-ContribAuthor">Tim H. M. Jonckers</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8046-8058. <a href="https://doi.org/10.1021/acs.jmedchem.0c00226" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00226%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-%252528%25257B5-Chloro-1-%25255B3-%252528methylsulfonyl%252529propyl%25255D-1H-indol-2-yl%25257Dmethyl%252529-1-%2525282%25252C2%25252C2-trifluoroethyl%252529-1%25252C3-dihydro-2H-imidazo%25255B4%25252C5-c%25255Dpyridin-2-one%252B%252528JNJ-53718678%252529%25252C%252Ba%252BPotent%252Band%252BOrally%252BBioavailable%252BFusion%252BInhibitor%252Bof%252BRespiratory%252BSyncytial%252BVirus%26aulast%3DVendeville%26aufirst%3DSandrine%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07022020%26date%3D15062020%26date%3D14052020%26volume%3D63%26issue%3D15%26spage%3D8046%26epage%3D8058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christoph Köllmann, Svenja M. Sake, Peter G. Jones, Thomas Pietschmann, <span class="NLM_string-name hlFld-ContribAuthor">Daniel B. Werz</span>. </span><span class="cited-content_cbyCitation_article-title">Protecting-Group-Mediated Diastereoselective Synthesis of C4′-Methylated Uridine Analogs and Their Activity against the Human Respiratory Syncytial Virus. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (6)
                                     , 4267-4278. <a href="https://doi.org/10.1021/acs.joc.9b03425" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03425%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DProtecting-Group-Mediated%252BDiastereoselective%252BSynthesis%252Bof%252BC4%2525E2%252580%2525B2-Methylated%252BUridine%252BAnalogs%252Band%252BTheir%252BActivity%252Bagainst%252Bthe%252BHuman%252BRespiratory%252BSyncytial%252BVirus%26aulast%3DK%25C3%25B6llmann%26aufirst%3DChristoph%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D19122019%26date%3D26022020%26date%3D10022020%26volume%3D85%26issue%3D6%26spage%3D4267%26epage%3D4278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guangyi Wang, Natalia Dyatkina, Marija Prhavc, Caroline Williams, Vladimir Serebryany, Yujian Hu, Yongfei Huang, Jinqiao Wan, Xiangyang Wu, Jerome Deval, Amy Fung, Zhinan Jin, Hua Tan, Kenneth Shaw, Hyunsoon Kang, Qingling Zhang, Yuen Tam, Antitsa Stoycheva, Andreas Jekle, David B. Smith, <span class="NLM_string-name hlFld-ContribAuthor">Leonid Beigelman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-HCV Activities of 4′-Fluoro-2′-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4′-Fluoro-2′-C-methyluridine 5′-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4555-4570. <a href="https://doi.org/10.1021/acs.jmedchem.9b00143" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00143%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnti-HCV%252BActivities%252Bof%252B4%2525E2%252580%2525B2-Fluoro-2%2525E2%252580%2525B2-Substituted%252BUridine%252BTriphosphates%252Band%252BNucleotide%252BProdrugs%25253A%252BDiscovery%252Bof%252B4%2525E2%252580%2525B2-Fluoro-2%2525E2%252580%2525B2-C-methyluridine%252B5%2525E2%252580%2525B2-Phosphoramidate%252BProdrug%252B%252528AL-335%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BInfection%26aulast%3DWang%26aufirst%3DGuangyi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23012019%26date%3D19042019%26date%3D05042019%26volume%3D62%26issue%3D9%26spage%3D4555%26epage%3D4570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">G. Stuart Cockerill, James A. D. Good, <span class="NLM_string-name hlFld-ContribAuthor">Neil Mathews</span>. </span><span class="cited-content_cbyCitation_article-title">State of the Art in Respiratory Syncytial Virus Drug Discovery and Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3206-3227. <a href="https://doi.org/10.1021/acs.jmedchem.8b01361" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DState%252Bof%252Bthe%252BArt%252Bin%252BRespiratory%252BSyncytial%252BVirus%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DCockerill%26aufirst%3DG.%2BStuart%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D31082018%26date%3D21112018%26date%3D09112018%26volume%3D62%26issue%3D7%26spage%3D3206%26epage%3D3227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elise Malek-Adamian, Mihai Burai Patrascu, Sunit Kumar Jana, Saúl Martínez-Montero, Nicolas Moitessier, <span class="NLM_string-name hlFld-ContribAuthor">Masad J. Damha</span>. </span><span class="cited-content_cbyCitation_article-title">Adjusting the Structure of 2′-Modified Nucleosides and Oligonucleotides via C4′-α-F or C4′-α-OMe Substitution: Synthesis and Conformational Analysis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (17)
                                     , 9839-9849. <a href="https://doi.org/10.1021/acs.joc.8b01329" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01329%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAdjusting%252Bthe%252BStructure%252Bof%252B2%2525E2%252580%2525B2-Modified%252BNucleosides%252Band%252BOligonucleotides%252Bvia%252BC4%2525E2%252580%2525B2-%2525CE%2525B1-F%252Bor%252BC4%2525E2%252580%2525B2-%2525CE%2525B1-OMe%252BSubstitution%25253A%252BSynthesis%252Band%252BConformational%252BAnalysis%26aulast%3DMalek-Adamian%26aufirst%3DElise%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D24052018%26date%3D17072018%26date%3D02072018%26volume%3D83%26issue%3D17%26spage%3D9839%26epage%3D9849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elise  Malek-Adamian</span>, <span class="hlFld-ContribAuthor ">Dale C.  Guenther</span>, <span class="hlFld-ContribAuthor ">Shigeo  Matsuda</span>, <span class="hlFld-ContribAuthor ">Saúl  Martínez-Montero</span>, <span class="hlFld-ContribAuthor ">Ivan  Zlatev</span>, <span class="hlFld-ContribAuthor ">Joel  Harp</span>, <span class="hlFld-ContribAuthor ">Mihai  Burai Patrascu</span>, <span class="hlFld-ContribAuthor ">Donald J.  Foster</span>, <span class="hlFld-ContribAuthor ">Johans  Fakhoury</span>, <span class="hlFld-ContribAuthor ">Lydia  Perkins</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>, <span class="hlFld-ContribAuthor ">Rajar M.  Manoharan</span>, <span class="hlFld-ContribAuthor ">Nate  Taneja</span>, <span class="hlFld-ContribAuthor ">Anna  Bisbe</span>, <span class="hlFld-ContribAuthor ">Klaus  Charisse</span>, <span class="hlFld-ContribAuthor ">Martin  Maier</span>, <span class="hlFld-ContribAuthor ">Kallanthottathil G.  Rajeev</span>, <span class="hlFld-ContribAuthor ">Martin  Egli</span>, <span class="hlFld-ContribAuthor ">Muthiah  Manoharan</span>, and <span class="hlFld-ContribAuthor ">Masad J.  Damha</span>  . </span><span class="cited-content_cbyCitation_article-title">4′-C-Methoxy-2′-deoxy-2′-fluoro Modified Ribonucleotides Improve Metabolic Stability and Elicit Efficient RNAi-Mediated Gene Silencing. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2017,</strong> <em>139 </em>
                                    (41)
                                     , 14542-14555. <a href="https://doi.org/10.1021/jacs.7b07582" title="DOI URL">https://doi.org/10.1021/jacs.7b07582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.7b07582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.7b07582%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3D4%2525E2%252580%2525B2-C-Methoxy-2%2525E2%252580%2525B2-deoxy-2%2525E2%252580%2525B2-fluoro%252BModified%252BRibonucleotides%252BImprove%252BMetabolic%252BStability%252Band%252BElicit%252BEfficient%252BRNAi-Mediated%252BGene%252BSilencing%26aulast%3DMalek-Adamian%26aufirst%3DElise%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20072017%26date%3D06102017%26date%3D18102017%26date%3D22092017%26volume%3D139%26issue%3D41%26spage%3D14542%26epage%3D14555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Jiménez-Somarribas</span>, <span class="hlFld-ContribAuthor ">Shuli  Mao</span>, <span class="hlFld-ContribAuthor ">Jeong-Joong  Yoon</span>, <span class="hlFld-ContribAuthor ">Marco  Weisshaar</span>, <span class="hlFld-ContribAuthor ">Robert M.  Cox</span>, <span class="hlFld-ContribAuthor ">Jose R.  Marengo</span>, <span class="hlFld-ContribAuthor ">Deborah G.  Mitchell</span>, <span class="hlFld-ContribAuthor ">Zachary P.  Morehouse</span>, <span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Ivan  Solis</span>, <span class="hlFld-ContribAuthor ">Dennis C.  Liotta</span>, <span class="hlFld-ContribAuthor ">Michael G.  Natchus</span>, and <span class="hlFld-ContribAuthor ">Richard K.  Plemper</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (6)
                                     , 2305-2325. <a href="https://doi.org/10.1021/acs.jmedchem.6b01568" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01568%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BNon-Nucleoside%252BInhibitors%252Bof%252Bthe%252BRespiratory%252BSyncytial%252BVirus%252BPolymerase%252BComplex%26aulast%3DJim%25C3%25A9nez-Somarribas%26aufirst%3DAlberto%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D26102016%26date%3D13032017%26date%3D23032017%26date%3D28022017%26volume%3D60%26issue%3D6%26spage%3D2305%26epage%3D2325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul C.  Jordan</span>, <span class="hlFld-ContribAuthor ">Sarah K.  Stevens</span>, <span class="hlFld-ContribAuthor ">Yuen  Tam</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Pemberton</span>, <span class="hlFld-ContribAuthor ">Shuvam  Chaudhuri</span>, <span class="hlFld-ContribAuthor ">Antitsa D.  Stoycheva</span>, <span class="hlFld-ContribAuthor ">Natalia  Dyatkina</span>, <span class="hlFld-ContribAuthor ">Guangyi  Wang</span>, <span class="hlFld-ContribAuthor ">Julian A.  Symons</span>, <span class="hlFld-ContribAuthor ">Jerome  Deval</span>, and <span class="hlFld-ContribAuthor ">Leo  Beigelman</span>  . </span><span class="cited-content_cbyCitation_article-title">Activation Pathway of a Nucleoside Analog Inhibiting Respiratory Syncytial Virus Polymerase. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (1)
                                     , 83-91. <a href="https://doi.org/10.1021/acschembio.6b00788" title="DOI URL">https://doi.org/10.1021/acschembio.6b00788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.6b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.6b00788%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DActivation%252BPathway%252Bof%252Ba%252BNucleoside%252BAnalog%252BInhibiting%252BRespiratory%252BSyncytial%252BVirus%252BPolymerase%26aulast%3DJordan%26aufirst%3DPaul%2BC.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D09092016%26date%3D14112016%26date%3D22112016%26date%3D20012017%26date%3D14112016%26volume%3D12%26issue%3D1%26spage%3D83%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangyi  Wang</span>, <span class="hlFld-ContribAuthor ">Jinqiao  Wan</span>, <span class="hlFld-ContribAuthor ">Yujian  Hu</span>, <span class="hlFld-ContribAuthor ">Xiangyang  Wu</span>, <span class="hlFld-ContribAuthor ">Marija  Prhavc</span>, <span class="hlFld-ContribAuthor ">Natalia  Dyatkina</span>, <span class="hlFld-ContribAuthor ">Vivek K.  Rajwanshi</span>, <span class="hlFld-ContribAuthor ">David B.  Smith</span>, <span class="hlFld-ContribAuthor ">Andreas  Jekle</span>, <span class="hlFld-ContribAuthor ">April  Kinkade</span>, <span class="hlFld-ContribAuthor ">Julian A.  Symons</span>, <span class="hlFld-ContribAuthor ">Zhinan  Jin</span>, <span class="hlFld-ContribAuthor ">Jerome  Deval</span>, <span class="hlFld-ContribAuthor ">Qingling  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuen  Tam</span>, <span class="hlFld-ContribAuthor ">Sushmita  Chanda</span>, <span class="hlFld-ContribAuthor ">Lawrence  Blatt</span>, and <span class="hlFld-ContribAuthor ">Leonid  Beigelman</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-Influenza Activity of Pyridine, Pyridazine, and Pyrimidine C-Nucleosides as Favipiravir (T-705) Analogues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4611-4624. <a href="https://doi.org/10.1021/acs.jmedchem.5b01933" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01933%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnti-Influenza%252BActivity%252Bof%252BPyridine%25252C%252BPyridazine%25252C%252Band%252BPyrimidine%252BC-Nucleosides%252Bas%252BFavipiravir%252B%252528T-705%252529%252BAnalogues%26aulast%3DWang%26aufirst%3DGuangyi%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D14122015%26date%3D27042016%26date%3D26052016%26volume%3D59%26issue%3D10%26spage%3D4611%26epage%3D4624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander V.  Kel′in</span>, <span class="hlFld-ContribAuthor ">Ivan  Zlatev</span>, <span class="hlFld-ContribAuthor ">Joel  Harp</span>, <span class="hlFld-ContribAuthor ">Muthusamy  Jayaraman</span>, <span class="hlFld-ContribAuthor ">Anna  Bisbe</span>, <span class="hlFld-ContribAuthor ">Jonathan  O′Shea</span>, <span class="hlFld-ContribAuthor ">Nate  Taneja</span>, <span class="hlFld-ContribAuthor ">Rajar M.  Manoharan</span>, <span class="hlFld-ContribAuthor ">Saeed  Khan</span>, <span class="hlFld-ContribAuthor ">Klaus  Charisse</span>, <span class="hlFld-ContribAuthor ">Martin A.  Maier</span>, <span class="hlFld-ContribAuthor ">Martin  Egli</span>, <span class="hlFld-ContribAuthor ">Kallanthottathil G.  Rajeev</span>, and <span class="hlFld-ContribAuthor ">Muthiah  Manoharan</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Basis of Duplex Thermodynamic Stability and Enhanced Nuclease Resistance of 5′-C-Methyl Pyrimidine-Modified Oligonucleotides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (6)
                                     , 2261-2279. <a href="https://doi.org/10.1021/acs.joc.5b02375" title="DOI URL">https://doi.org/10.1021/acs.joc.5b02375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b02375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b02375%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStructural%252BBasis%252Bof%252BDuplex%252BThermodynamic%252BStability%252Band%252BEnhanced%252BNuclease%252BResistance%252Bof%252B5%2525E2%252580%2525B2-C-Methyl%252BPyrimidine-Modified%252BOligonucleotides%26aulast%3DKel%25E2%2580%25B2in%26aufirst%3DAlexander%2BV.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D12112015%26date%3D04032016%26date%3D18032016%26volume%3D81%26issue%3D6%26spage%3D2261%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jimin  Xu</span>, <span class="hlFld-ContribAuthor ">Wenzhe  Wu</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Xiaoyong  Bao</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>39 </em>, 116157. <a href="https://doi.org/10.1016/j.bmc.2021.116157" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116157%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSubstituted%252BN-%2525284-amino-2-chlorophenyl%252529-5-chloro-2-hydroxybenzamide%252Banalogues%252Bpotently%252Binhibit%252Brespiratory%252Bsyncytial%252Bvirus%252B%252528RSV%252529%252Breplication%252Band%252BRSV%252Binfection-associated%252Binflammatory%252Bresponses%26aulast%3DXu%26aufirst%3DJimin%26date%3D2021%26volume%3D39%26spage%3D116157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Qihui  Zhu</span>, <span class="hlFld-ContribAuthor ">Kunlun  Xiang</span>, <span class="hlFld-ContribAuthor ">Yaling  Zhang</span>, <span class="hlFld-ContribAuthor ">Baocun  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Yu</span>, <span class="hlFld-ContribAuthor ">Guang  Yang</span>, <span class="hlFld-ContribAuthor ">Chungen  Liang</span>, <span class="hlFld-ContribAuthor ">Hongying  Yun</span>, <span class="hlFld-ContribAuthor ">Meifang  Zhang</span>, <span class="hlFld-ContribAuthor ">Ning  Qin</span>, <span class="hlFld-ContribAuthor ">Lu  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Respiratory Syncytial Virus Replication Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2021,</strong> <em>65 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/AAC.02576-20" title="DOI URL">https://doi.org/10.1128/AAC.02576-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.02576-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.02576-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BRespiratory%252BSyncytial%252BVirus%252BReplication%252BInhibitor%26aulast%3DWang%26aufirst%3DLi%26date%3D2021%26volume%3D65%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuzhen  Gao</span>, <span class="hlFld-ContribAuthor ">Jingjing  Cao</span>, <span class="hlFld-ContribAuthor ">Pan  Xing</span>, <span class="hlFld-ContribAuthor ">Ralf  Altmeyer</span>, <span class="hlFld-ContribAuthor ">Youming  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2607. <a href="https://doi.org/10.3390/molecules26092607" title="DOI URL">https://doi.org/10.3390/molecules26092607</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092607%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEvaluation%252Bof%252BSmall%252BMolecule%252BCombinations%252Bagainst%252BRespiratory%252BSyncytial%252BVirus%252BIn%252BVitro%26aulast%3DGao%26aufirst%3DYuzhen%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael H. J.  Rhodin</span>, <span class="hlFld-ContribAuthor ">Nicole V.  McAllister</span>, <span class="hlFld-ContribAuthor ">Jonathan  Castillo</span>, <span class="hlFld-ContribAuthor ">Sarah L.  Noton</span>, <span class="hlFld-ContribAuthor ">Rachel  Fearns</span>, <span class="hlFld-ContribAuthor ">In Jong  Kim</span>, <span class="hlFld-ContribAuthor ">Jianming  Yu</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Blaisdell</span>, <span class="hlFld-ContribAuthor ">Joseph  Panarese</span>, <span class="hlFld-ContribAuthor ">Brian C.  Shook</span>, <span class="hlFld-ContribAuthor ">Yat Sun  Or</span>, <span class="hlFld-ContribAuthor ">Bryan  Goodwin</span>, <span class="hlFld-ContribAuthor ">Kai  Lin</span>, . </span><span class="cited-content_cbyCitation_article-title">EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2021,</strong> <em>17 </em>
                                    (3)
                                     , e1009428. <a href="https://doi.org/10.1371/journal.ppat.1009428" title="DOI URL">https://doi.org/10.1371/journal.ppat.1009428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1009428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1009428%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DEDP-938%25252C%252Ba%252Bnovel%252Bnucleoprotein%252Binhibitor%252Bof%252Brespiratory%252Bsyncytial%252Bvirus%25252C%252Bdemonstrates%252Bpotent%252Bantiviral%252Bactivities%252Bin%252Bvitro%252Band%252Bin%252Ba%252Bnon-human%252Bprimate%252Bmodel%26aulast%3DRhodin%26aufirst%3DMichael%2BH.%2BJ.%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D3%26spage%3De1009428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Tian</span>, <span class="hlFld-ContribAuthor ">Taotao  Qiang</span>, <span class="hlFld-ContribAuthor ">Chengyuan  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ren</span>, <span class="hlFld-ContribAuthor ">Minyi  Jia</span>, <span class="hlFld-ContribAuthor ">Jiayun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingyi  Li</span>, <span class="hlFld-ContribAuthor ">Minge  Wan</span>, <span class="hlFld-ContribAuthor ">Xin  YuWen</span>, <span class="hlFld-ContribAuthor ">Han  Li</span>, <span class="hlFld-ContribAuthor ">Wenqiang  Cao</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113201. <a href="https://doi.org/10.1016/j.ejmech.2021.113201" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113201%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRNA-dependent%252BRNA%252Bpolymerase%252B%252528RdRp%252529%252Binhibitors%25253A%252BThe%252Bcurrent%252Blandscape%252Band%252Brepurposing%252Bfor%252Bthe%252BCOVID-19%252Bpandemic%26aulast%3DTian%26aufirst%3DLei%26date%3D2021%26volume%3D213%26spage%3D113201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid G.  Menchikov</span>, <span class="hlFld-ContribAuthor ">Evgeny V.  Shulishov</span>, <span class="hlFld-ContribAuthor ">Yury V.  Tomilov</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the catalytic cyclopropanation of unsaturated compounds with diazomethane. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2021,</strong> <em>90 </em>
                                    (2)
                                     , 199-230. <a href="https://doi.org/10.1070/RCR4982" title="DOI URL">https://doi.org/10.1070/RCR4982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4982%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bcatalytic%252Bcyclopropanation%252Bof%252Bunsaturated%252Bcompounds%252Bwith%252Bdiazomethane%26aulast%3DMenchikov%26aufirst%3DLeonid%2BG.%26date%3D2021%26volume%3D90%26issue%3D2%26spage%3D199%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas  Murgolo</span>, <span class="hlFld-ContribAuthor ">Alex G.  Therien</span>, <span class="hlFld-ContribAuthor ">Bonnie  Howell</span>, <span class="hlFld-ContribAuthor ">Daniel  Klein</span>, <span class="hlFld-ContribAuthor ">Kenneth  Koeplinger</span>, <span class="hlFld-ContribAuthor ">Linda A.  Lieberman</span>, <span class="hlFld-ContribAuthor ">Gregory C.  Adam</span>, <span class="hlFld-ContribAuthor ">Jessica  Flynn</span>, <span class="hlFld-ContribAuthor ">Philip  McKenna</span>, <span class="hlFld-ContribAuthor ">Gokul  Swaminathan</span>, <span class="hlFld-ContribAuthor ">Daria J.  Hazuda</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, . </span><span class="cited-content_cbyCitation_article-title">SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2021,</strong> <em>17 </em>
                                    (2)
                                     , e1009225. <a href="https://doi.org/10.1371/journal.ppat.1009225" title="DOI URL">https://doi.org/10.1371/journal.ppat.1009225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1009225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1009225%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DSARS-CoV-2%252Btropism%25252C%252Bentry%25252C%252Breplication%25252C%252Band%252Bpropagation%25253A%252BConsiderations%252Bfor%252Bdrug%252Bdiscovery%252Band%252Bdevelopment%26aulast%3DMurgolo%26aufirst%3DNicholas%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D2%26spage%3De1009225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangdi  Li</span>, <span class="hlFld-ContribAuthor ">Xixi  Jing</span>, <span class="hlFld-ContribAuthor ">Pan  Zhang</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Classification. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 121-130. <a href="https://doi.org/10.1016/B978-0-12-814515-9.00126-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-814515-9.00126-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-814515-9.00126-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-814515-9.00126-0%26sid%3Dliteratum%253Aachs%26atitle%3DAntiviral%252BClassification%26aulast%3DLi%26aufirst%3DGuangdi%26date%3D2021%26spage%3D121%26epage%3D130%26pub%3DElsevier%26atitle%3DEncyclopedia%252Bof%252BVirology%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keivan  Zandi</span>, <span class="hlFld-ContribAuthor ">Franck  Amblard</span>, <span class="hlFld-ContribAuthor ">Katie  Musall</span>, <span class="hlFld-ContribAuthor ">Jessica  Downs-Bowen</span>, <span class="hlFld-ContribAuthor ">Ruby  Kleinbard</span>, <span class="hlFld-ContribAuthor ">Adrian  Oo</span>, <span class="hlFld-ContribAuthor ">Dongdong  Cao</span>, <span class="hlFld-ContribAuthor ">Bo  Liang</span>, <span class="hlFld-ContribAuthor ">Olivia O.  Russell</span>, <span class="hlFld-ContribAuthor ">Tamara  McBrayer</span>, <span class="hlFld-ContribAuthor ">Leda  Bassit</span>, <span class="hlFld-ContribAuthor ">Baek  Kim</span>, <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing Nucleoside Analogs for Human Coronaviruses. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>65 </em>
                                    (1)
                                     <a href="https://doi.org/10.1128/AAC.01652-20" title="DOI URL">https://doi.org/10.1128/AAC.01652-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01652-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01652-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DRepurposing%252BNucleoside%252BAnalogs%252Bfor%252BHuman%252BCoronaviruses%26aulast%3DZandi%26aufirst%3DKeivan%26date%3D2020%26volume%3D65%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Holger  Hannemann</span>. </span><span class="cited-content_cbyCitation_article-title">Viral replicons as valuable tools for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (6)
                                     , 1026-1033. <a href="https://doi.org/10.1016/j.drudis.2020.03.010" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DViral%252Breplicons%252Bas%252Bvaluable%252Btools%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DHannemann%26aufirst%3DHolger%26date%3D2020%26volume%3D25%26issue%3D6%26spage%3D1026%26epage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salvatore  Ferla</span>, <span class="hlFld-ContribAuthor ">Roberto  Manganaro</span>, <span class="hlFld-ContribAuthor ">Sara  Benato</span>, <span class="hlFld-ContribAuthor ">Jasmine  Paulissen</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">Dirk  Jochmans</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>, <span class="hlFld-ContribAuthor ">Marcella  Bassetto</span>. </span><span class="cited-content_cbyCitation_article-title">Rational modifications, synthesis and biological evaluation of new potential antivirals for RSV designed to target the M2-1 protein. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (8)
                                     , 115401. <a href="https://doi.org/10.1016/j.bmc.2020.115401" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115401%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bmodifications%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252Bpotential%252Bantivirals%252Bfor%252BRSV%252Bdesigned%252Bto%252Btarget%252Bthe%252BM2-1%252Bprotein%26aulast%3DFerla%26aufirst%3DSalvatore%26date%3D2020%26volume%3D28%26issue%3D8%26spage%3D115401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harrison C.  Bergeron</span>, <span class="hlFld-ContribAuthor ">Ralph A.  Tripp</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging small and large molecule therapeutics for respiratory syncytial virus. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2020,</strong> <em>29 </em>
                                    (3)
                                     , 285-294. <a href="https://doi.org/10.1080/13543784.2020.1735349" title="DOI URL">https://doi.org/10.1080/13543784.2020.1735349</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2020.1735349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2020.1735349%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DEmerging%252Bsmall%252Band%252Blarge%252Bmolecule%252Btherapeutics%252Bfor%252Brespiratory%252Bsyncytial%252Bvirus%26aulast%3DBergeron%26aufirst%3DHarrison%2BC.%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D3%26spage%3D285%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael K.  Lo</span>, <span class="hlFld-ContribAuthor ">Franck  Amblard</span>, <span class="hlFld-ContribAuthor ">Mike  Flint</span>, <span class="hlFld-ContribAuthor ">Payel  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Mahesh  Kasthuri</span>, <span class="hlFld-ContribAuthor ">Chengwei  Li</span>, <span class="hlFld-ContribAuthor ">Olivia  Russell</span>, <span class="hlFld-ContribAuthor ">Kiran  Verma</span>, <span class="hlFld-ContribAuthor ">Leda  Bassit</span>, <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>, <span class="hlFld-ContribAuthor ">Stuart T.  Nichol</span>, <span class="hlFld-ContribAuthor ">Christina F.  Spiropoulou</span>. </span><span class="cited-content_cbyCitation_article-title">Potent in vitro activity of β-D-4ʹ-chloromethyl-2ʹ-deoxy-2ʹ-fluorocytidine against Nipah virus. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2020,</strong> <em>175 </em>, 104712. <a href="https://doi.org/10.1016/j.antiviral.2020.104712" title="DOI URL">https://doi.org/10.1016/j.antiviral.2020.104712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2020.104712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2020.104712%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DPotent%252Bin%252Bvitro%252Bactivity%252Bof%252B%2525CE%2525B2-D-4%2525CA%2525B9-chloromethyl-2%2525CA%2525B9-deoxy-2%2525CA%2525B9-fluorocytidine%252Bagainst%252BNipah%252Bvirus%26aulast%3DLo%26aufirst%3DMichael%2BK.%26date%3D2020%26volume%3D175%26spage%3D104712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahesh  Kasthuri</span>, <span class="hlFld-ContribAuthor ">Chengwei  Li</span>, <span class="hlFld-ContribAuthor ">Kiran  Verma</span>, <span class="hlFld-ContribAuthor ">Olivia Ollinger  Russell</span>, <span class="hlFld-ContribAuthor ">Lyndsey  Dickson</span>, <span class="hlFld-ContribAuthor ">Louise  McCormick</span>, <span class="hlFld-ContribAuthor ">Leda  Bassit</span>, <span class="hlFld-ContribAuthor ">Franck  Amblard</span>, <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4′-Substituted-2′-Deoxy-2′-α-Fluoro Nucleoside Analogs as Potential Antiviral Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (6)
                                     , 1258. <a href="https://doi.org/10.3390/molecules25061258" title="DOI URL">https://doi.org/10.3390/molecules25061258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25061258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25061258%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Bof%252B4%2525E2%252580%2525B2-Substituted-2%2525E2%252580%2525B2-Deoxy-2%2525E2%252580%2525B2-%2525CE%2525B1-Fluoro%252BNucleoside%252BAnalogs%252Bas%252BPotential%252BAntiviral%252BAgents%26aulast%3DKasthuri%26aufirst%3DMahesh%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D6%26spage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Ludeke</span>, <span class="hlFld-ContribAuthor ">Rachel  Fearns</span>. </span><span class="cited-content_cbyCitation_article-title">The respiratory syncytial virus polymerase can perform RNA synthesis with modified primers and nucleotide analogs. </span><span class="cited-content_cbyCitation_journal-name">Virology</span><span> <strong>2020,</strong> <em>540 </em>, 66-74. <a href="https://doi.org/10.1016/j.virol.2019.11.002" title="DOI URL">https://doi.org/10.1016/j.virol.2019.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.virol.2019.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.virol.2019.11.002%26sid%3Dliteratum%253Aachs%26jtitle%3DVirology%26atitle%3DThe%252Brespiratory%252Bsyncytial%252Bvirus%252Bpolymerase%252Bcan%252Bperform%252BRNA%252Bsynthesis%252Bwith%252Bmodified%252Bprimers%252Band%252Bnucleotide%252Banalogs%26aulast%3DLudeke%26aufirst%3DBarbara%26date%3D2020%26volume%3D540%26spage%3D66%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morgan S.A.  Gilman</span>, <span class="hlFld-ContribAuthor ">Cheng  Liu</span>, <span class="hlFld-ContribAuthor ">Amy  Fung</span>, <span class="hlFld-ContribAuthor ">Ishani  Behera</span>, <span class="hlFld-ContribAuthor ">Paul  Jordan</span>, <span class="hlFld-ContribAuthor ">Peter  Rigaux</span>, <span class="hlFld-ContribAuthor ">Nina  Ysebaert</span>, <span class="hlFld-ContribAuthor ">Sergey  Tcherniuk</span>, <span class="hlFld-ContribAuthor ">Julien  Sourimant</span>, <span class="hlFld-ContribAuthor ">Jean-François  Eléouët</span>, <span class="hlFld-ContribAuthor ">Priscila  Sutto-Ortiz</span>, <span class="hlFld-ContribAuthor ">Etienne  Decroly</span>, <span class="hlFld-ContribAuthor ">Dirk  Roymans</span>, <span class="hlFld-ContribAuthor ">Zhinan  Jin</span>, <span class="hlFld-ContribAuthor ">Jason S.  McLellan</span>. </span><span class="cited-content_cbyCitation_article-title">Structure of the Respiratory Syncytial Virus Polymerase Complex. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2019,</strong> <em>179 </em>
                                    (1)
                                     , 193-204.e14. <a href="https://doi.org/10.1016/j.cell.2019.08.014" title="DOI URL">https://doi.org/10.1016/j.cell.2019.08.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2019.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2019.08.014%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DStructure%252Bof%252Bthe%252BRespiratory%252BSyncytial%252BVirus%252BPolymerase%252BComplex%26aulast%3DGilman%26aufirst%3DMorgan%2BS.A.%26date%3D2019%26volume%3D179%26issue%3D1%26spage%3D193%26epage%3D204.e14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keivan  Zandi</span>, <span class="hlFld-ContribAuthor ">Franck  Amblard</span>, <span class="hlFld-ContribAuthor ">Sarah  Amichai</span>, <span class="hlFld-ContribAuthor ">Leda  Bassit</span>, <span class="hlFld-ContribAuthor ">Sijia  Tao</span>, <span class="hlFld-ContribAuthor ">Yong  Jiang</span>, <span class="hlFld-ContribAuthor ">Longhu  Zhou</span>, <span class="hlFld-ContribAuthor ">Olivia  Ollinger Russell</span>, <span class="hlFld-ContribAuthor ">Seema  Mengshetti</span>, <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2019,</strong> <em>63 </em>
                                    (9)
                                     <a href="https://doi.org/10.1128/AAC.00889-19" title="DOI URL">https://doi.org/10.1128/AAC.00889-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00889-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00889-19%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DNucleoside%252BAnalogs%252Bwith%252BAntiviral%252BActivity%252Bagainst%252BYellow%252BFever%252BVirus%26aulast%3DZandi%26aufirst%3DKeivan%26date%3D2019%26volume%3D63%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Duan</span>, <span class="hlFld-ContribAuthor ">Xue  Yang</span>, <span class="hlFld-ContribAuthor ">Changfeng  Li</span>, <span class="hlFld-ContribAuthor ">Lihua  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Water-Soluble Methotrexate-Polyethyleneglycol-Rhodamine Prodrug Micelle for High Tumor Inhibition Activity. </span><span class="cited-content_cbyCitation_journal-name">AAPS PharmSciTech</span><span> <strong>2019,</strong> <em>20 </em>
                                    (6)
                                     <a href="https://doi.org/10.1208/s12249-019-1462-4" title="DOI URL">https://doi.org/10.1208/s12249-019-1462-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12249-019-1462-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12249-019-1462-4%26sid%3Dliteratum%253Aachs%26jtitle%3DAAPS%2520PharmSciTech%26atitle%3DHighly%252BWater-Soluble%252BMethotrexate-Polyethyleneglycol-Rhodamine%252BProdrug%252BMicelle%252Bfor%252BHigh%252BTumor%252BInhibition%252BActivity%26aulast%3DDuan%26aufirst%3DXiao%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Xing</span>, <span class="hlFld-ContribAuthor ">Marijke  Proesmans</span>. </span><span class="cited-content_cbyCitation_article-title">New therapies for acute RSV infections: where are we?. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pediatrics</span><span> <strong>2019,</strong> <em>178 </em>
                                    (2)
                                     , 131-138. <a href="https://doi.org/10.1007/s00431-018-03310-7" title="DOI URL">https://doi.org/10.1007/s00431-018-03310-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00431-018-03310-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00431-018-03310-7%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pediatrics%26atitle%3DNew%252Btherapies%252Bfor%252Bacute%252BRSV%252Binfections%25253A%252Bwhere%252Bare%252Bwe%25253F%26aulast%3DXing%26aufirst%3DYing%26date%3D2019%26date%3D2019%26volume%3D178%26issue%3D2%26spage%3D131%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kashyap  Patel</span>, <span class="hlFld-ContribAuthor ">Carl M  Kirkpatrick</span>, <span class="hlFld-ContribAuthor ">Keith A  Nieforth</span>, <span class="hlFld-ContribAuthor ">Sushmita  Chanda</span>, <span class="hlFld-ContribAuthor ">Qingling  Zhang</span>, <span class="hlFld-ContribAuthor ">Matthew  McClure</span>, <span class="hlFld-ContribAuthor ">John  Fry</span>, <span class="hlFld-ContribAuthor ">Julian A  Symons</span>, <span class="hlFld-ContribAuthor ">Lawrence M  Blatt</span>, <span class="hlFld-ContribAuthor ">Leo  Beigelman</span>, <span class="hlFld-ContribAuthor ">John P  DeVincenzo</span>, <span class="hlFld-ContribAuthor ">Dymphy R  Huntjens</span>, <span class="hlFld-ContribAuthor ">Patrick F  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans. </span><span class="cited-content_cbyCitation_journal-name">Journal of Antimicrobial Chemotherapy</span><span> <strong>2019,</strong> <em>74 </em>
                                    (2)
                                     , 442-452. <a href="https://doi.org/10.1093/jac/dky415" title="DOI URL">https://doi.org/10.1093/jac/dky415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jac/dky415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjac%2Fdky415%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Antimicrobial%2520Chemotherapy%26atitle%3DRespiratory%252Bsyncytial%252Bvirus-A%252Bdynamics%252Band%252Bthe%252Beffects%252Bof%252Blumicitabine%25252C%252Ba%252Bnucleoside%252Bviral%252Breplication%252Binhibitor%25252C%252Bin%252Bexperimentally%252Binfected%252Bhumans%26aulast%3DPatel%26aufirst%3DKashyap%26date%3D2019%26date%3D2018%26volume%3D74%26issue%3D2%26spage%3D442%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mary K.  Yates</span>, <span class="hlFld-ContribAuthor ">Katherine L.  Seley-Radtke</span>. </span><span class="cited-content_cbyCitation_article-title">The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2019,</strong> <em>162 </em>, 5-21. <a href="https://doi.org/10.1016/j.antiviral.2018.11.016" title="DOI URL">https://doi.org/10.1016/j.antiviral.2018.11.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2018.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2018.11.016%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DThe%252Bevolution%252Bof%252Bantiviral%252Bnucleoside%252Banalogues%25253A%252BA%252Breview%252Bfor%252Bchemists%252Band%252Bnon-chemists.%252BPart%252BII%25253A%252BComplex%252Bmodifications%252Bto%252Bthe%252Bnucleoside%252Bscaffold%26aulast%3DYates%26aufirst%3DMary%2BK.%26date%3D2019%26volume%3D162%26spage%3D5%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shailly  Tomar</span>, <span class="hlFld-ContribAuthor ">Ramanjit  Kaur</span>, <span class="hlFld-ContribAuthor ">Vedita Anand  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Function Relationship of Negative-Stranded Viral RNA Polymerases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 43-67. <a href="https://doi.org/10.1016/B978-0-12-815422-9.00002-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-815422-9.00002-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-815422-9.00002-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-815422-9.00002-4%26sid%3Dliteratum%253Aachs%26atitle%3DStructure%2525E2%252580%252593Function%252BRelationship%252Bof%252BNegative-Stranded%252BViral%252BRNA%252BPolymerases%26aulast%3DTomar%26aufirst%3DShailly%26date%3D2019%26spage%3D43%26epage%3D67%26pub%3DElsevier%26atitle%3DViral%252BPolymerases%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raj  Kalkeri</span>, <span class="hlFld-ContribAuthor ">Govinda  Bhisetti</span>, <span class="hlFld-ContribAuthor ">Nagraj  Mani</span>. </span><span class="cited-content_cbyCitation_article-title">Human respiratory syncytial virus methyl transferase: a potential antiviral target?. </span><span class="cited-content_cbyCitation_journal-name">F1000Research</span><span> <strong>2019,</strong> <em>8 </em>, 750. <a href="https://doi.org/10.12688/f1000research.18800.2" title="DOI URL">https://doi.org/10.12688/f1000research.18800.2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12688/f1000research.18800.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12688%2Ff1000research.18800.2%26sid%3Dliteratum%253Aachs%26jtitle%3DF1000Research%26atitle%3DHuman%252Brespiratory%252Bsyncytial%252Bvirus%252Bmethyl%252Btransferase%25253A%2525C2%2525A0a%252Bpotential%252Bantiviral%252Btarget%25253F%26aulast%3DKalkeri%26aufirst%3DRaj%26date%3D2019%26date%3D2019%26volume%3D8%26spage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  O'Reilly</span>, <span class="hlFld-ContribAuthor ">Robin S.  Stein</span>, <span class="hlFld-ContribAuthor ">Mihai Burai  Patrascu</span>, <span class="hlFld-ContribAuthor ">Sunit Kumar  Jana</span>, <span class="hlFld-ContribAuthor ">Jerry  Kurian</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>, <span class="hlFld-ContribAuthor ">Masad J.  Damha</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Atypical Fluorine-Hydrogen Bonds and Their Effects on Nucleoside Conformations. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2018,</strong> <em>24 </em>
                                    (61)
                                     , 16432-16439. <a href="https://doi.org/10.1002/chem.201803940" title="DOI URL">https://doi.org/10.1002/chem.201803940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201803940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201803940%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DExploring%252BAtypical%252BFluorine-Hydrogen%252BBonds%252Band%252BTheir%252BEffects%252Bon%252BNucleoside%252BConformations%26aulast%3DO%2527Reilly%26aufirst%3DDaniel%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D61%26spage%3D16432%26epage%3D16439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert M.  Cox</span>, <span class="hlFld-ContribAuthor ">Mart  Toots</span>, <span class="hlFld-ContribAuthor ">Jeong-Joong  Yoon</span>, <span class="hlFld-ContribAuthor ">Julien  Sourimant</span>, <span class="hlFld-ContribAuthor ">Barbara  Ludeke</span>, <span class="hlFld-ContribAuthor ">Rachel  Fearns</span>, <span class="hlFld-ContribAuthor ">Elyse  Bourque</span>, <span class="hlFld-ContribAuthor ">Joseph  Patti</span>, <span class="hlFld-ContribAuthor ">Edward  Lee</span>, <span class="hlFld-ContribAuthor ">John  Vernachio</span>, <span class="hlFld-ContribAuthor ">Richard K.  Plemper</span>. </span><span class="cited-content_cbyCitation_article-title">Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (43)
                                     , 16761-16777. <a href="https://doi.org/10.1074/jbc.RA118.004862" title="DOI URL">https://doi.org/10.1074/jbc.RA118.004862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA118.004862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA118.004862%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ban%252Ballosteric%252Binhibitor%252Bclass%252Bblocking%252BRNA%252Belongation%252Bby%252Bthe%252Brespiratory%252Bsyncytial%252Bvirus%252Bpolymerase%252Bcomplex%26aulast%3DCox%26aufirst%3DRobert%2BM.%26date%3D2018%26volume%3D293%26issue%3D43%26spage%3D16761%26epage%3D16777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Yang  He</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Dan-Dan  Lu</span>, <span class="hlFld-ContribAuthor ">Sheng-Qi  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antisense Properties of 2′β-F-Arabinouridine Modified Oligonucleotides with 4′-C-OMe Substituent. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (9)
                                     , 2374. <a href="https://doi.org/10.3390/molecules23092374" title="DOI URL">https://doi.org/10.3390/molecules23092374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23092374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23092374%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BAntisense%252BProperties%252Bof%252B2%2525E2%252580%2525B2%2525CE%2525B2-F-Arabinouridine%252BModified%252BOligonucleotides%252Bwith%252B4%2525E2%252580%2525B2-C-OMe%252BSubstituent%26aulast%3DHe%26aufirst%3DXiao-Yang%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D9%26spage%3D2374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Mantero</span>, <span class="hlFld-ContribAuthor ">Paola  Rogliani</span>, <span class="hlFld-ContribAuthor ">Mario  Cazzola</span>, <span class="hlFld-ContribAuthor ">Francesco  Blasi</span>, <span class="hlFld-ContribAuthor ">Marta  Di Pasquale</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging antibacterial and antiviral drugs for treating respiratory tract infections. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2018,</strong> <em>23 </em>
                                    (3)
                                     , 185-199. <a href="https://doi.org/10.1080/14728214.2018.1504020" title="DOI URL">https://doi.org/10.1080/14728214.2018.1504020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728214.2018.1504020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728214.2018.1504020%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DEmerging%252Bantibacterial%252Band%252Bantiviral%252Bdrugs%252Bfor%252Btreating%252Brespiratory%252Btract%252Binfections%26aulast%3DMantero%26aufirst%3DMarco%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D185%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen  Mirabelli</span>, <span class="hlFld-ContribAuthor ">Martine  Jaspers</span>, <span class="hlFld-ContribAuthor ">Mieke  Boon</span>, <span class="hlFld-ContribAuthor ">Mark  Jorissen</span>, <span class="hlFld-ContribAuthor ">Mohamed  Koukni</span>, <span class="hlFld-ContribAuthor ">Dorothée  Bardiot</span>, <span class="hlFld-ContribAuthor ">Patrick  Chaltin</span>, <span class="hlFld-ContribAuthor ">Arnaud  Marchand</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">Dirk  Jochmans</span>. </span><span class="cited-content_cbyCitation_article-title">Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium. </span><span class="cited-content_cbyCitation_journal-name">Journal of Antimicrobial Chemotherapy</span><span> <strong>2018,</strong> <em>73 </em>
                                    (7)
                                     , 1823-1829. <a href="https://doi.org/10.1093/jac/dky089" title="DOI URL">https://doi.org/10.1093/jac/dky089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jac/dky089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjac%2Fdky089%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Antimicrobial%2520Chemotherapy%26atitle%3DDifferential%252Bantiviral%252Bactivities%252Bof%252Brespiratory%252Bsyncytial%252Bvirus%252B%252528RSV%252529%252Binhibitors%252Bin%252Bhuman%252Bairway%252Bepithelium%26aulast%3DMirabelli%26aufirst%3DCarmen%26date%3D2018%26date%3D2018%26volume%3D73%26issue%3D7%26spage%3D1823%26epage%3D1829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  da Paixao Soares</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Groaz</span>, <span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphorus Pentachloride Promoted gem-Dichlorination of 2′- and 3′-Deoxynucleosides. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (6)
                                     , 1457. <a href="https://doi.org/10.3390/molecules23061457" title="DOI URL">https://doi.org/10.3390/molecules23061457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23061457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23061457%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPhosphorus%252BPentachloride%252BPromoted%252Bgem-Dichlorination%252Bof%252B2%2525E2%252580%2525B2-%252Band%252B3%2525E2%252580%2525B2-Deoxynucleosides%26aulast%3Dda%2BPaixao%2BSoares%26aufirst%3DFabio%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D6%26spage%3D1457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael K.  Lo</span>, <span class="hlFld-ContribAuthor ">Paul C.  Jordan</span>, <span class="hlFld-ContribAuthor ">Sarah  Stevens</span>, <span class="hlFld-ContribAuthor ">Yuen  Tam</span>, <span class="hlFld-ContribAuthor ">Jerome  Deval</span>, <span class="hlFld-ContribAuthor ">Stuart T.  Nichol</span>, <span class="hlFld-ContribAuthor ">Christina F.  Spiropoulou</span>. </span><span class="cited-content_cbyCitation_article-title">Susceptibility of paramyxoviruses and filoviruses to inhibition by 2′-monofluoro- and 2′-difluoro-4′-azidocytidine analogs. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2018,</strong> <em>153 </em>, 101-113. <a href="https://doi.org/10.1016/j.antiviral.2018.03.009" title="DOI URL">https://doi.org/10.1016/j.antiviral.2018.03.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2018.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2018.03.009%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DSusceptibility%252Bof%252Bparamyxoviruses%252Band%252Bfiloviruses%252Bto%252Binhibition%252Bby%252B2%2525E2%252580%2525B2-monofluoro-%252Band%252B2%2525E2%252580%2525B2-difluoro-4%2525E2%252580%2525B2-azidocytidine%252Banalogs%26aulast%3DLo%26aufirst%3DMichael%2BK.%26date%3D2018%26volume%3D153%26spage%3D101%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andri  Vasou</span>, <span class="hlFld-ContribAuthor ">Christina  Paulus</span>, <span class="hlFld-ContribAuthor ">Janina  Narloch</span>, <span class="hlFld-ContribAuthor ">Zoe O.  Gage</span>, <span class="hlFld-ContribAuthor ">Marie-Anne  Rameix-Welti</span>, <span class="hlFld-ContribAuthor ">Jean-François  Eléouët</span>, <span class="hlFld-ContribAuthor ">Michael  Nevels</span>, <span class="hlFld-ContribAuthor ">Richard E.  Randall</span>, <span class="hlFld-ContribAuthor ">Catherine S.  Adamson</span>. </span><span class="cited-content_cbyCitation_article-title">Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2018,</strong> <em>150 </em>, 79-92. <a href="https://doi.org/10.1016/j.antiviral.2017.10.012" title="DOI URL">https://doi.org/10.1016/j.antiviral.2017.10.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2017.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2017.10.012%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DModular%252Bcell-based%252Bplatform%252Bfor%252Bhigh%252Bthroughput%252Bidentification%252Bof%252Bcompounds%252Bthat%252Binhibit%252Ba%252Bviral%252Binterferon%252Bantagonist%252Bof%252Bchoice%26aulast%3DVasou%26aufirst%3DAndri%26date%3D2018%26volume%3D150%26spage%3D79%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul C  Jordan</span>, <span class="hlFld-ContribAuthor ">Sarah K  Stevens</span>, <span class="hlFld-ContribAuthor ">Jerome  Deval</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleosides for the treatment of respiratory RNA virus infections. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Chemistry and Chemotherapy</span><span> <strong>2018,</strong> <em>26 </em>, 204020661876448. <a href="https://doi.org/10.1177/2040206618764483" title="DOI URL">https://doi.org/10.1177/2040206618764483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2040206618764483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2040206618764483%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Chemistry%2520and%2520Chemotherapy%26atitle%3DNucleosides%252Bfor%252Bthe%252Btreatment%252Bof%252Brespiratory%252BRNA%252Bvirus%252Binfections%26aulast%3DJordan%26aufirst%3DPaul%2BC%26date%3D2018%26date%3D2018%26volume%3D26%26spage%3D204020661876448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naveen Kumar  Rayala</span>, <span class="hlFld-ContribAuthor ">Seongmin  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">3-Nitro-1,2,4-triazole. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-4. <a href="https://doi.org/10.1002/047084289X.rn02016" title="DOI URL">https://doi.org/10.1002/047084289X.rn02016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rn02016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rn02016%26sid%3Dliteratum%253Aachs%26atitle%3D3-Nitro-1%25252C2%25252C4-triazole%26aulast%3DRayala%26aufirst%3DNaveen%2BKumar%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D4%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Coates</span>, <span class="hlFld-ContribAuthor ">Daniel  Brookes</span>, <span class="hlFld-ContribAuthor ">Young-In  Kim</span>, <span class="hlFld-ContribAuthor ">Heather  Allen</span>, <span class="hlFld-ContribAuthor ">Euan A. F.  Fordyce</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Meals</span>, <span class="hlFld-ContribAuthor ">Thomas  Colley</span>, <span class="hlFld-ContribAuthor ">Claire-Lise  Ciana</span>, <span class="hlFld-ContribAuthor ">Guillaume F.  Parra</span>, <span class="hlFld-ContribAuthor ">Vladimir  Sherbukhin</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Stockwell</span>, <span class="hlFld-ContribAuthor ">Jennifer C.  Thomas</span>, <span class="hlFld-ContribAuthor ">S. Fraser  Hunt</span>, <span class="hlFld-ContribAuthor ">Lauren  Anderson-Dring</span>, <span class="hlFld-ContribAuthor ">Stuart T.  Onions</span>, <span class="hlFld-ContribAuthor ">Lindsey  Cass</span>, <span class="hlFld-ContribAuthor ">Peter J.  Murray</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Ito</span>, <span class="hlFld-ContribAuthor ">Pete  Strong</span>, <span class="hlFld-ContribAuthor ">John P.  DeVincenzo</span>, <span class="hlFld-ContribAuthor ">Garth  Rapeport</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2017,</strong> <em>61 </em>
                                    (9)
                                     <a href="https://doi.org/10.1128/AAC.00737-17" title="DOI URL">https://doi.org/10.1128/AAC.00737-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00737-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00737-17%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DPreclinical%252BCharacterization%252Bof%252BPC786%25252C%252Ban%252BInhaled%252BSmall-Molecule%252BRespiratory%252BSyncytial%252BVirus%252BL%252BProtein%252BPolymerase%252BInhibitor%26aulast%3DCoates%26aufirst%3DMatthew%26date%3D2017%26volume%3D61%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne L.  Hotard</span>, <span class="hlFld-ContribAuthor ">Biao  He</span>, <span class="hlFld-ContribAuthor ">Stuart T.  Nichol</span>, <span class="hlFld-ContribAuthor ">Christina F.  Spiropoulou</span>, <span class="hlFld-ContribAuthor ">Michael K.  Lo</span>. </span><span class="cited-content_cbyCitation_article-title">4′-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2017,</strong> <em>144 </em>, 147-152. <a href="https://doi.org/10.1016/j.antiviral.2017.06.011" title="DOI URL">https://doi.org/10.1016/j.antiviral.2017.06.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2017.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2017.06.011%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3D4%2525E2%252580%2525B2-Azidocytidine%252B%252528R1479%252529%252Binhibits%252Bhenipaviruses%252Band%252Bother%252Bparamyxoviruses%252Bwith%252Bhigh%252Bpotency%26aulast%3DHotard%26aufirst%3DAnne%2BL.%26date%3D2017%26volume%3D144%26spage%3D147%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Franchini</span>, <span class="hlFld-ContribAuthor ">Umberto M.  Battisti</span>, <span class="hlFld-ContribAuthor ">Claudia  Sorbi</span>, <span class="hlFld-ContribAuthor ">Annalisa  Tait</span>, <span class="hlFld-ContribAuthor ">Andrea  Cornia</span>, <span class="hlFld-ContribAuthor ">Lak Shin  Jeong</span>, <span class="hlFld-ContribAuthor ">Sang Kook  Lee</span>, <span class="hlFld-ContribAuthor ">Jayoung  Song</span>, <span class="hlFld-ContribAuthor ">Roberta  Loddo</span>, <span class="hlFld-ContribAuthor ">Silvia  Madeddu</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Sanna</span>, <span class="hlFld-ContribAuthor ">Livio  Brasili</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structural characterization and biological evaluation of 4′-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2017,</strong> <em>40 </em>
                                    (5)
                                     , 537-549. <a href="https://doi.org/10.1007/s12272-016-0825-6" title="DOI URL">https://doi.org/10.1007/s12272-016-0825-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-016-0825-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-016-0825-6%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DSynthesis%25252C%252Bstructural%252Bcharacterization%252Band%252Bbiological%252Bevaluation%252Bof%252B4%2525E2%252580%2525B2-C-methyl-%252Band%252Bphenyl-dioxolane%252Bpyrimidine%252Band%252Bpurine%252Bnucleosides%26aulast%3DFranchini%26aufirst%3DSilvia%26date%3D2017%26date%3D2016%26volume%3D40%26issue%3D5%26spage%3D537%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Euan A.F.  Fordyce</span>, <span class="hlFld-ContribAuthor ">Daniel W.  Brookes</span>, <span class="hlFld-ContribAuthor ">Claire  Lise-Ciana</span>, <span class="hlFld-ContribAuthor ">Matthew S.  Coates</span>, <span class="hlFld-ContribAuthor ">S. Fraser  Hunt</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Ito</span>, <span class="hlFld-ContribAuthor ">John  King-Underwood</span>, <span class="hlFld-ContribAuthor ">Stuart T.  Onions</span>, <span class="hlFld-ContribAuthor ">Guillaume F.  Parra</span>, <span class="hlFld-ContribAuthor ">Garth  Rapeport</span>, <span class="hlFld-ContribAuthor ">Vladimir  Sherbukhin</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Stockwell</span>, <span class="hlFld-ContribAuthor ">Peter  Strong</span>, <span class="hlFld-ContribAuthor ">Jennifer C.  Thomas</span>, <span class="hlFld-ContribAuthor ">John  Murray</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel benzothienoazepine derivatives as potent inhibitors of respiratory syncytial virus. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (10)
                                     , 2201-2206. <a href="https://doi.org/10.1016/j.bmcl.2017.03.053" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bbenzothienoazepine%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bof%252Brespiratory%252Bsyncytial%252Bvirus%26aulast%3DFordyce%26aufirst%3DEuan%2BA.F.%26date%3D2017%26volume%3D27%26issue%3D10%26spage%3D2201%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lokesh  Shahani</span>, <span class="hlFld-ContribAuthor ">Ella J.  Ariza-Heredia</span>, <span class="hlFld-ContribAuthor ">Roy F.  Chemaly</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral therapy for respiratory viral infections in immunocompromised patients. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anti-infective Therapy</span><span> <strong>2017,</strong> <em>15 </em>
                                    (4)
                                     , 401-415. <a href="https://doi.org/10.1080/14787210.2017.1279970" title="DOI URL">https://doi.org/10.1080/14787210.2017.1279970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14787210.2017.1279970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14787210.2017.1279970%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anti-infective%2520Therapy%26atitle%3DAntiviral%252Btherapy%252Bfor%252Brespiratory%252Bviral%252Binfections%252Bin%252Bimmunocompromised%252Bpatients%26aulast%3DShahani%26aufirst%3DLokesh%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D4%26spage%3D401%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai Sen  Tan</span>, <span class="hlFld-ContribAuthor ">Yan  Yan</span>, <span class="hlFld-ContribAuthor ">Hsiao Hui  Ong</span>, <span class="hlFld-ContribAuthor ">Vincent T. K.  Chow</span>, <span class="hlFld-ContribAuthor ">Li  Shi</span>, <span class="hlFld-ContribAuthor ">De-Yun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Respiratory Virus Infections in Exacerbation of Acute and Chronic Rhinosinusitis. </span><span class="cited-content_cbyCitation_journal-name">Current Allergy and Asthma Reports</span><span> <strong>2017,</strong> <em>17 </em>
                                    (4)
                                     <a href="https://doi.org/10.1007/s11882-017-0693-2" title="DOI URL">https://doi.org/10.1007/s11882-017-0693-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11882-017-0693-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11882-017-0693-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Allergy%2520and%2520Asthma%2520Reports%26atitle%3DImpact%252Bof%252BRespiratory%252BVirus%252BInfections%252Bin%252BExacerbation%252Bof%252BAcute%252Band%252BChronic%252BRhinosinusitis%26aulast%3DTan%26aufirst%3DKai%2BSen%26date%3D2017%26date%3D2017%26volume%3D17%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian C.  Shook</span>, <span class="hlFld-ContribAuthor ">Kai  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Developing Antiviral Therapies for Respiratory Syncytial Virus. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2017,</strong> <em>375 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-017-0129-4" title="DOI URL">https://doi.org/10.1007/s41061-017-0129-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-017-0129-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-017-0129-4%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bin%252BDeveloping%252BAntiviral%252BTherapies%252Bfor%252BRespiratory%252BSyncytial%252BVirus%26aulast%3DShook%26aufirst%3DBrian%2BC.%26date%3D2017%26date%3D2017%26volume%3D375%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Pflug</span>, <span class="hlFld-ContribAuthor ">Maria  Lukarska</span>, <span class="hlFld-ContribAuthor ">Patricia  Resa-Infante</span>, <span class="hlFld-ContribAuthor ">Stefan  Reich</span>, <span class="hlFld-ContribAuthor ">Stephen  Cusack</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insights into RNA synthesis by the influenza virus transcription-replication machine. </span><span class="cited-content_cbyCitation_journal-name">Virus Research</span><span> <strong>2017,</strong> <em>234 </em>, 103-117. <a href="https://doi.org/10.1016/j.virusres.2017.01.013" title="DOI URL">https://doi.org/10.1016/j.virusres.2017.01.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.virusres.2017.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.virusres.2017.01.013%26sid%3Dliteratum%253Aachs%26jtitle%3DVirus%2520Research%26atitle%3DStructural%252Binsights%252Binto%252BRNA%252Bsynthesis%252Bby%252Bthe%252Binfluenza%252Bvirus%252Btranscription-replication%252Bmachine%26aulast%3DPflug%26aufirst%3DAlexander%26date%3D2017%26volume%3D234%26spage%3D103%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.L.  Powell</span>, <span class="hlFld-ContribAuthor ">E.  Thomas</span>, <span class="hlFld-ContribAuthor ">G.S.  Cockerill</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Drugs for Acute Infections. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 665-681. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12408-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12408-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12408-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12408-4%26sid%3Dliteratum%253Aachs%26atitle%3DAntiviral%252BDrugs%252Bfor%252BAcute%252BInfections%26aulast%3DPowell%26aufirst%3DK.L.%26date%3D2017%26spage%3D665%26epage%3D681%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Heterocycles with Applications in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 13-33. <a href="https://doi.org/10.1016/bs.aihch.2016.03.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.03.004%26sid%3Dliteratum%253Aachs%26atitle%3DSaturated%252BHeterocycles%252Bwith%252BApplications%252Bin%252BMedicinal%252BChemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2017%26spage%3D13%26epage%3D33%26pub%3DElsevier%26atitle%3DHeterocyclic%252BChemistry%252Bin%252Bthe%252B21st%252BCentury%252B-%252BA%252BTribute%252Bto%252BAlan%252BKatritzky%26date%3D2017%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuichi  Yoshimura</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Glycosylation Reaction: A Key to Accessing Structurally Unique Nucleosides. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2017,</strong> <em>94 </em>
                                    (9)
                                     , 1625. <a href="https://doi.org/10.3987/REV-17-865" title="DOI URL">https://doi.org/10.3987/REV-17-865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/REV-17-865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FREV-17-865%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DDevelopment%252Bof%252Ba%252BGlycosylation%252BReaction%25253A%252BA%252BKey%252Bto%252BAccessing%252BStructurally%252BUnique%252BNucleosides%26aulast%3DYoshimura%26aufirst%3DYuichi%26date%3D2017%26volume%3D94%26issue%3D9%26spage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cameron  Griffiths</span>, <span class="hlFld-ContribAuthor ">Steven J.  Drews</span>, <span class="hlFld-ContribAuthor ">David J.  Marchant</span>. </span><span class="cited-content_cbyCitation_article-title">Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. </span><span class="cited-content_cbyCitation_journal-name">Clinical Microbiology Reviews</span><span> <strong>2017,</strong> <em>30 </em>
                                    (1)
                                     , 277-319. <a href="https://doi.org/10.1128/CMR.00010-16" title="DOI URL">https://doi.org/10.1128/CMR.00010-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/CMR.00010-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FCMR.00010-16%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Microbiology%2520Reviews%26atitle%3DRespiratory%252BSyncytial%252BVirus%25253A%252BInfection%25252C%252BDetection%25252C%252Band%252BNew%252BOptions%252Bfor%252BPrevention%252Band%252BTreatment%26aulast%3DGriffiths%26aufirst%3DCameron%26date%3D2017%26volume%3D30%26issue%3D1%26spage%3D277%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yin-guang  Cao</span>, <span class="hlFld-ContribAuthor ">Yu  Hao</span>, <span class="hlFld-ContribAuthor ">Zhi-hui  Li</span>, <span class="hlFld-ContribAuthor ">Shun-tao  Liu</span>, <span class="hlFld-ContribAuthor ">Le-xin  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral activity of polysaccharide extract from Laminaria japonica against respiratory syncytial virus. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2016,</strong> <em>84 </em>, 1705-1710. <a href="https://doi.org/10.1016/j.biopha.2016.10.082" title="DOI URL">https://doi.org/10.1016/j.biopha.2016.10.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2016.10.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2016.10.082%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DAntiviral%252Bactivity%252Bof%252Bpolysaccharide%252Bextract%252Bfrom%252BLaminaria%252Bjaponica%252Bagainst%252Brespiratory%252Bsyncytial%252Bvirus%26aulast%3DCao%26aufirst%3DYin-guang%26date%3D2016%26volume%3D84%26spage%3D1705%26epage%3D1710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annelies  Stevaert</span>, <span class="hlFld-ContribAuthor ">Lieve  Naesens</span>. </span><span class="cited-content_cbyCitation_article-title">The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2016,</strong> <em>36 </em>
                                    (6)
                                     , 1127-1173. <a href="https://doi.org/10.1002/med.21401" title="DOI URL">https://doi.org/10.1002/med.21401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21401%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DThe%252BInfluenza%252BVirus%252BPolymerase%252BComplex%25253A%252BAn%252BUpdate%252Bon%252BIts%252BStructure%25252C%252BFunctions%25252C%252Band%252BSignificance%252Bfor%252BAntiviral%252BDrug%252BDesign%26aulast%3DStevaert%26aufirst%3DAnnelies%26date%3D2016%26date%3D2016%26volume%3D36%26issue%3D6%26spage%3D1127%26epage%3D1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel  Fearns</span>, <span class="hlFld-ContribAuthor ">Jerome  Deval</span>. </span><span class="cited-content_cbyCitation_article-title">New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2016,</strong> <em>134 </em>, 63-76. <a href="https://doi.org/10.1016/j.antiviral.2016.08.006" title="DOI URL">https://doi.org/10.1016/j.antiviral.2016.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2016.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2016.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DNew%252Bantiviral%252Bapproaches%252Bfor%252Brespiratory%252Bsyncytial%252Bvirus%252Band%252Bother%252Bmononegaviruses%25253A%252BInhibiting%252Bthe%252BRNA%252Bpolymerase%26aulast%3DFearns%26aufirst%3DRachel%26date%3D2016%26volume%3D134%26spage%3D63%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Weisshaar</span>, <span class="hlFld-ContribAuthor ">Robert  Cox</span>, <span class="hlFld-ContribAuthor ">Zachary  Morehouse</span>, <span class="hlFld-ContribAuthor ">Shiva  Kumar Kyasa</span>, <span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Phil  Oberacker</span>, <span class="hlFld-ContribAuthor ">Shuli  Mao</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Golden</span>, <span class="hlFld-ContribAuthor ">Anice C.  Lowen</span>, <span class="hlFld-ContribAuthor ">Michael G.  Natchus</span>, <span class="hlFld-ContribAuthor ">Richard K.  Plemper</span>, . </span><span class="cited-content_cbyCitation_article-title">Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2016,</strong> <em>90 </em>
                                    (16)
                                     , 7368-7387. <a href="https://doi.org/10.1128/JVI.00898-16" title="DOI URL">https://doi.org/10.1128/JVI.00898-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.00898-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.00898-16%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DIdentification%252Band%252BCharacterization%252Bof%252BInfluenza%252BVirus%252BEntry%252BInhibitors%252Bthrough%252BDual%252BMyxovirus%252BHigh-Throughput%252BScreening%26aulast%3DWeisshaar%26aufirst%3DMarco%26date%3D2016%26volume%3D90%26issue%3D16%26spage%3D7368%26epage%3D7387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahien  Shahsavari</span>, <span class="hlFld-ContribAuthor ">Jinsen  Chen</span>, <span class="hlFld-ContribAuthor ">Travis  Wigstrom</span>, <span class="hlFld-ContribAuthor ">James  Gooding</span>, <span class="hlFld-ContribAuthor ">Alexander  Gauronskas</span>, <span class="hlFld-ContribAuthor ">Shiyue  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Tritylation of alcohols under mild conditions without using silver salts. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (34)
                                     , 3877-3880. <a href="https://doi.org/10.1016/j.tetlet.2016.07.062" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.07.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.07.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.07.062%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DTritylation%252Bof%252Balcohols%252Bunder%252Bmild%252Bconditions%252Bwithout%252Busing%252Bsilver%252Bsalts%26aulast%3DShahsavari%26aufirst%3DShahien%26date%3D2016%26volume%3D57%26issue%3D34%26spage%3D3877%26epage%3D3880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Cox</span>, <span class="hlFld-ContribAuthor ">Richard K.  Plemper</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided design of small-molecule therapeutics against RSV disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (6)
                                     , 543-556. <a href="https://doi.org/10.1517/17460441.2016.1174212" title="DOI URL">https://doi.org/10.1517/17460441.2016.1174212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2016.1174212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2016.1174212%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DStructure-guided%252Bdesign%252Bof%252Bsmall-molecule%252Btherapeutics%252Bagainst%252BRSV%252Bdisease%26aulast%3DCox%26aufirst%3DRobert%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3D543%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jerome  Deval</span>, <span class="hlFld-ContribAuthor ">Amy  Fung</span>, <span class="hlFld-ContribAuthor ">Sarah K.  Stevens</span>, <span class="hlFld-ContribAuthor ">Paul C.  Jordan</span>, <span class="hlFld-ContribAuthor ">Tatiana  Gromova</span>, <span class="hlFld-ContribAuthor ">Joshua S.  Taylor</span>, <span class="hlFld-ContribAuthor ">Jin  Hong</span>, <span class="hlFld-ContribAuthor ">Jia  Meng</span>, <span class="hlFld-ContribAuthor ">Guangyi  Wang</span>, <span class="hlFld-ContribAuthor ">Natalia  Dyatkina</span>, <span class="hlFld-ContribAuthor ">Marija  Prhavc</span>, <span class="hlFld-ContribAuthor ">Julian A.  Symons</span>, <span class="hlFld-ContribAuthor ">Leo  Beigelman</span>, . </span><span class="cited-content_cbyCitation_article-title">Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (5)
                                     , e0154097. <a href="https://doi.org/10.1371/journal.pone.0154097" title="DOI URL">https://doi.org/10.1371/journal.pone.0154097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0154097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0154097%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DBiochemical%252BEffect%252Bof%252BResistance%252BMutations%252Bagainst%252BSynergistic%252BInhibitors%252Bof%252BRSV%252BRNA%252BPolymerase%26aulast%3DDeval%26aufirst%3DJerome%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D5%26spage%3De0154097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B.  Bailly</span>, <span class="hlFld-ContribAuthor ">C.-A.  Richard</span>, <span class="hlFld-ContribAuthor ">G.  Sharma</span>, <span class="hlFld-ContribAuthor ">L.  Wang</span>, <span class="hlFld-ContribAuthor ">L.  Johansen</span>, <span class="hlFld-ContribAuthor ">J.  Cao</span>, <span class="hlFld-ContribAuthor ">V.  Pendharkar</span>, <span class="hlFld-ContribAuthor ">D.-C.  Sharma</span>, <span class="hlFld-ContribAuthor ">M.  Galloux</span>, <span class="hlFld-ContribAuthor ">Y.  Wang</span>, <span class="hlFld-ContribAuthor ">R.  Cui</span>, <span class="hlFld-ContribAuthor ">G.  Zou</span>, <span class="hlFld-ContribAuthor ">P.  Guillon</span>, <span class="hlFld-ContribAuthor ">M.  von Itzstein</span>, <span class="hlFld-ContribAuthor ">J.-F.  Eléouët</span>, <span class="hlFld-ContribAuthor ">R.  Altmeyer</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep25806" title="DOI URL">https://doi.org/10.1038/srep25806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep25806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep25806%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DTargeting%252Bhuman%252Brespiratory%252Bsyncytial%252Bvirus%252Btranscription%252Banti-termination%252Bfactor%252BM2-1%252Bto%252Binhibit%252Bin%252Bvivo%252Bviral%252Breplication%26aulast%3DBailly%26aufirst%3DB.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiahui  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiangning  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuming  Liu</span>, <span class="hlFld-ContribAuthor ">Ziyou  Wang</span>, <span class="hlFld-ContribAuthor ">Qicong  Chen</span>, <span class="hlFld-ContribAuthor ">Yongfu  Wu</span>, <span class="hlFld-ContribAuthor ">Zhiwei  He</span>, <span class="hlFld-ContribAuthor ">Zunnan  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Genetic association of
              TLR
              4 Asp299Gly,
              TLR
              4 Thr399Ile, and
              CD
              14 C‐159T polymorphisms with the risk of severe
              RSV
              infection: a meta‐analysis. </span><span class="cited-content_cbyCitation_journal-name">Influenza and Other Respiratory Viruses</span><span> <strong>2016,</strong> <em>10 </em>
                                    (3)
                                     , 224-233. <a href="https://doi.org/10.1111/irv.12378" title="DOI URL">https://doi.org/10.1111/irv.12378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/irv.12378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Firv.12378%26sid%3Dliteratum%253Aachs%26jtitle%3DInfluenza%2520and%2520Other%2520Respiratory%2520Viruses%26atitle%3DGenetic%252Bassociation%252Bof%252BTLR%252B4%252BAsp299Gly%25252C%252BTLR%252B4%252BThr399Ile%25252C%252Band%252BCD%252B14%252BC%2525E2%252580%252590159T%252Bpolymorphisms%252Bwith%252Bthe%252Brisk%252Bof%252Bsevere%252BRSV%252Binfection%25253A%252Ba%252Bmeta%2525E2%252580%252590analysis%26aulast%3DZhou%26aufirst%3DJiahui%26date%3D2016%26date%3D2016%26volume%3D10%26issue%3D3%26spage%3D224%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michel  Perron</span>, <span class="hlFld-ContribAuthor ">Kirsten  Stray</span>, <span class="hlFld-ContribAuthor ">April  Kinkade</span>, <span class="hlFld-ContribAuthor ">Dorothy  Theodore</span>, <span class="hlFld-ContribAuthor ">Gary  Lee</span>, <span class="hlFld-ContribAuthor ">Eugene  Eisenberg</span>, <span class="hlFld-ContribAuthor ">Michael  Sangi</span>, <span class="hlFld-ContribAuthor ">Brian E.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Robert  Jordan</span>, <span class="hlFld-ContribAuthor ">Pedro A.  Piedra</span>, <span class="hlFld-ContribAuthor ">Geoffery L.  Toms</span>, <span class="hlFld-ContribAuthor ">Richard  Mackman</span>, <span class="hlFld-ContribAuthor ">Tomas  Cihlar</span>. </span><span class="cited-content_cbyCitation_article-title">GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2016,</strong> <em>60 </em>
                                    (3)
                                     , 1264-1273. <a href="https://doi.org/10.1128/AAC.01497-15" title="DOI URL">https://doi.org/10.1128/AAC.01497-15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01497-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01497-15%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DGS-5806%252BInhibits%252Ba%252BBroad%252BRange%252Bof%252BRespiratory%252BSyncytial%252BVirus%252BClinical%252BIsolates%252Bby%252BBlocking%252Bthe%252BVirus-Cell%252BFusion%252BProcess%26aulast%3DPerron%26aufirst%3DMichel%26date%3D2016%26volume%3D60%26issue%3D3%26spage%3D1264%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Reguera</span>, <span class="hlFld-ContribAuthor ">Piotr  Gerlach</span>, <span class="hlFld-ContribAuthor ">Stephen  Cusack</span>. </span><span class="cited-content_cbyCitation_article-title">Towards a structural understanding of RNA synthesis by negative strand RNA viral polymerases. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Structural Biology</span><span> <strong>2016,</strong> <em>36 </em>, 75-84. <a href="https://doi.org/10.1016/j.sbi.2016.01.002" title="DOI URL">https://doi.org/10.1016/j.sbi.2016.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.sbi.2016.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.sbi.2016.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Structural%2520Biology%26atitle%3DTowards%252Ba%252Bstructural%252Bunderstanding%252Bof%252BRNA%252Bsynthesis%252Bby%252Bnegative%252Bstrand%252BRNA%252Bviral%252Bpolymerases%26aulast%3DReguera%26aufirst%3DJuan%26date%3D2016%26volume%3D36%26spage%3D75%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wade  Blair</span>, <span class="hlFld-ContribAuthor ">Christopher  Cox</span>. </span><span class="cited-content_cbyCitation_article-title">Current Landscape of Antiviral Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">F1000Research</span><span> <strong>2016,</strong> <em>5 </em>, 202. <a href="https://doi.org/10.12688/f1000research.7665.1" title="DOI URL">https://doi.org/10.12688/f1000research.7665.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12688/f1000research.7665.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12688%2Ff1000research.7665.1%26sid%3Dliteratum%253Aachs%26jtitle%3DF1000Research%26atitle%3DCurrent%252BLandscape%252Bof%252BAntiviral%252BDrug%252BDiscovery%26aulast%3DBlair%26aufirst%3DWade%26date%3D2016%26date%3D2016%26volume%3D5%26spage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Meng</span>, <span class="hlFld-ContribAuthor ">Anne L.  Hotard</span>, <span class="hlFld-ContribAuthor ">Michael G.  Currier</span>, <span class="hlFld-ContribAuthor ">Sujin  Lee</span>, <span class="hlFld-ContribAuthor ">Christopher C.  Stobart</span>, <span class="hlFld-ContribAuthor ">Martin L.  Moore</span>, . </span><span class="cited-content_cbyCitation_article-title">Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2016,</strong> <em>90 </em>
                                    (1)
                                     , 245-253. <a href="https://doi.org/10.1128/JVI.02140-15" title="DOI URL">https://doi.org/10.1128/JVI.02140-15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.02140-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.02140-15%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DRespiratory%252BSyncytial%252BVirus%252BAttachment%252BGlycoprotein%252BContribution%252Bto%252BInfection%252BDepends%252Bon%252Bthe%252BSpecific%252BFusion%252BProtein%26aulast%3DMeng%26aufirst%3DJia%26date%3D2016%26volume%3D90%26issue%3D1%26spage%3D245%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petr  Nauš</span>, <span class="hlFld-ContribAuthor ">Olga  Caletková</span>, <span class="hlFld-ContribAuthor ">Pavla  Perlíková</span>, <span class="hlFld-ContribAuthor ">Lenka  Poštová Slavětínská</span>, <span class="hlFld-ContribAuthor ">Eva  Tloušťová</span>, <span class="hlFld-ContribAuthor ">Jan  Hodek</span>, <span class="hlFld-ContribAuthor ">Jan  Weber</span>, <span class="hlFld-ContribAuthor ">Petr  Džubák</span>, <span class="hlFld-ContribAuthor ">Marián  Hajdúch</span>, <span class="hlFld-ContribAuthor ">Michal  Hocek</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological profiling of 6- or 7-(het)aryl-7-deazapurine 4′-C-methylribonucleosides. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (23)
                                     , 7422-7438. <a href="https://doi.org/10.1016/j.bmc.2015.10.040" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.10.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.10.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.10.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bprofiling%252Bof%252B6-%252Bor%252B7-%252528het%252529aryl-7-deazapurine%252B4%2525E2%252580%2525B2-C-methylribonucleosides%26aulast%3DNau%25C5%25A1%26aufirst%3DPetr%26date%3D2015%26volume%3D23%26issue%3D23%26spage%3D7422%26epage%3D7438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michela  Cancellieri</span>, <span class="hlFld-ContribAuthor ">Marcella  Bassetto</span>, <span class="hlFld-ContribAuthor ">Ivy  Widjaja</span>, <span class="hlFld-ContribAuthor ">Frank  van Kuppeveld</span>, <span class="hlFld-ContribAuthor ">Cornelis A.M.  de Haan</span>, <span class="hlFld-ContribAuthor ">Andrea  Brancale</span>. </span><span class="cited-content_cbyCitation_article-title">In silico structure-based design and synthesis of novel anti-RSV compounds. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2015,</strong> <em>122 </em>, 46-50. <a href="https://doi.org/10.1016/j.antiviral.2015.08.003" title="DOI URL">https://doi.org/10.1016/j.antiviral.2015.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2015.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2015.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DIn%252Bsilico%252Bstructure-based%252Bdesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Banti-RSV%252Bcompounds%26aulast%3DCancellieri%26aufirst%3DMichela%26date%3D2015%26volume%3D122%26spage%3D46%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuele  Ciceri</span>, <span class="hlFld-ContribAuthor ">Pierangela  Ciuffreda</span>, <span class="hlFld-ContribAuthor ">Paride  Grisenti</span>, <span class="hlFld-ContribAuthor ">Patrizia  Ferraboschi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of the antitumoral nucleoside capecitabine through a chemo-enzymatic approach. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (43)
                                     , 5909-5913. <a href="https://doi.org/10.1016/j.tetlet.2015.09.027" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.09.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.09.027%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bthe%252Bantitumoral%252Bnucleoside%252Bcapecitabine%252Bthrough%252Ba%252Bchemo-enzymatic%252Bapproach%26aulast%3DCiceri%26aufirst%3DSamuele%26date%3D2015%26volume%3D56%26issue%3D43%26spage%3D5909%26epage%3D5913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carrie W.  Evans</span>, <span class="hlFld-ContribAuthor ">Colm  Atkins</span>, <span class="hlFld-ContribAuthor ">Ashish  Pathak</span>, <span class="hlFld-ContribAuthor ">Brian E.  Gilbert</span>, <span class="hlFld-ContribAuthor ">James W.  Noah</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazole analogs inhibit respiratory syncytial virus G protein function. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2015,</strong> <em>121 </em>, 31-38. <a href="https://doi.org/10.1016/j.antiviral.2015.06.016" title="DOI URL">https://doi.org/10.1016/j.antiviral.2015.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2015.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2015.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DBenzimidazole%252Banalogs%252Binhibit%252Brespiratory%252Bsyncytial%252Bvirus%252BG%252Bprotein%252Bfunction%26aulast%3DEvans%26aufirst%3DCarrie%2BW.%26date%3D2015%26volume%3D121%26spage%3D31%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Weisshaar</span>, <span class="hlFld-ContribAuthor ">Robert  Cox</span>, <span class="hlFld-ContribAuthor ">Richard K.  Plemper</span>. </span><span class="cited-content_cbyCitation_article-title">Blocking Respiratory Syncytial Virus Entry: A Story with Twists. </span><span class="cited-content_cbyCitation_journal-name">DNA and Cell Biology</span><span> <strong>2015,</strong> <em>34 </em>
                                    (8)
                                     , 505-510. <a href="https://doi.org/10.1089/dna.2015.2896" title="DOI URL">https://doi.org/10.1089/dna.2015.2896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/dna.2015.2896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fdna.2015.2896%26sid%3Dliteratum%253Aachs%26jtitle%3DDNA%2520and%2520Cell%2520Biology%26atitle%3DBlocking%252BRespiratory%252BSyncytial%252BVirus%252BEntry%25253A%252BA%252BStory%252Bwith%252BTwists%26aulast%3DWeisshaar%26aufirst%3DMarco%26date%3D2015%26volume%3D34%26issue%3D8%26spage%3D505%26epage%3D510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah L.  Noton</span>, <span class="hlFld-ContribAuthor ">Kartikeya  Nagendra</span>, <span class="hlFld-ContribAuthor ">Ewan F.  Dunn</span>, <span class="hlFld-ContribAuthor ">Michael E.  Mawhorter</span>, <span class="hlFld-ContribAuthor ">Qin  Yu</span>, <span class="hlFld-ContribAuthor ">Rachel  Fearns</span>, . </span><span class="cited-content_cbyCitation_article-title">Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2015,</strong> <em>89 </em>
                                    (15)
                                     , 7786-7798. <a href="https://doi.org/10.1128/JVI.00530-15" title="DOI URL">https://doi.org/10.1128/JVI.00530-15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.00530-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.00530-15%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DRespiratory%252BSyncytial%252BVirus%252BInhibitor%252BAZ-27%252BDifferentially%252BInhibits%252BDifferent%252BPolymerase%252BActivities%252Bat%252Bthe%252BPromoter%26aulast%3DNoton%26aufirst%3DSarah%2BL.%26date%3D2015%26volume%3D89%26issue%3D15%26spage%3D7786%26epage%3D7798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jerome  Deval</span>, <span class="hlFld-ContribAuthor ">Jin  Hong</span>, <span class="hlFld-ContribAuthor ">Guangyi  Wang</span>, <span class="hlFld-ContribAuthor ">Josh  Taylor</span>, <span class="hlFld-ContribAuthor ">Lucas K.  Smith</span>, <span class="hlFld-ContribAuthor ">Amy  Fung</span>, <span class="hlFld-ContribAuthor ">Sarah K.  Stevens</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Zhinan  Jin</span>, <span class="hlFld-ContribAuthor ">Natalia  Dyatkina</span>, <span class="hlFld-ContribAuthor ">Marija  Prhavc</span>, <span class="hlFld-ContribAuthor ">Antitsa D.  Stoycheva</span>, <span class="hlFld-ContribAuthor ">Vladimir  Serebryany</span>, <span class="hlFld-ContribAuthor ">Jyanwei  Liu</span>, <span class="hlFld-ContribAuthor ">David B.  Smith</span>, <span class="hlFld-ContribAuthor ">Yuen  Tam</span>, <span class="hlFld-ContribAuthor ">Qingling  Zhang</span>, <span class="hlFld-ContribAuthor ">Martin L.  Moore</span>, <span class="hlFld-ContribAuthor ">Rachel  Fearns</span>, <span class="hlFld-ContribAuthor ">Sushmita M.  Chanda</span>, <span class="hlFld-ContribAuthor ">Lawrence M.  Blatt</span>, <span class="hlFld-ContribAuthor ">Julian A.  Symons</span>, <span class="hlFld-ContribAuthor ">Leo  Beigelman</span>, . </span><span class="cited-content_cbyCitation_article-title">Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2015,</strong> <em>11 </em>
                                    (6)
                                     , e1004995. <a href="https://doi.org/10.1371/journal.ppat.1004995" title="DOI URL">https://doi.org/10.1371/journal.ppat.1004995</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1004995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1004995%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DMolecular%252BBasis%252Bfor%252Bthe%252BSelective%252BInhibition%252Bof%252BRespiratory%252BSyncytial%252BVirus%252BRNA%252BPolymerase%252Bby%252B2%252527-Fluoro-4%252527-Chloromethyl-Cytidine%252BTriphosphate%26aulast%3DDeval%26aufirst%3DJerome%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D6%26spage%3De1004995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. RSV nucleoside inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) DMTrCl, py, (ii) TBSCl, imidazole, DCM, (iii) 80% AcOH, 89% (3 steps); (b) IBX, CH<sub>3</sub>CN, reflux; (c) (i) 37% CH<sub>2</sub>O, NaOH, 1,4-dioxane, (ii) NaBH<sub>4</sub>, 36% (3 steps); (d) DMTrCl, py; 63%; (e) TBDPSCl, imidazole, DCM; (f) 80% AcOH, 72% (2 steps); (g) (i) Ph<sub>3</sub>P, I<sub>2</sub>, imidazole, 80 °C, THF, 43%, (ii) H<sub>2</sub>, 10% Pd/C, TEA, EtOH, 95% of <b>11</b>; (h) Ph<sub>3</sub>P, CCl<sub>4</sub>, DCE, 130 °C, MW, 69% of <b>12</b>; (i) (i) DMP, DCM, (ii) Ph<sub>3</sub>P═CH<sub>2</sub>, THF, 71% of <b>13</b> (2 steps); (j) (i) BzCl, DMAP, TEA, DCM, (ii) CH<sub>2</sub>N<sub>2</sub>, Pd(OAc)<sub>2</sub>, DCM, (iii) NH<sub>3</sub>, MeOH, 28% (3 steps); (k) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, then NH<sub>3</sub>; (l) H<sub>2</sub>, Pd/C, MeOH, 91%; (m) NH<sub>4</sub>F, MeOH, reflux, 22% of <b>2a</b> (2 steps from <b>11</b>), 42% of <b>2c</b> (2 steps from <b>12</b>), 63% of <b>2e</b> (2 steps from <b>13</b>), 62% of <b>2f</b> (2 steps from <b>17</b>), 24% of <b>2j</b> (2 steps from <b>14</b>); (n) (i) PMBCl, K<sub>2</sub>CO<sub>3</sub>, DMF, 75%, (ii) TBAF, THF, 82%; (o) (i) BnBr, NaH, THF, 79%, (ii) Same as f, 73%, (iii) DAST, toluene, 60 °C, 45%; (p) CAN, CH<sub>3</sub>CN, 50%, (q) (i) same as k, (ii) same as d, 40% (2 steps); (r) (i) ammonium formate, 10% Pd/C, acetone, reflux, 68%, (ii) 80% HCOOH, 50 °C, 72%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) TBDPSCl, py, (ii) MMTrCl, AgNO<sub>3</sub>, collidine, DCM, (iii) TBAF, THF, 86% of <b>26</b> from <b>4</b>, 82% of <b>27</b> from <b>24</b>, 29% of <b>28</b> from <b>25</b>; (b) (i) DMP, py, DCM, (ii) 37% HCHO, NaOH, 1,4-dioxane, 63% of <b>29</b> from <b>26</b>, 56% of <b>30</b> from <b>27</b>, 51% of <b>31</b> from <b>28</b>; (c) Tf<sub>2</sub>O, py, DCM, −35 °C, 88% of <b>32</b>, 70% of <b>33</b>, 67% of <b>34</b>; (d) NaH, DMF, 0 °C; (e) (i) LiBr, DMF, (ii) NaOH, H<sub>2</sub>O, THF, 0 °C, 59% of <b>38</b> (3 steps); (f) NaSMe, DMF, 15-crown-5, 59% of <b>39</b> (2 steps from <b>32</b>); (g) (i) LiCl, DMF, (ii) NaOH, H<sub>2</sub>O, THF, 0 °C, 83% of <b>40</b> from <b>33</b>, 72% of <b>41</b> from <b>34</b>; (h) MMTrCl, AgNO<sub>3</sub>, collidine, DCM, 73% of <b>42</b>, 66% of <b>43</b>; (i) TBSCl, py, 60% of <b>44,</b> 90% of <b>45</b>; (j) (i) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, (ii) aq NH<sub>3</sub>, (iii) 80% AcOH, 60 °C, 22% of <b>2d</b> (3 steps), 43% of <b>2k</b> (3 steps); (k) (i) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, then NH<sub>3</sub>, (ii) MMTrCl, AgNO<sub>3</sub>, collidine, DCM, (iii) TBAF, THF, (iv) 80% AcOH, 45% of <b>3a</b> from <b>44</b>; (l) (i) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, then NH<sub>3</sub>, (ii) 80% HCOOH, 49% of <b>3b</b> from <b>45</b>.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) TBSCl, py, (ii) MMTrCl, AgNO<sub>3</sub>, collidine, DCM, (iii) TBAF, THF, 66% (3 steps); (b) (i) DMSO, EDCI, TFA, py, (ii) 37% HCHO, NaOH, 1,4-dioxane, overnight, then NaBH<sub>4</sub>, 60% (2 steps); (c) same as (a), 28% (3 steps); (d) (i) DMP, DCM, (ii) Ph<sub>3</sub>P═CHCl, THF, (iii) BuLi, THF, −78 °C, 61% (3 steps); (e) 80% AcOH, 40 °C, 45%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) I<sub>2</sub>, Ph<sub>3</sub>P, imidazole, THF, (ii) DBU, THF, 60 °C, 47% (2 steps); (b) (i) TBSCl, imidazole, DCM, 71%, (ii) DMDO in acetone, DCM; (c) allyl-TMS, SnCl<sub>4</sub>, DCM, −40 to 0 °C, 41% (2 steps); (d) TBSCl, imidazole, DCM; (e) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, overnight, then aq NH<sub>3</sub>, 69% (2 steps); (f) NH<sub>4</sub>F, MeOH, reflux, 50%; (g) MMTrCl, AgNO<sub>3</sub>, collidine, DCM, 76%; (h) H<sub>2</sub>, 10% Pd/C, 84%; (i) TBAF, THF, 74%; (j) 80% HCOOH, 65%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) I<sub>2</sub>, PbCO<sub>3</sub>, MeOH, 72%; (b) BzCl, py; (c) NaOBz, 15-crown-5, DMF 70 °C, 35% (2 steps); (d) (i) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, (ii) NH<sub>3</sub>, (iii) BzCl, py, 15% (3 steps); (e) NH<sub>3</sub>/MeOH, 79%.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) IBX, CH<sub>3</sub>CN, 80 °C, (ii) aq CH<sub>2</sub>O, NaOH, dioxane, (iii) NaBH<sub>4,</sub> 60% (3 steps); (b) (i) Tf<sub>2</sub>O, py, DCM, (ii) NaH, DMF, (iii) LiCl, DMF, (iv) aq NaOH, THF, 28% (4 steps); (c) (i) BzCl, TEA, DCM, (ii) TPSCl, DMAP, TEA, (iii) aq NH<sub>3</sub>, 39% (3 steps); (d) (i) 80% HCOOH, (ii) NH<sub>3</sub>/MeOH, 40% (2 steps); (e) (i) 80% HCOOH, 50 °C, (ii) (PhO)<sub>2</sub>CO, NaHCO<sub>3</sub>, DMF, 100 °C, 60% (2 steps); (f) (i) aq NaOH, EtOH/H<sub>2</sub>O, (ii) TBSCl, imidazole, AgNO<sub>3</sub>, DMF, (iii) TPSCl, DMAP, TEA, CH<sub>3</sub>CN; (iv) aq NH<sub>3</sub>, 39% (4 steps); (g) (i) DMTrCl, AgNO<sub>3</sub>, collidine, DCM, (ii) NH<sub>4</sub>F, MeOH, reflux, (iii) TFA, 50 °C, 30% (3 steps).</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) DMTrCl, py, (ii) TBAF, THF, 70% (2 steps); (b) (i) acid anhydride, py, (ii) 80% HCOOH, 40 °C, 43–61% for <b>70</b>–<b>73</b> (2 steps); (c) (i) <i>n</i>-octanoic acid, DCC, DMAP, py, (ii) 80% HCOOH, 40 °C, 24% of <b>74</b>, 9% of <b>75</b>, 9% of <b>76</b> (2 steps).</p></p></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) NaH, DMF, (ii) LiCl, (iii) aq NaOH, THF, (iv) TBSCl, imidazole, DCM; (b) (i) TPSCl, DMAP, TEA, CH<sub>3</sub>CN, then NH<sub>3</sub>, (ii) DMTrCl, AgNO<sub>3</sub>, collidine, DCM, (iii) TBAF, THF; (c) (i) <i>N</i>-Boc-Val-OH, BOP-Cl, 3-nitro-1,2,4-triazole, DIPEA, THF, (ii) 80% HCOOH; (d) (i) isobutyric anhydride, py, (ii) 80% HCOOH.</p></p></figure><figure data-id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/medium/jm-2014-017279_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Incorporation of nucleotide analogues at 100 μM NTP by human mitochondrial RNA polymerase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-4/jm5017279/20150220/images/large/jm-2014-017279_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017279&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Borchers, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershwin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershwin, L. J.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus—a comprehensive review</span> <span class="citation_source-journal">Clin. Rev. Allergy Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1007%2Fs12016-013-8368-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=23575961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSqtb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=331-379&author=A.+T.+Borchersauthor=C.+Changauthor=M.+E.+Gershwinauthor=L.+J.+Gershwin&title=Respiratory+syncytial+virus%E2%80%94a+comprehensive+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory Syncytial Virus-A Comprehensive Review</span></div><div class="casAuthors">Borchers, Andrea T.; Chang, Christopher; Gershwin, M. Eric; Gershwin, Laurel J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Reviews in Allergy & Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-379</span>CODEN:
                <span class="NLM_cas:coden">CRAIF2</span>;
        ISSN:<span class="NLM_cas:issn">1080-0549</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Respiratory syncytial virus (RSV) is amongst the most important pathogenic infections of childhood and is assocd. with significant morbidity and mortality.  Although there have been extensive studies of epidemiol., clin. manifestations, diagnostic techniques, animal models and the immunobiol. of infection, there is not yet a convincing and safe vaccine available.  The major histopathol. characteristics of RSV infection are acute bronchiolitis, mucosal and submucosal edema, and luminal occlusion by cellular debris of sloughed epithelial cells mixed with macrophages, strands of fibrin, and some mucin.  There is a single RSV serotype with two major antigenic subgroups, A and B. Strains of both subtypes often co-circulate, but usually one subtype predominates.  In temperate climates, RSV infections reflect a distinct seasonality with onset in late fall or early winter.  It is believed that most children will experience at least one RSV infection by the age of 2 years.  There are several key animal models of RSV.  These include a model in mice and, more importantly, a bovine model; the latter reflects distinct similarity to the human disease.  Importantly, the prevalence of asthma is significantly higher amongst children who are hospitalized with RSV in infancy or early childhood.  However, there have been only limited investigations of candidate genes that have the potential to explain this increase in susceptibility.  An atopic predisposition appears to predispose to subsequent development of asthma and it is likely that subsequent development of asthma is secondary to the pathogenic inflammatory response involving cytokines, chemokines and their cognate receptors.  Numerous approaches to the development of RSV vaccines are being evaluated, as are the use of newer antiviral agents to mitigate disease.  There is also significant attention being placed on the potential impact of co-infection and defining the natural history of RSV.  Clearly, more research is required to define the relationships between RSV bronchiolitis, other viral induced inflammatory responses, and asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz4EZ4rD5YZLVg90H21EOLACvtfcHk0lhCs0RSwBivXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSqtb7L&md5=dc062b5f24682fc2f57bcd00f5233a49</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs12016-013-8368-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12016-013-8368-9%26sid%3Dliteratum%253Aachs%26aulast%3DBorchers%26aufirst%3DA.%2BT.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DGershwin%26aufirst%3DM.%2BE.%26aulast%3DGershwin%26aufirst%3DL.%2BJ.%26atitle%3DRespiratory%2520syncytial%2520virus%25E2%2580%2594a%2520comprehensive%2520review%26jtitle%3DClin.%2520Rev.%2520Allergy%2520Immunol.%26date%3D2013%26volume%3D45%26spage%3D331%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Tawar, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquerroy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varela, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damier-Piolle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagné, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLellan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedouelle, H.</span><span> </span><span class="NLM_article-title">Crystal structure of a nucleocapsid-like nucleoprotein–RNA complex of respiratory syncytial virus</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2009&pages=1279-1283&author=R.+G.+Tawarauthor=S.+Duquerroyauthor=C.+Vonrheinauthor=P.+F.+Varelaauthor=L.+Damier-Piolleauthor=N.+Castagn%C3%A9author=K.+MacLellanauthor=H.+Bedouelle&title=Crystal+structure+of+a+nucleocapsid-like+nucleoprotein%E2%80%93RNA+complex+of+respiratory+syncytial+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTawar%26aufirst%3DR.%2BG.%26aulast%3DDuquerroy%26aufirst%3DS.%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DVarela%26aufirst%3DP.%2BF.%26aulast%3DDamier-Piolle%26aufirst%3DL.%26aulast%3DCastagn%25C3%25A9%26aufirst%3DN.%26aulast%3DMacLellan%26aufirst%3DK.%26aulast%3DBedouelle%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520a%2520nucleocapsid-like%2520nucleoprotein%25E2%2580%2593RNA%2520complex%2520of%2520respiratory%2520syncytial%2520virus%26jtitle%3DScience%26date%3D2009%26volume%3D326%26spage%3D1279%26epage%3D1283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piedimonte, G.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus prevention and therapy: past, present, and future</span> <span class="citation_source-journal">Pediatr. Pulmonol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1002%2Fppul.21377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=21438168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ps1Ciug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=324-347&author=M.+Wrightauthor=G.+Piedimonte&title=Respiratory+syncytial+virus+prevention+and+therapy%3A+past%2C+present%2C+and+future"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus prevention and therapy: past, present, and future</span></div><div class="casAuthors">Wright Melvin; Piedimonte Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Pediatric pulmonology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">324-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Respiratory syncytial virus (RSV) is the most common respiratory pathogen in infants and young children worldwide.  More than 50 years after its discovery, and despite relentless attempts to identify pharmacological therapies to improve the clinical course and outcomes of this disease, the most effective therapy remains supportive care.  Although the quest for a safe and effective vaccine remains unsuccessful, pediatricians practicing during the past decade have been able to protect at least the more vulnerable patients with safe and effective passive prophylaxis.  This review summarizes the history, microbiology, epidemiology, pathophysiology, and clinical manifestations of this infection in order to provide the reader with the background information necessary to fully appreciate the many challenges presented by the clinical management of young children with bronchiolitis.  The last part of this article attempts an evidence-based review of the pharmacologic strategies currently available and those being evaluated, intentionally omitting highly experimental approaches not yet tested in clinical trials and, therefore, not likely to become available in the foreseeable future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoHpmXTQa9F3qj_yg7twvpfW6udTcc2eZdvHcChuouFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ps1Ciug%253D%253D&md5=0b2cf1bd2f7393c702cfd31d1a849ff2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fppul.21377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fppul.21377%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%26aulast%3DPiedimonte%26aufirst%3DG.%26atitle%3DRespiratory%2520syncytial%2520virus%2520prevention%2520and%2520therapy%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DPediatr.%2520Pulmonol.%26date%3D2011%26volume%3D46%26spage%3D324%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Piedimonte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M. K.</span><span> </span><span class="NLM_article-title">Alternative mechanisms for respiratory syncytial virus (RSV) infection and persistence: could RSV be transmitted through the placenta and persist into developing fetal lungs?</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1016%2Fj.coph.2014.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=24810284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSlt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=82-88&author=G.+Piedimonteauthor=M.+K.+Perez&title=Alternative+mechanisms+for+respiratory+syncytial+virus+%28RSV%29+infection+and+persistence%3A+could+RSV+be+transmitted+through+the+placenta+and+persist+into+developing+fetal+lungs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative mechanisms for respiratory syncytial virus (RSV) infection and persistence: could RSV be transmitted through the placenta and persist into developing fetal lungs?</span></div><div class="casAuthors">Piedimonte, Giovanni; Perez, Miriam K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-88</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Respiratory syncytial virus (RSV) represents the most common respiratory pathogen obsd. worldwide in infants and young children and may play a role in the inception of recurrent wheezing and asthma in childhood.  We discuss herein the recent hypothesis that RSV vertically transmitted from the mother to the fetus in utero causes persistent structural and functional changes in the developing lungs of the offspring, thereby predisposing to postnatal airway obstruction.  A no. of observations in humans support the notion that extrapulmonary tissues may be infected hematogenously by RSV and harbor this virus allowing the persistence of latent infection.  More recent data from animal models suggest that RSV can be transmitted across the placenta from the respiratory tract of the mother to that of the fetus, and persist in the lungs both during development, as well as during adulthood.  Vertical RSV infection is assocd. with dysregulation of crucial neurotrophic pathways during ontogenesis, leading to aberrant parasympathetic innervation and airway hyperreactivity after postnatal reinfection.  These new data challenge the current paradigm that acquisition of RSV infection occurs only after birth and shift attention to the prenatal effects of the virus, with the potential to result in more severe and lasting consequences by interfering with crucial developmental processes.  The most immediate implication is that prophylactic strategies targeted to the mother-fetus dyad may reduce the incidence of postviral sequelae like childhood wheezing and asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw69INmVAwVrVg90H21EOLACvtfcHk0lhmqE0bB2rrAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSlt7jN&md5=7314f36462331ceaec2ea4f27ea433c0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2014.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2014.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DPiedimonte%26aufirst%3DG.%26aulast%3DPerez%26aufirst%3DM.%2BK.%26atitle%3DAlternative%2520mechanisms%2520for%2520respiratory%2520syncytial%2520virus%2520%2528RSV%2529%2520infection%2520and%2520persistence%253A%2520could%2520RSV%2520be%2520transmitted%2520through%2520the%2520placenta%2520and%2520persist%2520into%2520developing%2520fetal%2520lungs%253F%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2014%26volume%3D16%26spage%3D82%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ohmit, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moler, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monto, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, A. S.</span><span> </span><span class="NLM_article-title">Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection</span> <span class="citation_source-journal">J. Clin. Epidemiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1016%2F0895-4356%2896%2900137-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=8780603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A280%3ADyaK28znsVeisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1996&pages=963-967&author=S.+E.+Ohmitauthor=F.+W.+Molerauthor=A.+S.+Montoauthor=A.+S.+Khan&title=Ribavirin+utilization+and+clinical+effectiveness+in+children+hospitalized+with+respiratory+syncytial+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection</span></div><div class="casAuthors">Ohmit S E; Moler F W; Monto A S; Khan A S</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical epidemiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">963-7</span>
        ISSN:<span class="NLM_cas:issn">0895-4356</span>.
    </div><div class="casAbstract">Ribavirin was approved in early 1986 for treatment of illness associated with respiratory syncytial virus (RSV) infection in hospitalized children; however, the value of its use remains controversial.  This investigation was undertaken to describe ribavirin utilization and to evaluate the effectiveness of ribavirin in reducing the period of hospitalization.  All children with laboratory-confirmed RSV infection, hospitalized over seven epidemic periods at a single institution, were identified.  Characteristics from the medical records of the 768 children and their course of hospitalization were evaluated as determinants of treatment with ribavirin.  Very young age as well as diagnoses of congenital heart disease, certain pulmonary conditions, and failure to thrive were all significantly related to increased likelihood of treatment.  Children requiring intensive care were likely to be treated; however, the most critically ill children, those who required mechanical ventilation, were not treated.  Although these results were in keeping with treatment guidelines for the use of ribavirin, actual utilization declined significantly over the course of the evaluation.  The effect of ribavirin treatment on the duration of hospitalization among children with community-acquired infection was evaluated in a multivariate model, which controlled for the effects of underlying conditions, measures of illness severity, and epidemic year.  This analysis failed to demonstrate a benefit for ribavirin in reducing length of stay; in fact, ribavirin treatment was significantly associated with prolonged hospitalization.  It was not likely that the explanation for ribavirin's association with prolonged hospitalization was that the most seriously ill children were treated; however, it was not possible to determine whether this association was due to an adverse effect of treatment or resulted from a perceived need to complete the course of therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVAZQffUn-JQqdek-gHSrIfW6udTcc2eYw9s1QeToMybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28znsVeisA%253D%253D&md5=011155b5b2b5c092f5d163f5e54ba8b4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0895-4356%2896%2900137-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0895-4356%252896%252900137-0%26sid%3Dliteratum%253Aachs%26aulast%3DOhmit%26aufirst%3DS.%2BE.%26aulast%3DMoler%26aufirst%3DF.%2BW.%26aulast%3DMonto%26aufirst%3DA.%2BS.%26aulast%3DKhan%26aufirst%3DA.%2BS.%26atitle%3DRibavirin%2520utilization%2520and%2520clinical%2520effectiveness%2520in%2520children%2520hospitalized%2520with%2520respiratory%2520syncytial%2520virus%2520infection%26jtitle%3DJ.%2520Clin.%2520Epidemiol.%26date%3D1996%26volume%3D49%26spage%3D963%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wyde, P. R.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus (RSV) disease and prospects for its control</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=63-79&author=P.+R.+Wyde&title=Respiratory+syncytial+virus+%28RSV%29+disease+and+prospects+for+its+control"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyde%26aufirst%3DP.%2BR.%26atitle%3DRespiratory%2520syncytial%2520virus%2520%2528RSV%2529%2520disease%2520and%2520prospects%2520for%2520its%2520control%26jtitle%3DAntiviral%2520Res.%26date%3D1998%26volume%3D39%26spage%3D63%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ding, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulabaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaccardi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feld, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazumyan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raifeld, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonia Nikitenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gluzman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Hara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellestad, G. A.</span><span> </span><span class="NLM_article-title">Novel and specific respiratory syncytial virus inhibitors that target virus fusion</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2671</span><span class="NLM_x">–</span> <span class="NLM_lpage">2675</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980239e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADyaK1cXksVKrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2671-2675&author=W.+D.+Dingauthor=B.+Mitsnerauthor=G.+Krishnamurthyauthor=A.+Aulabaughauthor=C.+D.+Hessauthor=J.+Zaccardiauthor=M.+Cutlerauthor=B.+Feldauthor=A.+Gazumyanauthor=Y.+Raifeldauthor=A.+Antonia+Nikitenkoauthor=S.+A.+Langauthor=Y.+Gluzmanauthor=B.+O%E2%80%99Haraauthor=G.+A.+Ellestad&title=Novel+and+specific+respiratory+syncytial+virus+inhibitors+that+target+virus+fusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and Specific Respiratory Syncytial Virus Inhibitors That Target Virus Fusion</span></div><div class="casAuthors">Ding, Wei-dong; Mitsner, Boris; Krishnamurthy, Girija; Aulabaugh, Ann; Hess, Cynthia D.; Zaccardi, Joe; Cutler, Mark; Feld, Boris; Gazumyan, Anna; Raifeld, Yuri; Nikitenko, Antonia; Lang, Stanley A.; Gluzman, Yakov; O'Hara, Bryan; Ellestad, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2671-2675</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A screening program was initiated to look for inhibitors of respiratory syncytial virus (RSV).  An active lead [I, R = SO2N(CH2CH2CONH2)2 throughout, X = CH:CH] (II) was identified from a 20,000 compd. library with a high-throughput screen using a whole virus cell-based assay.  The synthesis and SAR of a class of RSV inhibitors based on the stilbene II and the somewhat more active biphenyl analog I (X = bond) was described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPHEbXWr2MDbVg90H21EOLACvtfcHk0lhCOmgQQMCFjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXksVKrsrY%253D&md5=0f7f809cf71c10c25b48b700f07f03a8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm980239e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980239e%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DW.%2BD.%26aulast%3DMitsner%26aufirst%3DB.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DHess%26aufirst%3DC.%2BD.%26aulast%3DZaccardi%26aufirst%3DJ.%26aulast%3DCutler%26aufirst%3DM.%26aulast%3DFeld%26aufirst%3DB.%26aulast%3DGazumyan%26aufirst%3DA.%26aulast%3DRaifeld%26aufirst%3DY.%26aulast%3DAntonia%2BNikitenko%26aufirst%3DA.%26aulast%3DLang%26aufirst%3DS.%2BA.%26aulast%3DGluzman%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Hara%26aufirst%3DB.%26aulast%3DEllestad%26aufirst%3DG.%2BA.%26atitle%3DNovel%2520and%2520specific%2520respiratory%2520syncytial%2520virus%2520inhibitors%2520that%2520target%2520virus%2520fusion%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2671%26epage%3D2675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeremans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willebrords, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacrampe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyde, P. R.</span><span> </span><span class="NLM_article-title">Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1016%2Fj.antiviral.2003.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=14638397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1eqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=209-219&author=K.+Andriesauthor=M.+Moeremansauthor=T.+Geversauthor=R.+Willebrordsauthor=C.+Sommenauthor=J.+Lacrampeauthor=F.+Janssensauthor=P.+R.+Wyde&title=Substituted+benzimidazoles+with+nanomolar+activity+against+respiratory+syncytial+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus</span></div><div class="casAuthors">Andries, Koen; Moeremans, Marc; Gevers, Tom; Willebrords, Rudy; Sommen, Cois; Lacrampe, Jean; Janssens, Frans; Wyde, Philip R.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-219</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A cell-based assay was used to discover compds. inhibiting respiratory syncytial virus (RSV)-induced fusion in HeLa/M cells.  A lead compd. was identified and subsequent synthesis of >300 analogs led to the identification of JNJ 2408068 (R170591), a low mol. wt. (MW 395) benzimidazole deriv. with an EC50 (0.16 nM) against some lab. strains almost 100,000 times better than that of ribavirin (15 μM).  Antiviral activity was confirmed for subgroup A and B clin. isolates of human RSV and for a bovine RSV isolate.  The compd. did not inhibit the growth of representative viruses from other Paramyxovirus genera, i.e. HPIV2 and Mumps Virus (genus Rubulavirus), HPIV3 (genus Respirovirus), Measles virus (genus Morbillivirus) and hMPV.  Efficacy in cytopathic effect inhibition assays correlated well with efficacy in virus yield redn. assays.  A concn. of 10 nM reduced RSV prodn. 1000-fold in multi-cycle expts., irresp. of the multiplicity of infection.  Time of addn. studies pointed to a dual mode of action: inhibition of virus-cell fusion early in the infection cycle and inhibition of cell-cell fusion at the end of the replication cycle.  Two resistant mutants were raised and shown to have single point mutations in the F-gene (S398L and D486N).  JNJ 2408068 was also shown to inhibit the release of proinflammatory cytokines IL-6, IL-8 and Rantes from RSV-infected A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH25-cUfGD5LVg90H21EOLACvtfcHk0lgDh9ZZFBNFFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1eqs7c%253D&md5=2fbf116384f9775d4c371a134f8e1d92</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2003.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2003.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DMoeremans%26aufirst%3DM.%26aulast%3DGevers%26aufirst%3DT.%26aulast%3DWillebrords%26aufirst%3DR.%26aulast%3DSommen%26aufirst%3DC.%26aulast%3DLacrampe%26aufirst%3DJ.%26aulast%3DJanssens%26aufirst%3DF.%26aulast%3DWyde%26aufirst%3DP.%2BR.%26atitle%3DSubstituted%2520benzimidazoles%2520with%2520nanomolar%2520activity%2520against%2520respiratory%2520syncytial%2520virus%26jtitle%3DAntiviral%2520Res.%26date%3D2003%26volume%3D60%26spage%3D209%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bonfanti, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doublet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queguiner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willebrords, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuyts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Remoortere, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span> </span><span class="NLM_article-title">Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701284j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=875-896&author=J.-F.+Bonfantiauthor=C.+Meyerauthor=F.+Doubletauthor=J.+Fortinauthor=P.+Mullerauthor=L.+Queguinerauthor=T.+Geversauthor=P.+Janssensauthor=H.+Szelauthor=R.+Willebrordsauthor=P.+Timmermanauthor=K.+Wuytsauthor=P.+van+Remoortereauthor=F.+Janssensauthor=P.+Wigerinckauthor=K.+Andries&title=Selection+of+a+respiratory+syncytial+virus+fusion+inhibitor+clinical+candidate.+2.+Discovery+of+a+morpholinopropylaminobenzimidazole+derivative+%28TMC353121%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm701284j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701284j%26sid%3Dliteratum%253Aachs%26aulast%3DBonfanti%26aufirst%3DJ.-F.%26aulast%3DMeyer%26aufirst%3DC.%26aulast%3DDoublet%26aufirst%3DF.%26aulast%3DFortin%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DP.%26aulast%3DQueguiner%26aufirst%3DL.%26aulast%3DGevers%26aufirst%3DT.%26aulast%3DJanssens%26aufirst%3DP.%26aulast%3DSzel%26aufirst%3DH.%26aulast%3DWillebrords%26aufirst%3DR.%26aulast%3DTimmerman%26aufirst%3DP.%26aulast%3DWuyts%26aufirst%3DK.%26aulast%3Dvan%2BRemoortere%26aufirst%3DP.%26aulast%3DJanssens%26aufirst%3DF.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DAndries%26aufirst%3DK.%26atitle%3DSelection%2520of%2520a%2520respiratory%2520syncytial%2520virus%2520fusion%2520inhibitor%2520clinical%2520candidate.%25202.%2520Discovery%2520of%2520a%2520morpholinopropylaminobenzimidazole%2520derivative%2520%2528TMC353121%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D875%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span> </span><span class="NLM_article-title">Respiratory syncytial virus entry inhibitors targeting the F protein</span> <span class="citation_source-journal">Viruses</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.3390%2Fv5010211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=23325327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=211-225&author=Z.+Sunauthor=Y.+Panauthor=S.+Jiangauthor=L.+Lu&title=Respiratory+syncytial+virus+entry+inhibitors+targeting+the+F+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory syncytial virus entry inhibitors targeting the F protein</span></div><div class="casAuthors">Sun, Zhiwu; Pan, Yanbin; Jiang, Shibo; Lu, Lu</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">211-225</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Human respiratory syncytial virus (RSV) is the main viral cause of respiratory tract infection in infants as well as some elderly and high-risk adults with chronic pulmonary disease and the severely immunocompromised.  So far, no specific anti-R SV therapeutics or effective anti-RSV vaccines have been reported.  Only one humanized monoclonal antibody, Palivizumab, has been approved for use in high-risk infants to prevent RSV infection.  Ribavirin is the only drug licensed for therapy of RSV infection, but its clin. use is limited by its nonspecific anti-RSV activity, toxic effect, and relatively high cost.  Therefore, development of novel effective anti-RSV therapeutics is urgently needed.  The RSV envelope glycoprotein F plays an important role in RSV fusion with, and entry into, the host cell and, consequently, serves as an attractive target for developing RSV entry inhibitors.  This article reviews advances made in studies of the structure and function of the F protein and the development of RSV entry inhibitors targeting it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPOeEk3HJ9DbVg90H21EOLACvtfcHk0lgDh9ZZFBNFFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yqtLY%253D&md5=845867182964c18a459de59ed022f6d1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3390%2Fv5010211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv5010211%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DL.%26atitle%3DRespiratory%2520syncytial%2520virus%2520entry%2520inhibitors%2520targeting%2520the%2520F%2520protein%26jtitle%3DViruses%26date%3D2013%26volume%3D5%26spage%3D211%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">DeVincenzo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaglioni-Weinlich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambkin-Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Riordan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toback, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, J. W.</span><span> </span><span class="NLM_article-title">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1056%2FNEJMoa1401184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=25140957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=711-722&author=J.+P.+DeVincenzoauthor=R.+J.+Whitleyauthor=R.+L.+Mackmanauthor=C.+Scaglioni-Weinlichauthor=L.+Harrisonauthor=E.+Farrellauthor=S.+McBrideauthor=R.+Lambkin-Williamsauthor=R.+Jordanauthor=Y.+Xinauthor=S.+Ramanathanauthor=T.+O%E2%80%99Riordanauthor=S.+A.+Lewisauthor=X.+Liauthor=S.+L.+Tobackauthor=S.+L.+Linauthor=J.+W.+Chien&title=Oral+GS-5806+activity+in+a+respiratory+syncytial+virus+challenge+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Oral GS-5806 activity in a respiratory syncytial virus challenge study</span></div><div class="casAuthors">DeVincenzo, John P.; Whitley, Richard J.; Mackman, Richard L.; Scaglioni-Weinlich, Cecilia; Harrison, Lisa; Farrell, Eric; McBride, Stephen; Lambkin-Williams, Robert; Jordan, Robert; Xin, Yan; Ramanathan, Srini; O'Riordan, Thomas; Lewis, Sandra A.; Li, Xiaoming; Toback, Seth L.; Lin, Shao-Lee; Chien, Jason W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">711-722, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Respiratory syncytial virus (RSV) is a common cause of infant hospitalizations and is increasingly recognized as a cause of considerable morbidity and mortality.  No accepted antiviral treatment exists.  Methods: We conducted a double-blind, placebo-controlled study of GS-5806, an oral RSV-entry inhibitor, in healthy adults who received a clin. challenge strain of RSV intranasally.  Participants were monitored for 12 days.  At the time of a pos. test for RSV infection or 5 days after inoculation, whichever occurred first, participants were randomly assigned to receive GS-5806 or placebo in one of seven sequential cohorts.  Cohorts 1 to 4 received a first dose of 50 mg of GS-5806 and then 25 mg daily for the next 4 days, cohort 5 received a first dose of 50 mg and then 25 mg daily for the next 2 days, cohort 6 received one 100-mg dose, and cohort 7 received a first dose of 10 mg and then 5 mg daily for the next 4 days.  Dose selection for cohorts 5, 6, and 7 occurred after an interim anal. of data for cohorts 1 to 4.  The primary end point was the area under the curve (AUC) for the viral load, which was assessed after administration of the first dose through the 12th day after inoculation.  Secondary end points were mucus wt. and symptom scores.  Results: Among the 54 participants in cohorts 1 to 4 who were infected with RSV, active treatment was assocd. with a lower viral load (adjusted mean, 250.7 vs. 757.7 log10 plaque-forming-unit equiv. [PFUe] × hours per mL; P<0.001), lower total mucus wt. (mean, 6.9 g vs. 15.1 g; P = 0.03), and a lower AUC for the change from baseline in symptom scores (adjusted mean, -20.2 vs. 204.9 × hours; P = 0.005).  The results were similar in cohorts 5, 6, and 7.  Adverse events, including low neutrophil counts and increased levels of alanine aminotransferase, were more common among participants receiving GS-5806.  Conclusions: Treatment with GS-5806 reduced the viral load and the severity of clin. disease in a challenge study of healthy adults.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqxDrIVO5aQLVg90H21EOLACvtfcHk0ljqSRgh_4Jheg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Cjsb7O&md5=72276739a80d55a732269359e338fb95</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1401184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1401184%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%2BP.%26aulast%3DWhitley%26aufirst%3DR.%2BJ.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DScaglioni-Weinlich%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DL.%26aulast%3DFarrell%26aufirst%3DE.%26aulast%3DMcBride%26aufirst%3DS.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DXin%26aufirst%3DY.%26aulast%3DRamanathan%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Riordan%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DToback%26aufirst%3DS.%2BL.%26aulast%3DLin%26aufirst%3DS.%2BL.%26aulast%3DChien%26aufirst%3DJ.%2BW.%26atitle%3DOral%2520GS-5806%2520activity%2520in%2520a%2520respiratory%2520syncytial%2520virus%2520challenge%2520study%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D711%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">DeVincenzo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambkin-Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cehelsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nochur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walshe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gollob, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaishnaw, A.</span><span> </span><span class="NLM_article-title">A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">8800</span><span class="NLM_x">–</span> <span class="NLM_lpage">8805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=8800-8805&author=J.+DeVincenzoauthor=R.+Lambkin-Williamsauthor=T.+Wilkinsonauthor=J.+Cehelskyauthor=S.+Nochurauthor=E.+Walsheauthor=R.+Meyersauthor=J.+Gollobauthor=A.+Vaishnaw&title=A+randomized%2C+double-blind%2C+placebo-controlled+study+of+an+RNAi-based+therapy+directed+against+respiratory+syncytial+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%26aulast%3DLambkin-Williams%26aufirst%3DR.%26aulast%3DWilkinson%26aufirst%3DT.%26aulast%3DCehelsky%26aufirst%3DJ.%26aulast%3DNochur%26aufirst%3DS.%26aulast%3DWalshe%26aufirst%3DE.%26aulast%3DMeyers%26aufirst%3DR.%26aulast%3DGollob%26aufirst%3DJ.%26aulast%3DVaishnaw%26aufirst%3DA.%26atitle%3DA%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%2520of%2520an%2520RNAi-based%2520therapy%2520directed%2520against%2520respiratory%2520syncytial%2520virus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D8800%26epage%3D8805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Liuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawetz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCollum, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudette, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massariol, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scouten, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordeleau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulrez Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span> </span><span class="NLM_article-title">Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">13105</span><span class="NLM_x">–</span> <span class="NLM_lpage">13115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1128%2FJVI.79.20.13105-13115.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=16189012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWisbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=13105-13115&author=M.+Liuzziauthor=S.+W.+Masonauthor=M.+Cartierauthor=C.+Lawetzauthor=R.+S.+McCollumauthor=N.+Dansereauauthor=G.+Bolgerauthor=N.+Lapeyreauthor=Y.+Gaudetteauthor=L.+Lagaceauthor=M.-J.+Massariolauthor=F.+Doauthor=P.+Whiteheadauthor=L.+Lamarreauthor=E.+Scoutenauthor=J.+Bordeleauauthor=S.+Landryauthor=J.+Rancourtauthor=G.+Gulrez+Fazalauthor=B.+Simoneau&title=Inhibitors+of+respiratory+syncytial+virus+replication+target+cotranscriptional+mRNA+guanylylation+by+viral+RNA-dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase</span></div><div class="casAuthors">Liuzzi, Michel; Mason, Stephen W.; Cartier, Mireille; Lawetz, Carol; McCollum, Robert S.; Dansereau, Nathalie; Bolger, Gordon; Lapeyre, Nicole; Gaudette, Yvon; Lagace, Lisette; Massariol, Marie-Josee; Do, Florence; Whitehead, Paul; Lamarre, Lyne; Scouten, Erika; Bordeleau, Josee; Landry, Serge; Rancourt, Jean; Fazal, Gulrez; Simoneau, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">13105-13115</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) is a major cause of respiratory illness in infants, immunocompromised patients, and the elderly.  New antiviral agents would be important tools in the treatment of acute RSV disease.  RSV encodes its own RNA-dependent RNA polymerase that is responsible for the synthesis of both genomic RNA and subgenomic mRNAs.  The viral polymerase also cotranscriptionally caps and polyadenylates the RSV mRNAs at their 5' and 3' ends, resp.  The authors have previously reported the discovery of the first nonnucleoside transcriptase inhibitor of RSV polymerase through high-throughput screening.  Here the authors report the design of inhibitors that have improved potency both in vitro and in antiviral assays and that also exhibit activity in a mouse model of RSV infection.  The authors have isolated virus with reduced susceptibility to this class of inhibitors.  The mutations conferring resistance mapped to a novel motif within the RSV L gene, which encodes the catalytic subunit of RSV polymerase.  This motif is distinct from the catalytic region of the L protein and bears some similarity to the nucleotide binding domain within nucleoside diphosphate kinases.  These findings lead to the hypothesis that this class of inhibitors may block synthesis of RSV mRNAs by inhibiting guanylylation of viral transcripts.  The authors show that short transcripts produced in the presence of inhibitor in vitro do not contain a 5' cap but, instead, are triphosphorylated, confirming this hypothesis.  These inhibitors constitute useful tools for elucidating the mol. mechanism of RSV capping and represent valid leads for the development of novel anti-RSV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIoHs26iOUQ7Vg90H21EOLACvtfcHk0ljihnDyiNUrlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWisbjN&md5=46e93fff53e2d22c832f5949fe967ef8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.20.13105-13115.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.20.13105-13115.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DMason%26aufirst%3DS.%2BW.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DLawetz%26aufirst%3DC.%26aulast%3DMcCollum%26aufirst%3DR.%2BS.%26aulast%3DDansereau%26aufirst%3DN.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DLapeyre%26aufirst%3DN.%26aulast%3DGaudette%26aufirst%3DY.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DMassariol%26aufirst%3DM.-J.%26aulast%3DDo%26aufirst%3DF.%26aulast%3DWhitehead%26aufirst%3DP.%26aulast%3DLamarre%26aufirst%3DL.%26aulast%3DScouten%26aufirst%3DE.%26aulast%3DBordeleau%26aufirst%3DJ.%26aulast%3DLandry%26aufirst%3DS.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DGulrez%2BFazal%26aufirst%3DG.%26aulast%3DSimoneau%26aufirst%3DB.%26atitle%3DInhibitors%2520of%2520respiratory%2520syncytial%2520virus%2520replication%2520target%2520cotranscriptional%2520mRNA%2520guanylylation%2520by%2520viral%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D13105%26epage%3D13115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sudo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shintani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, Y.</span><span> </span><span class="NLM_article-title">YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=125-131&author=K.+Sudoauthor=Y.+Miyazakiauthor=N.+Kojimaauthor=M.+Kobayashiauthor=H.+Suzukiauthor=M.+Shintaniauthor=Y.+Shimizu&title=YM-53403%2C+a+unique+anti-respiratory+syncytial+virus+agent+with+a+novel+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSudo%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DY.%26aulast%3DKojima%26aufirst%3DN.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DShintani%26aufirst%3DM.%26aulast%3DShimizu%26aufirst%3DY.%26atitle%3DYM-53403%252C%2520a%2520unique%2520anti-respiratory%2520syncytial%2520virus%2520agent%2520with%2520a%2520novel%2520mechanism%2520of%2520action%26jtitle%3DAntiviral%2520Res.%26date%3D2005%26volume%3D65%26spage%3D125%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Xiong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschenbrenner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiong-Yip, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moustakas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span> </span><span class="NLM_article-title">Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6789</span><span class="NLM_x">–</span> <span class="NLM_lpage">6793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6789-6793&author=H.+Xiongauthor=M.+Foulkauthor=L.+Aschenbrennerauthor=J.+Fanauthor=C.-L.+Tiong-Yipauthor=K.+D.+Johnsonauthor=D.+Moustakasauthor=P.+R.+Flemingauthor=D.+G.+Brownauthor=M.+Zhangauthor=D.+Fergusonauthor=D.+Wuauthor=Q.+Yu&title=Discovery+of+a+potent+respiratory+syncytial+virus+RNA+polymerase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DFoulk%26aufirst%3DM.%26aulast%3DAschenbrenner%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DTiong-Yip%26aufirst%3DC.-L.%26aulast%3DJohnson%26aufirst%3DK.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%26aulast%3DFleming%26aufirst%3DP.%2BR.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DQ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520respiratory%2520syncytial%2520virus%2520RNA%2520polymerase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6789%26epage%3D6793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Leyssen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyts, J.</span><span> </span><span class="NLM_article-title">The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1128%2FJVI.79.3.1943-1947.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=15650220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=1943-1947&author=P.+Leyssenauthor=J.+Balzariniauthor=E.+De+Clercqauthor=J.+Neyts&title=The+predominant+mechanism+by+which+ribavirin+exerts+its+antiviral+activity+in+vitro+against+flaviviruses+and+paramyxoviruses+is+mediated+by+inhibition+of+IMP+dehydrogenase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase</span></div><div class="casAuthors">Leyssen, Pieter; Balzarini, Jan; De Clercq, Erik; Neyts, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1943-1947</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">It is not yet clear to what extent depletion of intracellular GTP pools contributes to the antiviral activity of ribavirin.  Therefore, the antiviral activities of (i) ribavirin, (ii) its 5-ethynyl analog, 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR), and (iii) mycophenolic acid (MPA) (a compd. that inhibits only cellular IMP dehydrogenase activity) were studied on the replication of flaviviruses and paramyxoviruses.  In addn., the effects of these three compds. on intracellular GTP pools were assessed.  A linear correlation was obsd. over a broad concn. range between the antiviral activities of ribavirin, EICAR, and MPA and the effects of these compds. on GTP pool depletion.  When the 50% effective concns. (EC50s) for the antiviral activities of ribavirin, EICAR, and MPA were plotted against the resp. EC50 values for GTP pool depletion, a linear correlation was calcd.  These data provide compelling evidence that the predominant mechanism of action of ribavirin in vitro against flavi- and paramyxoviruses is based on inhibition of cellular IMP dehydrogenase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq--VWj2w0ZRrVg90H21EOLACvtfcHk0ljihnDyiNUrlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCisro%253D&md5=be4ce47865e8b4dca75f473c17e3ad10</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.3.1943-1947.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.3.1943-1947.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLeyssen%26aufirst%3DP.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DNeyts%26aufirst%3DJ.%26atitle%3DThe%2520predominant%2520mechanism%2520by%2520which%2520ribavirin%2520exerts%2520its%2520antiviral%2520activity%2520in%2520vitro%2520against%2520flaviviruses%2520and%2520paramyxoviruses%2520is%2520mediated%2520by%2520inhibition%2520of%2520IMP%2520dehydrogenase%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D1943%26epage%3D1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, D. M.</span><span> </span><span class="NLM_article-title">Ribavirin in the treatment of chronic hepatitis C</span> <span class="citation_source-journal">J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1111%2Fj.1440-1746.2008.05398.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=18565019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFyls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=844-855&author=P.+Martinauthor=D.+M.+Jensen&title=Ribavirin+in+the+treatment+of+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin in the treatment of chronic hepatitis C</span></div><div class="casAuthors">Martin, Paul; Jensen, Donald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">844-855</span>CODEN:
                <span class="NLM_cas:coden">JGHEEO</span>;
        ISSN:<span class="NLM_cas:issn">0815-9319</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Background and Aim: Current practice guidelines recommend that individuals chronically infected with the hepatitis C virus (HCV) be treated with pegylated interferon plus ribavirin.  Ribavirin, however, is assocd. with serious adverse events (AE), esp. anemia.  We review its mechanism of action, its importance in treating chronic hepatitis C (CHC) patients, the AE assocd. with its use, and techniques used to lessen these AE.  Methods: Medline searches were performed using the keywords ribavirin and hepatitis, together with the keywords mechanism, anemia, liver transplant, renal function, pharmacokinetics, and dose redn.  Searches of abstrs. of recent Digestive Diseases Week, American Assocn. for the Study of Liver Diseases, and European Assocn. for the Study of Liver Diseases meetings were also performed.  Results: Ribavirin may be effective in treating CHC by affecting the virus or the host; for example by inducing viral mutations, blocking cellular enzymes, or affecting the host immune response.  Although the pegylated interferons are the primary drugs used to treat CHC, a combination with ribavirin is more effective than pegylated interferon alone.  Ribavirin-assocd. AE may be lessened by ribavirin dose redns. and by maintenance of the hematocrit.  Conclusions: Treatments of ribavirin toxicities, esp. anemia, can allow patients to continue full-dose combination therapy with peginterferon and ribavirin, enhancing their probability of attaining a sustained virol. response (SVR).  Treatment of CHC should be tailored to individual patients, esp. those with renal dysfunction, and should include agents that treat the side-effects of CHC treatment.  Monitoring of plasma ribavirin concns. during treatment may help in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopgTg12R89U7Vg90H21EOLACvtfcHk0lj7ep8BPEzHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFyls7o%253D&md5=e01104f2f31f1134b8ca41d9fb133e5c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1746.2008.05398.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1746.2008.05398.x%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DD.%2BM.%26atitle%3DRibavirin%2520in%2520the%2520treatment%2520of%2520chronic%2520hepatitis%2520C%26jtitle%3DJ.%2520Gastroenterol.%2520Hepatol.%26date%3D2008%26volume%3D23%26spage%3D844%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Crotty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andino, R.</span><span> </span><span class="NLM_article-title">Ribavirin’s antiviral mechanism of action: lethal mutagenesis?</span> <span class="citation_source-journal">J. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1007%2Fs00109-001-0308-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=11907645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFOlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=86-95&author=S.+Crottyauthor=C.+Cameronauthor=R.+Andino&title=Ribavirin%E2%80%99s+antiviral+mechanism+of+action%3A+lethal+mutagenesis%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin's antiviral mechanism of action: Lethal mutagenesis?</span></div><div class="casAuthors">Crotty, Shane; Cameron, Craig; Andino, Raul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">86-95</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  Ribavirin, an antiviral drug discovered in 1972, is interesting and important for three reasons: (a) it exhibits antiviral activity against a broad range of RNA viruses; (b) it is currently used clin. to treat hepatitis C virus infections, respiratory syncytial virus infections, and Lassa fever virus infections; and (c) ribavirin's mechanism of action has remained unclear for many years.  Here we recount the history of ribavirin and review recent reports regarding ribavirin's mechanism of action, including our studies demonstrating that ribavirin is an RNA virus mutagen and ribavirin's primary antiviral mechanism of action against a model RNA virus is via lethal mutagenesis of the RNA virus genomes.  Implications for the development of improved versions of ribavirin and for the development of novel antiviral drugs are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0CTPDtNCY_LVg90H21EOLACvtfcHk0lj7ep8BPEzHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFOlsrc%253D&md5=478924c4b358db2f39eabf02f112ffbb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00109-001-0308-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-001-0308-0%26sid%3Dliteratum%253Aachs%26aulast%3DCrotty%26aufirst%3DS.%26aulast%3DCameron%26aufirst%3DC.%26aulast%3DAndino%26aufirst%3DR.%26atitle%3DRibavirin%25E2%2580%2599s%2520antiviral%2520mechanism%2520of%2520action%253A%2520lethal%2520mutagenesis%253F%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2002%26volume%3D80%26spage%3D86%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Andrei, C.; De Clercq, E.; Snoeck, R.; Viral, D. N. A.</span><span> </span><span class="NLM_article-title">Polymerase Inhibitors</span>. In  <span class="citation_source-book">Viral Genome Replication</span>; <span class="NLM_contrib-group">Cameron, C. E.; Gotte, M.; Raney, K.</span>, Eds.; <span class="NLM_publisher-name">Springer Science and Business Media</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Chapter 22.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1007%2Fb135974_22" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+Andrei&author=E.+De+Clercq&author=R.+Snoeck&author=D.+N.+A.+Viralauthor=C.+E.+Cameron&author=M.+Gotte&author=K.+Raney&title=Viral+Genome+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fb135974_22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252Fb135974_22%26sid%3Dliteratum%253Aachs%26aulast%3DAndrei%26aufirst%3DC.%26atitle%3DPolymerase%2520Inhibitors%26btitle%3DViral%2520Genome%2520Replication%26aulast%3DCameron%26aufirst%3DC.%2BE.%26pub%3DSpringer%2520Science%2520and%2520Business%2520Media%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Nelson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferenci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herring, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pockros, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomason, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G.</span><span> </span><span class="NLM_article-title">Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients</span> <span class="citation_source-journal">Ann. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=22166557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFWmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=15-31&author=D.+R.+Nelsonauthor=S.+Zeuzemauthor=P.+Andreoneauthor=P.+Ferenciauthor=R.+Herringauthor=D.+M.+Jensenauthor=P.+Marcellinauthor=P.+J.+Pockrosauthor=M.+Rodr%C3%ADguez-Torresauthor=L.+Rossaroauthor=V.+K.+Rustgiauthor=T.+Sepeauthor=M.+Sulkowskiauthor=I.+R.+Thomasonauthor=E.+M.+Yoshidaauthor=A.+Chanauthor=G.+Hill&title=Balapiravir+plus+peginterferon+alfa-2a+%2840KD%29%2Fribavirin+in+a+randomized+trial+of+hepatitis+C+genotype+1+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients</span></div><div class="casAuthors">Nelson, David R.; Zeuzem, Stefan; Andreone, Pietro; Ferenci, Peter; Herring, Robert; Jensen, Donald M.; Marcellin, Patrick; Pockros, Paul J.; Rodriguez-Torres, Maribel; Rossaro, Lorenzo; Rustgi, Vinod K.; Sepe, Thomas; Sulkowski, Mark; Thomason, Isaac R.; Yoshida, Eric M.; Chan, Anna; Hill, George</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hepatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-31</span>CODEN:
                <span class="NLM_cas:coden">AHNEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1665-2681</span>.
    
            (<span class="NLM_cas:orgname">Mexican Association of Hepatology</span>)
        </div><div class="casAbstract">Balapiravir (R1626, RG1626) is the prodrug of a nucleoside analog inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479).  This phase 2, double-blind international trial evaluated the optimal treatment regimen of balapiravir plus peginterferon alfa-2a (40KD)/ribavirin.  Treatment-naive genotype 1 patients (N = 516) were randomized to one of seven treatment groups in which they received balapiravir 500, 1000, or 1500 mg twice daily, peginterferon alfa-2a (40KD) 180 or 90 μg/wk and ribavirin 1000/1200 mg/day or peginterferon alfa-2a (40KD)/ribavirin.  The planned treatment duration with balapiravir was reduced from 24 to 12 wk due to safety concerns.  The percentage of patients with undetectable HCV RNA was consistently higher in all balapiravir groups from week 2 to 12.  However, high rates of dose modifications and discontinuations of one/all study drugs compromised the efficacy assessment and resulted in similar sustained virol. response rates in the balapiravir groups (range 32-50%) and the peginterferon alfa-2a (40KD)/ribavirin group (43%).  Balapiravir was discontinued for safety reasons in 28-36% of patients (most often for lymphopenia) and the percentage of patients with serious adverse events (esp. hematol., infection, ocular events) was dose related.  Serious hematol. adverse events (particularly neutropenia, lymphopenia) were more common in balapiravir recipients.  Two deaths in the balapiravir/peginterferon alfa-2a/ribavirin combination groups were considered possibly related to study medication.  Further development of balapiravir for the treatment of chronic hepatitis C has been halted because of the unacceptable benefit to risk ratio revealed in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRO0zUfNS5ILVg90H21EOLACvtfcHk0lj7ep8BPEzHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFWmtQ%253D%253D&md5=cc59339beba23a752f77cc3c7e5d0c3c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BR.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DAndreone%26aufirst%3DP.%26aulast%3DFerenci%26aufirst%3DP.%26aulast%3DHerring%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DD.%2BM.%26aulast%3DMarcellin%26aufirst%3DP.%26aulast%3DPockros%26aufirst%3DP.%2BJ.%26aulast%3DRodr%25C3%25ADguez-Torres%26aufirst%3DM.%26aulast%3DRossaro%26aufirst%3DL.%26aulast%3DRustgi%26aufirst%3DV.%2BK.%26aulast%3DSepe%26aufirst%3DT.%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DThomason%26aufirst%3DI.%2BR.%26aulast%3DYoshida%26aufirst%3DE.%2BM.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DG.%26atitle%3DBalapiravir%2520plus%2520peginterferon%2520alfa-2a%2520%252840KD%2529%252Fribavirin%2520in%2520a%2520randomized%2520trial%2520of%2520hepatitis%2520C%2520genotype%25201%2520patients%26jtitle%3DAnn.%2520Hepatol.%26date%3D2012%26volume%3D11%26spage%3D15%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">DeVincenzo, J.; Fathi, H.; McClure, M.; Westland, C.; Chanda, S.; Lambkin-Williams, R.; Smith, P.; Harrison, L.; Symons, J.; Scaglioni-Weinlich, C.; Zhang, Q.; Nieforth, K.; Beigelman, L.; Blatt, L.; Fry, J.</span><span> </span><span class="NLM_article-title">Treatment with oral ALS-008176, a nucleoside analog, rapidly reduces RSV viral load and clinical disease severity in a healthy volunteer challenge study</span>. <span class="NLM_conf-name">IDWeek</span>, <span class="NLM_conf-loc">Philadelphia, PA</span>, <span class="NLM_conf-date">October 8-12, 2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DeVincenzo%2C+J.%3B+Fathi%2C+H.%3B+McClure%2C+M.%3B+Westland%2C+C.%3B+Chanda%2C+S.%3B+Lambkin-Williams%2C+R.%3B+Smith%2C+P.%3B+Harrison%2C+L.%3B+Symons%2C+J.%3B+Scaglioni-Weinlich%2C+C.%3B+Zhang%2C+Q.%3B+Nieforth%2C+K.%3B+Beigelman%2C+L.%3B+Blatt%2C+L.%3B+Fry%2C+J.+Treatment+with+oral+ALS-008176%2C+a+nucleoside+analog%2C+rapidly+reduces+RSV+viral+load+and+clinical+disease+severity+in+a+healthy+volunteer+challenge+study.+IDWeek%2C+Philadelphia%2C+PA%2C+October+8-12%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDeVincenzo%26aufirst%3DJ.%26atitle%3DTreatment%2520with%2520oral%2520ALS-008176%252C%2520a%2520nucleoside%2520analog%252C%2520rapidly%2520reduces%2520RSV%2520viral%2520load%2520and%2520clinical%2520disease%2520severity%2520in%2520a%2520healthy%2520volunteer%2520challenge%2520study" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomgren, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granycome, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laxton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrett, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span> </span><span class="NLM_article-title">Design, synthesis and antiviral properties of 4′-substituted ribonucleosides as inhibitors of hepatitis C virus placation: The discovery of R1479</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2570</span><span class="NLM_x">–</span> <span class="NLM_lpage">2576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2570-2576&author=D.+B.+Smithauthor=J.+A.+Martinauthor=K.+Klumppauthor=S.+J.+Bakerauthor=P.+A.+Blomgrenauthor=R.+Devosauthor=C.+Granycomeauthor=J.+Hangauthor=C.+J.+Hobbsauthor=W.-R.+Jiangauthor=C.+Laxtonauthor=S.+Le+Pogamauthor=V.+Levequeauthor=H.+Maauthor=G.+Maileauthor=J.+H.+Merrettauthor=A.+Pichotaauthor=K.+Sarmaauthor=M.+Smithauthor=S.+Swallowauthor=J.+Symonsauthor=D.+Veseyauthor=I.+Najeraauthor=N.+Cammack&title=Design%2C+synthesis+and+antiviral+properties+of+4%E2%80%B2-substituted+ribonucleosides+as+inhibitors+of+hepatitis+C+virus+placation%3A+The+discovery+of+R1479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBlomgren%26aufirst%3DP.%2BA.%26aulast%3DDevos%26aufirst%3DR.%26aulast%3DGranycome%26aufirst%3DC.%26aulast%3DHang%26aufirst%3DJ.%26aulast%3DHobbs%26aufirst%3DC.%2BJ.%26aulast%3DJiang%26aufirst%3DW.-R.%26aulast%3DLaxton%26aufirst%3DC.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMerrett%26aufirst%3DJ.%2BH.%26aulast%3DPichota%26aufirst%3DA.%26aulast%3DSarma%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DCammack%26aufirst%3DN.%26atitle%3DDesign%252C%2520synthesis%2520and%2520antiviral%2520properties%2520of%25204%25E2%2580%25B2-substituted%2520ribonucleosides%2520as%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520placation%253A%2520The%2520discovery%2520of%2520R1479%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2570%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaynov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sund, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinho, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltseva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkenstock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunnar Johansson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span> </span><span class="NLM_article-title">The design, synthesis and antiviral activity of 4′-azidocytidine analogues against hepatitis C virus replication: the discovery of 4′-azidoarabinocytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800981y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=219-223&author=D.+B.+Smithauthor=G.+Kalaynovauthor=C.+Sundauthor=A.+Winqvistauthor=P.+Pinhoauthor=T.+Maltsevaauthor=V.+Morissonauthor=S.+Rajyaguruauthor=S.+Le+Pogamauthor=I.+Najeraauthor=K.+Benkenstockauthor=X.-X.+Zhouauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+Gunnar+Johanssonauthor=K.+Klumppauthor=M.+Smith&title=The+design%2C+synthesis+and+antiviral+activity+of+4%E2%80%B2-azidocytidine+analogues+against+hepatitis+C+virus+replication%3A+the+discovery+of+4%E2%80%B2-azidoarabinocytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm800981y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800981y%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalaynov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DC.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DPinho%26aufirst%3DP.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DMorisson%26aufirst%3DV.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DBenkenstock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGunnar%2BJohansson%26aufirst%3DN.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520design%252C%2520synthesis%2520and%2520antiviral%2520activity%2520of%25204%25E2%2580%25B2-azidocytidine%2520analogues%2520against%2520hepatitis%2520C%2520virus%2520replication%253A%2520the%2520discovery%2520of%25204%25E2%2580%25B2-azidoarabinocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D219%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalayanov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sund, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltseva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V. J-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ann C. Kaiser, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span> </span><span class="NLM_article-title">The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4′-azidocytidine against hepatitis C virus replication: the discovery of 4′-azido-2′-deoxy-2′-fluorocytidine and 4′-azido-2′-dideoxy-2′,2′-difluorocytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2971</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801595c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2971-2978&author=D.+B.+Smithauthor=G.+Kalayanovauthor=C.+Sundauthor=A.+Winqvistauthor=T.+Maltsevaauthor=V.+J-P.+Levequeauthor=S.+Rajyaguruauthor=S.+Le+Pogamauthor=I.+Najeraauthor=K.+Benkestockauthor=X.-X.+Zhouauthor=A.+C.+Ann+C.+Kaiserauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+G.+Johanssonauthor=K.+Klumppauthor=M.+Smith&title=The+design%2C+synthesis%2C+and+antiviral+activity+of+monofluoro+and+difluoro+analogues+of+4%E2%80%B2-azidocytidine+against+hepatitis+C+virus+replication%3A+the+discovery+of+4%E2%80%B2-azido-2%E2%80%B2-deoxy-2%E2%80%B2-fluorocytidine+and+4%E2%80%B2-azido-2%E2%80%B2-dideoxy-2%E2%80%B2%2C2%E2%80%B2-difluorocytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm801595c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801595c%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalayanov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DC.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DLeveque%26aufirst%3DV.%2BJ-P.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DAnn%2BC.%2BKaiser%26aufirst%3DA.%2BC.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DJohansson%26aufirst%3DN.%2BG.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520design%252C%2520synthesis%252C%2520and%2520antiviral%2520activity%2520of%2520monofluoro%2520and%2520difluoro%2520analogues%2520of%25204%25E2%2580%25B2-azidocytidine%2520against%2520hepatitis%2520C%2520virus%2520replication%253A%2520the%2520discovery%2520of%25204%25E2%2580%25B2-azido-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluorocytidine%2520and%25204%25E2%2580%25B2-azido-2%25E2%2580%25B2-dideoxy-2%25E2%2580%25B2%252C2%25E2%2580%25B2-difluorocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2971%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Nomura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, A.</span><span> </span><span class="NLM_article-title">Nucleosides and Nucleotides. 185. Synthesis and biological activities of 4′α-<i>C</i>-branched-chain sugar pyrimidine nucleosides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2901</span><span class="NLM_x">–</span> <span class="NLM_lpage">2908</span><div class="note"><p class="first last">25-1</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm990050i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2901-2908&author=M.+Nomuraauthor=S.+Shutoauthor=M.+Tanakaauthor=T.+Sasakiauthor=S.+Moriauthor=S.+Shigetaauthor=A.+Matsuda&title=Nucleosides+and+Nucleotides.+185.+Synthesis+and+biological+activities+of+4%E2%80%B2%CE%B1-C-branched-chain+sugar+pyrimidine+nucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm990050i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990050i%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DM.%26aulast%3DShuto%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DShigeta%26aufirst%3DS.%26aulast%3DMatsuda%26aufirst%3DA.%26atitle%3DNucleosides%2520and%2520Nucleotides.%2520185.%2520Synthesis%2520and%2520biological%2520activities%2520of%25204%25E2%2580%25B2%25CE%25B1-C-branched-chain%2520sugar%2520pyrimidine%2520nucleosides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2901%26epage%3D2908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">O-Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eugui, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRoberts, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheyden, J. P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurz, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, K. A. M.</span><span> </span><span class="NLM_article-title">4′-Substituted nucleosides as inhibitors of HIV: an unusual oxetane derivative</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1992&pages=41-44&author=C.+O-Yangauthor=W.+Kurzauthor=E.+M.+Euguiauthor=M.+J.+McRobertsauthor=J.+P.+H.+Verheydenauthor=L.+J.+Kurzauthor=K.+A.+M.+Walker&title=4%E2%80%B2-Substituted+nucleosides+as+inhibitors+of+HIV%3A+an+unusual+oxetane+derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO-Yang%26aufirst%3DC.%26aulast%3DKurz%26aufirst%3DW.%26aulast%3DEugui%26aufirst%3DE.%2BM.%26aulast%3DMcRoberts%26aufirst%3DM.%2BJ.%26aulast%3DVerheyden%26aufirst%3DJ.%2BP.%2BH.%26aulast%3DKurz%26aufirst%3DL.%2BJ.%26aulast%3DWalker%26aufirst%3DK.%2BA.%2BM.%26atitle%3D4%25E2%2580%25B2-Substituted%2520nucleosides%2520as%2520inhibitors%2520of%2520HIV%253A%2520an%2520unusual%2520oxetane%2520derivative%26jtitle%3DTetrahedron%2520Lett.%26date%3D1992%26volume%3D33%26spage%3D41%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span> </span><span class="NLM_article-title">Synthesis and anti-HIV activity of 2′-deoxy-2′-fluoro-4′-<i>C</i>-ethynyl nucleoside analogs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4053</span><span class="NLM_x">–</span> <span class="NLM_lpage">4056</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4053-4056&author=Q.+Wangauthor=Y.+Liauthor=C.+Songauthor=K.+Qianauthor=C.-H.+Chenauthor=K.-H.+Leeauthor=J.+Chang&title=Synthesis+and+anti-HIV+activity+of+2%E2%80%B2-deoxy-2%E2%80%B2-fluoro-4%E2%80%B2-C-ethynyl+nucleoside+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DLee%26aufirst%3DK.-H.%26aulast%3DChang%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520anti-HIV%2520activity%2520of%25202%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluoro-4%25E2%2580%25B2-C-ethynyl%2520nucleoside%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4053%26epage%3D4056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Haraguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span> </span><span class="NLM_article-title">Ring opening of 4′,5′-epoxynucleosides: a novel stereoselective entry to 4′-<i>C</i>-branched nucleosides</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1402</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol020259h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=1399-1402&author=K.+Haraguchiauthor=S.+Takedaauthor=H.+Tanaka&title=Ring+opening+of+4%E2%80%B2%2C5%E2%80%B2-epoxynucleosides%3A+a+novel+stereoselective+entry+to+4%E2%80%B2-C-branched+nucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fol020259h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol020259h%26sid%3Dliteratum%253Aachs%26aulast%3DHaraguchi%26aufirst%3DK.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DH.%26atitle%3DRing%2520opening%2520of%25204%25E2%2580%25B2%252C5%25E2%2580%25B2-epoxynucleosides%253A%2520a%2520novel%2520stereoselective%2520entry%2520to%25204%25E2%2580%25B2-C-branched%2520nucleosides%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D1399%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Richards, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheyden, J. P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span> </span><span class="NLM_article-title">Synthesis of 4’-methoxyadenosine and related compounds</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1982&pages=315-330&author=C.+M.+Richardsauthor=J.+P.+H.+Verheydenauthor=J.+G.+Moffat&title=Synthesis+of+4%E2%80%99-methoxyadenosine+and+related+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DC.%2BM.%26aulast%3DVerheyden%26aufirst%3DJ.%2BP.%2BH.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26atitle%3DSynthesis%2520of%25204%25E2%2580%2599-methoxyadenosine%2520and%2520related%2520compounds%26jtitle%3DCarbohydr.%2520Res.%26date%3D1982%26volume%3D100%26spage%3D315%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Brandl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birudaraj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micaela Reddy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfredson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrabee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadig, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washington, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span> </span><span class="NLM_article-title">Physicochemical properties of the nucleoside prodrug R1626 leading to high oral bioavailability</span> <span class="citation_source-journal">Drug Dev. Ind. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1080%2F03639040701836636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=18612909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVaisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2008&pages=683-691&author=M.+Brandlauthor=X.+Wuauthor=M.+Holperauthor=L.+Hongauthor=Z.+Jiaauthor=R.+Birudarajauthor=M.+Micaela+Reddyauthor=T.+Alfredsonauthor=T.+Tranauthor=S.+Larrabeeauthor=X.+Hadigauthor=K.+Sarmaauthor=C.+Washingtonauthor=G.+Hillauthor=D.+B.+Smith&title=Physicochemical+properties+of+the+nucleoside+prodrug+R1626+leading+to+high+oral+bioavailability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical Properties of the Nucleoside Prodrug R1626 Leading to High Oral Bioavailability</span></div><div class="casAuthors">Brandl, Michael; Wu, Xiaoyang; Holper, Marites; Hong, Lei; Jia, Zhongjiang; Birudaraj, Raj; Reddy, Micaela; Alfredson, Tom; Tran, Tony; Larrabee, Susan; Hadig, Xu; Sarma, Keshab; Washington, Carla; Hill, George; Smith, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Development and Industrial Pharmacy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">683-691</span>CODEN:
                <span class="NLM_cas:coden">DDIPD8</span>;
        ISSN:<span class="NLM_cas:issn">0363-9045</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The nucleoside analog R1479 is a potent and highly selective inhibitor of NS5b-directed hepatitis C virus (HCV) RNA polymerase in vitro.  Because of its limited permeability, lipophilic prodrugs of R1479 were screened.  Selection of the prodrug involved optimization of soly., permeability, and stability parameters.  R1626 has dissocn. const., intrinsic soly., log partition coeff. (n-octanol water), and Caco-2 permeability of 3.62, 0.19 mg/mL, 2.45, and 14.95 × 10-6 cm/s, resp.  The hydrolysis of the prodrug is significantly faster in the Caco-2 expts. than in hydrolytic expts., suggesting that the hydrolysis is catalyzed by enzymes in the cellular membrane.  Using GastroPlus, the phys. properties of R1626 successfully predict the dose dependence of the pharmacokinetics in humans previously studied.  The program predicts that if the particle size of R1626 is less than 25 μm, it will be well absorbed.  Prodrugs with a soly. of greater than 100 μg/mL and permeability in the Caco-2 assay greater than 3 × 10-6 cm/s are expected to achieve a high fraction absorbed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn2JvGjiHPNLVg90H21EOLACvtfcHk0lhAcZBVVEgegw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVaisro%253D&md5=222ee77af8ae55778417c97296da6df6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F03639040701836636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03639040701836636%26sid%3Dliteratum%253Aachs%26aulast%3DBrandl%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHolper%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DBirudaraj%26aufirst%3DR.%26aulast%3DMicaela%2BReddy%26aufirst%3DM.%26aulast%3DAlfredson%26aufirst%3DT.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DLarrabee%26aufirst%3DS.%26aulast%3DHadig%26aufirst%3DX.%26aulast%3DSarma%26aufirst%3DK.%26aulast%3DWashington%26aufirst%3DC.%26aulast%3DHill%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26atitle%3DPhysicochemical%2520properties%2520of%2520the%2520nucleoside%2520prodrug%2520R1626%2520leading%2520to%2520high%2520oral%2520bioavailability%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2008%26volume%3D34%26spage%3D683%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amours, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommadossi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2′-<i>C</i>-methylcytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6614</span><span class="NLM_x">–</span> <span class="NLM_lpage">6620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6614-6620&author=C.+Pierraauthor=A.+Amadorauthor=S.+Benzariaauthor=E.+Cretton-Scottauthor=M.+D%E2%80%99Amoursauthor=J.+Maoauthor=S.+Mathieuauthor=A.+Moussaauthor=E.+G.+Bridgesauthor=D.+N.+Standringauthor=J.+P.+Sommadossiauthor=R.+Storerauthor=G.+Gosselin&title=Synthesis+and+pharmacokinetics+of+valopicitabine+%28NM283%29%2C+an+efficient+prodrug+of+the+potent+anti-HCV+agent+2%E2%80%B2-C-methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm0603623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603623%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amours%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DBridges%26aufirst%3DE.%2BG.%26aulast%3DStandring%26aufirst%3DD.%2BN.%26aulast%3DSommadossi%26aufirst%3DJ.%2BP.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520pharmacokinetics%2520of%2520valopicitabine%2520%2528NM283%2529%252C%2520an%2520efficient%2520prodrug%2520of%2520the%2520potent%2520anti-HCV%2520agent%25202%25E2%2580%25B2-C-methylcytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6614%26epage%3D6620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mason, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawetz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudette, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dô, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scouten, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liuzzi, M.</span><span> </span><span class="NLM_article-title">Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">4758</span><span class="NLM_x">–</span> <span class="NLM_lpage">4767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=4758-4767&author=S.+W.+Masonauthor=C.+Lawetzauthor=Y.+Gaudetteauthor=F.+D%C3%B4author=E.+Scoutenauthor=L.+Lagac%C3%A9author=B.+Simoneauauthor=M.+Liuzzi&title=Polyadenylation-dependent+screening+assay+for+respiratory+syncytial+virus+RNA+transcriptase+activity+and+identification+of+an+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DS.%2BW.%26aulast%3DLawetz%26aufirst%3DC.%26aulast%3DGaudette%26aufirst%3DY.%26aulast%3DD%25C3%25B4%26aufirst%3DF.%26aulast%3DScouten%26aufirst%3DE.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DLiuzzi%26aufirst%3DM.%26atitle%3DPolyadenylation-dependent%2520screening%2520assay%2520for%2520respiratory%2520syncytial%2520virus%2520RNA%2520transcriptase%2520activity%2520and%2520identification%2520of%2520an%2520inhibitor%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3D4758%26epage%3D4767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Deval, J.; Hong, J.; Wang, G.; Taylor, J.; Smith, L.; Fung, A.; Stevens, S.; Liu, H.; Jin, Z.; Dyatkina, N.; Prhavc, M.; Serebryany, V.; Jyanwei Liu, J.; Smith, D. B.; Yuen Tam, Y.; Zhang, Q.; Chanda, S. M.; Blatt, L. B.; Symons, J. A.; Beigelman, L.</span><span> </span><span class="NLM_article-title">ALS-8176 is an orally bioavailable nucleoside analog acting as a chain terminator of respiratory syncytial virus rna polymerase activity</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Deval%2C+J.%3B+Hong%2C+J.%3B+Wang%2C+G.%3B+Taylor%2C+J.%3B+Smith%2C+L.%3B+Fung%2C+A.%3B+Stevens%2C+S.%3B+Liu%2C+H.%3B+Jin%2C+Z.%3B+Dyatkina%2C+N.%3B+Prhavc%2C+M.%3B+Serebryany%2C+V.%3B+Jyanwei+Liu%2C+J.%3B+Smith%2C+D.+B.%3B+Yuen+Tam%2C+Y.%3B+Zhang%2C+Q.%3B+Chanda%2C+S.+M.%3B+Blatt%2C+L.+B.%3B+Symons%2C+J.+A.%3B+Beigelman%2C+L.+ALS-8176+is+an+orally+bioavailable+nucleoside+analog+acting+as+a+chain+terminator+of+respiratory+syncytial+virus+rna+polymerase+activity.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DDeval%26aufirst%3DJ.%26atitle%3DALS-8176%2520is%2520an%2520orally%2520bioavailable%2520nucleoside%2520analog%2520acting%2520as%2520a%2520chain%2520terminator%2520of%2520respiratory%2520syncytial%2520virus%2520rna%2520polymerase%2520activity" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Arnold, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smidansky, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireeva, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vela, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babusis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barauskus, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnatt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashlev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, C. E.</span><span> </span><span class="NLM_article-title">Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides</span> <span class="citation_source-journal">PLOS Pathogens</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=e1003030&author=J.+J.+Arnoldauthor=S.+D.+Sharmaauthor=J.+Y.+Fengauthor=A.+S.+Rayauthor=E.+D.+Smidanskyauthor=M.+L.+Kireevaauthor=A.+Choauthor=J.+Perryauthor=J.+E.+Velaauthor=Y.+Parkauthor=Y.+Xuauthor=Y.+Tianauthor=D.+Babusisauthor=O.+Barauskusauthor=B.+R.+Petersonauthor=A.+Gnattauthor=M.+Kashlevauthor=W.+Zhongauthor=E.+Craigauthor=C.+E.+Cameron&title=Sensitivity+of+mitochondrial+transcription+and+resistance+of+RNA+polymerase+II+dependent+nuclear+transcription+to+antiviral+ribonucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DJ.%2BJ.%26aulast%3DSharma%26aufirst%3DS.%2BD.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DSmidansky%26aufirst%3DE.%2BD.%26aulast%3DKireeva%26aufirst%3DM.%2BL.%26aulast%3DCho%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DVela%26aufirst%3DJ.%2BE.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DBarauskus%26aufirst%3DO.%26aulast%3DPeterson%26aufirst%3DB.%2BR.%26aulast%3DGnatt%26aufirst%3DA.%26aulast%3DKashlev%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DCraig%26aufirst%3DE.%26aulast%3DCameron%26aufirst%3DC.%2BE.%26atitle%3DSensitivity%2520of%2520mitochondrial%2520transcription%2520and%2520resistance%2520of%2520RNA%2520polymerase%2520II%2520dependent%2520nuclear%2520transcription%2520to%2520antiviral%2520ribonucleosides%26jtitle%3DPLOS%2520Pathogens%26date%3D2012%26volume%3D8%26spage%3De1003030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Malykhina, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yednak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivo, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeples, M. E.</span><span> </span><span class="NLM_article-title">A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">4792</span><span class="NLM_x">–</span> <span class="NLM_lpage">4801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5017279&amp;key=10.1128%2FJVI.02399-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm5017279&amp;key=21389127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5017279&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Wlt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2011&pages=4792-4801&author=O.+Malykhinaauthor=M.+A.+Yednakauthor=P.+L.+Collinsauthor=P.+D.+Olivoauthor=M.+E.+Peeples&title=A+respiratory+syncytial+virus+replicon+that+is+noncytotoxic+and+capable+of+long-term+foreign+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression</span></div><div class="casAuthors">Malykhina, Olga; Yednak, Mark A.; Collins, Peter L.; Olivo, Paul D.; Peeples, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4792-4801</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Respiratory syncytial virus (RSV) infection of most cultured cell lines causes cell-cell fusion and death.  Cell fusion is caused by the fusion (F) glycoprotein and is clearly cytopathic, but other aspects of RSV infection may also contribute to cytopathol.  To investigate this possibility, we generated an RSV replicon that lacks all three of its glycoprotein genes and so cannot cause cell-cell fusion or virus spread.  This replicon includes a green fluorescent protein gene and an antibiotic resistance gene to enable detection and selection of replicon-contg. cells.  Adaptive mutations in the RSV replicon were not required for replicon maintenance.  Cells contg. the replicon could be cloned and passaged many times in the absence of antibiotic selection, with 99% or more of the cells retaining the replicon after each cell division.  Transient expression of the F and G (attachment) glycoproteins supported the prodn. of virions that could transfer the replicon into most cell lines tested.  Since the RSV replicon is not toxic to these cultured cells and does not affect their rate of cell division, none of the 8 internal viral proteins, the viral RNA transcripts, or the host response to these mols. or their activities is cytopathic.  However, the level of replicon genome and gene expression is controlled in some manner well below that of complete virus and, as such, might avoid cytotoxicity.  RSV replicons could be useful for cytoplasmic gene expression in vitro and in vivo and for screening for compds. active against the viral polymerase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8hxZsD49u17Vg90H21EOLACvtfcHk0lgJ4T9JifIJPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Wlt7fN&md5=e4eb52f351eca99dbe8366b493ff9aeb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1128%2FJVI.02399-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02399-10%26sid%3Dliteratum%253Aachs%26aulast%3DMalykhina%26aufirst%3DO.%26aulast%3DYednak%26aufirst%3DM.%2BA.%26aulast%3DCollins%26aufirst%3DP.%2BL.%26aulast%3DOlivo%26aufirst%3DP.%2BD.%26aulast%3DPeeples%26aufirst%3DM.%2BE.%26atitle%3DA%2520respiratory%2520syncytial%2520virus%2520replicon%2520that%2520is%2520noncytotoxic%2520and%2520capable%2520of%2520long-term%2520foreign%2520gene%2520expression%26jtitle%3DJ.%2520Virol.%26date%3D2011%26volume%3D85%26spage%3D4792%26epage%3D4801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Hertel, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroin, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tustin, J. M.</span><span> </span><span class="NLM_article-title">Synthesis of 2-deoxy-2,2-difluoro-<span class="smallcaps smallerCapital">d</span>-ribose and 2-deoxy-2,2-difluoro-<span class="smallcaps smallerCapital">d</span>-ribofuranosyl nucleosides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2406</span><span class="NLM_x">–</span> <span class="NLM_lpage">2409</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00246a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=2406-2409&author=L.+W.+Hertelauthor=J.+S.+Kroinauthor=J.+W.+Misnerauthor=J.+M.+Tustin&title=Synthesis+of+2-deoxy-2%2C2-difluoro-d-ribose+and+2-deoxy-2%2C2-difluoro-d-ribofuranosyl+nucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo00246a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00246a002%26sid%3Dliteratum%253Aachs%26aulast%3DHertel%26aufirst%3DL.%2BW.%26aulast%3DKroin%26aufirst%3DJ.%2BS.%26aulast%3DMisner%26aufirst%3DJ.%2BW.%26aulast%3DTustin%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%25202-deoxy-2%252C2-difluoro-d-ribose%2520and%25202-deoxy-2%252C2-difluoro-d-ribofuranosyl%2520nucleosides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D2406%26epage%3D2409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Martínez-Montero, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleavey, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-Pintado, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindovska, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Götte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damha, M. J.</span><span> </span><span class="NLM_article-title">Rigid 2′,4′-difluororibonucleosides: synthesis, conformational analysis, and incorporation into nascent RNA by HCV polymerase</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">5627</span><span class="NLM_x">–</span> <span class="NLM_lpage">5635</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo500794v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=5627-5635&author=S.+Mart%C3%ADnez-Monteroauthor=G.+F.+Deleaveyauthor=A.+Kulkarniauthor=N.+Mart%C3%ADn-Pintadoauthor=P.+Lindovskaauthor=M.+Thomsonauthor=C.+Gonz%C3%A1lezauthor=M.+G%C3%B6tteauthor=M.+J.+Damha&title=Rigid+2%E2%80%B2%2C4%E2%80%B2-difluororibonucleosides%3A+synthesis%2C+conformational+analysis%2C+and+incorporation+into+nascent+RNA+by+HCV+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo500794v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo500794v%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADnez-Montero%26aufirst%3DS.%26aulast%3DDeleavey%26aufirst%3DG.%2BF.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DMart%25C3%25ADn-Pintado%26aufirst%3DN.%26aulast%3DLindovska%26aufirst%3DP.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DC.%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26aulast%3DDamha%26aufirst%3DM.%2BJ.%26atitle%3DRigid%25202%25E2%2580%25B2%252C4%25E2%2580%25B2-difluororibonucleosides%253A%2520synthesis%252C%2520conformational%2520analysis%252C%2520and%2520incorporation%2520into%2520nascent%2520RNA%2520by%2520HCV%2520polymerase%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D5627%26epage%3D5635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Murray, R. W.; Singh, M.</span><span> </span><span class="NLM_article-title">Synthesis of epoxides using dimethyldioxirane: <i>trans</i>-stilbene oxide</span>,  <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span><i>Coll. Vol.</i> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1988&pages=288&author=R.+W.+Murray&author=M.+Singh&title=Synthesis+of+epoxides+using+dimethyldioxirane%3A+trans-stilbene+oxide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DR.%2BW.%26atitle%3DSynthesis%2520of%2520epoxides%2520using%2520dimethyldioxirane%253A%2520trans-stilbene%2520oxide%26jtitle%3DOrg.%2520Synth.%26date%3D1988%26volume%3D9%26spage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Luzzio, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menes, M. E.</span><span> </span><span class="NLM_article-title">A facile route to pyrimidine-based nucleoside olefins: application to the synthesis of d4T (Stavudine)</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7267</span><span class="NLM_x">–</span> <span class="NLM_lpage">7272</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00103a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=7267-7272&author=F.+A.+Luzzioauthor=M.+E.+Menes&title=A+facile+route+to+pyrimidine-based+nucleoside+olefins%3A+application+to+the+synthesis+of+d4T+%28Stavudine%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo00103a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00103a017%26sid%3Dliteratum%253Aachs%26aulast%3DLuzzio%26aufirst%3DF.%2BA.%26aulast%3DMenes%26aufirst%3DM.%2BE.%26atitle%3DA%2520facile%2520route%2520to%2520pyrimidine-based%2520nucleoside%2520olefins%253A%2520application%2520to%2520the%2520synthesis%2520of%2520d4T%2520%2528Stavudine%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D7267%26epage%3D7272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5017279&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm5017279%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-4" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5017279" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a0217ec673cfa","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
